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Abstract 
Ca2+ is a ubiquitous intracellular signalling molecule that is involved in the 
regulation of numerous cellular functions. To date Ca2+ influx pathways present 
in white fat adipocytes have not been characterised. Additionally impaired 
[Ca2+]i management is implicated in the induction of the insulin resistant state 
in adipocytes. As adipocytes have a prominent role in the management of 
energy homeostasis, the presence of Ca2+ influx pathways was examined. 
Initial [Ca2+]i measurements confirmed the presence of functional Ca
2+ influx 
and efflux pathways in adipocytes. Further [Ca2+]i measurements identified the 
Cav1.3 Voltage-gated Ca
2+ channel (VGCC). 7KHSUHVHQFH RI WKHĮ1 subunit of 
Cav1.3 channel protein in adipocytes was confirmed by Western blotting, the 
expression of which was reduced in adipocyte samples sourced from Zucker 
obese rats.  
Initial [Ca2+]i imaging experiments utilising conditions of elevated extracellular 
K+ (50mM) did not stimulate Ca2+ influx. The plasma membrane potential (Vm) 
regulates many physiological processes, including cellular Ca2+ influx by VGCCs, 
with dysregulations in Vm underlying functional pathologies. K+ is widely 
believed to be the predominant ion that controls Vm for many cell types, 
however, whether K+ regulates adipocyte Vm is also unknown, prompting, 
investigation into the ionic species involved in the regulation of Vm in primary 
and differentiated 3T3-L1 adipocyWHV $V LQVXOLQ DQG ǃ-adrenoceptors regulate 
adipocyte function, their effect on Vm was also explored. 
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The Vm of primary and 3T3-L1 adipocytes were -34.14mV (n=68) and -28.5mV 
(n=88) respectively. Elevation of extracellular K+ from 5.6mM to 50mM had no 
significant effect on the Vm of either type of adipocyte. The role of Cl- on 
adipocyte Vm was then investigated. Reduction of extracellular Cl- from 138 to 
5mM, by equimolar substitution with Gluconate significantly depolarised the Vm 
of both primary and 3T3-L1 adipocytes. Patch clamp investigations also revealed 
a role of Na+ in adipocyte Vm. Neither insuliQ Q0RU WKH ǃ-adrenocpetor 
agonist isoprenaline (10µM) significantly changed adipocyte Vm. 
The role of Cl- in adipocyte Vm is indicative of the presence of Cl- channels, 
however electrophysiological studies failed to characterise the Cl- currents 
underlying adipocyte Vm. 
Overall, further investigations are required to characterise not only the Ca2+ 
influx pathways in adipocytes, and the roles thereof, but also the means by 
which they are regulated. 
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1.1 Overview 
This introduction aims to present an overview of Ca2+ as a signalling molecule, 
an overview of adipocytes and the biochemical functions thereof and how they 
are regulated by insulin. The implications of dysregulated [Ca2+]i on adipocyte 
function are also discussed. 
1.2 Calcium as a signalling molecule 
Cytosolic Ca2+ is a ubiquitous intracellular signalling molecule. Not only does it 
play a role in intracellular signalling in virtually all kinds of mammalian cells, but 
it also regulates numerous cellular processes (Blaustein and Lederer, 1999). 
Examples of processes where Ca2+ signalling is implicated, include fertilisation, 
cardiac muscle contraction, nervous transmission and apoptotic cell death 
(Blaustein and Lederer, 1999, Szent-Gyorgyi, 1975, Berridge et al., 2000). Ca2+ 
homeostasis is essential, in order to enable the cell to carry out basic functions 
including proliferation, differentiation and metabolism (Roderick and Cook, 2008, 
Berridge et al., 2000). Dysregulated Ca2+ signalling is implicated in the 
pathogenesis of various disease states, LQFOXGLQJ KHDUW IDLOXUH $O]KHLPHU¶V
disease, cancer and diabetes (Small, 2009, Roderick and Cook, 2008, 
Tuomilehto et al., 1999). Each cell expresses a particular complement of Ca2+ 
signalling components, a combination of various Ca2+ influx/ efflux pathways 
and intracellular storage routes. This complement of Ca2+ signalling pathways 
enables the cell to generate [Ca2+]i signals pertaining to the requirements of 
both global and microdomains. This allows any particular cell to control [Ca2+]i 
in a specific manner in accordance with the cellular function that it regulates 
(Roderick and Cook, 2008). For example, in neurons, there is spatial variation in 
[Ca2+]i signalling (Nakamura et al., 2002). At synaptic junctions Ca
2+ triggers 
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exocytosis within a millisecond time period, conversely processes like gene 
transcription and cell proliferation require Ca2+ to operate from a minutes to 
hours time-scale (Berridge et al., 2003). Resting levels of [Ca2+]i are maintained 
at ~100nM. Elevations in [Ca2+]i through cellular Ca
2+ signalling arise from 
either or both external sources of Ca2+ through plasma membrane Ca2+ channel 
opening or via release of Ca2+ from internal ER or SR stores such that [Ca2+]i 
can rise, sometimes as high as ~1µM (Roderick and Cook, 2008, Parekh and 
Putney, 2005). 
A brief summary of extracellular Ca2+ influx pathways, intracellular release 
pathways and Ca2+ clearance mechanisms are presented herein. 
1.2.1 Pathways of Ca2+ influx 
Ca2+ can act as an intracellular signalling molecule following influx from the 
extracellular compartment, or following release from the endoplasmic reticulum. 
Ion channels mediating Ca2+ influx which are present on the plasma membrane 
surface comprise voltage gated Ca2+ channels (VGCCs), store operated Ca2+ 
channels (SOCs), second messenger operated channels (SMOC), receptor 
operated Ca2+ channels (ROC) (Barritt, 1999) and, in some instances, the 
reverse mode of the sodium calcium exchanger (NCX). Through alternative 
splicing (a process by which the exons of the RNA produced by gene 
transcription are joined in different ways, resulting in translation into differing 
protein isoforms), all Ca2+ channels and exchangers have numerous isoforms, 
resulting in a complement of proteins with subtly different properties, thus 
expanding the versatile nature of Ca2+ signalling (Berridge et al., 2003). 
VGCCs are activated upon membrane depolarisation (Catterall, 2000) and are 
discussed in more detail in Chapter 3. SOCS are involved in capacitative Ca2+ 
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entry and are activated by depletion of intracellular stores (Parekh and Putney, 
2005). The proposed mechanism is that store depletion activates Ca2+ entry via 
transient receptor potential (TRP) channels which are directly activated by 
Ins(1,4,5)P3 receptors (Boulay et al., 1999). SMOC are activated by inositol 
phosphates, cyclic nucleotides and lipid derived messengers such as 
diacylglycerol (Tu et al., 2009). ROCs activate following binding of a hormone or 
neurotransmitter agonist (Parekh and Putney, 2005). An example of an ROC 
Ca2+ channel is the N-methyl-D-aspartate receptor (NMDA) which is activated by 
glutamate (Nahum-Levy et al., 2001, Berridge et al., 2003). The NCX is a 
bidirectional exchanger, it is further discussed in Chapter 3. 
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Figure 1.1. A generalised overview of cellular Ca2+influx pathways, adapted from Rang et al 
(2003). Voltage-gated Ca2+ channels, VGCCs; Store operated Ca2+ channels, SOCs; Na+/Ca2+ 
exchanger, NCX; Adenosine triphosphate, ATP; Endoplasmic reticulum, ER; inositol triphosphate, IP3; 
Ryanodine receptor, RyRs.  
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1.2.2 Intracellular Ca2+ 
In addition to influx from the extracellular mileu, elevations in [Ca2+]i can also 
arise through release of Ca2+ from the internal stores. Intracellular Ca2+ 
channels are located on the membranes of the endoplasmic and sarcoplasmic 
reticulum (ER/SR). The release of Ca2+ from internal stores is regulated by 
inositol-1,4,5 triphosphate (Ins(1,4,5)P3) receptors or ryanodine receptors 
(RYRs) (Berridge et al., 2000). Both Ins(1,4,5)P3 receptors and RYRs are 
sensitive to Ca2+ and, as such, cause calcium-induced calcium release (CICR). 
Ins(1,4,5)P3 receptors are regulated by numerous substrates, however the most 
prominent substrates for the Ins(1,4,5)P3 receptors are Ins(1,4,5)P3 and Ca
2+.. 
Ins(1,4,5)P3 upon binding to its receptor increases the receptors sensitivity to 
Ca2+. Ca2+ has a biphasic action upon the Ins(1,4,5)P3 receptor. [Ca
2+]i 
stimulates the receptor at low concentrations (100-300nM), however following 
Ca2+ release into the cytosol, elevated [Ca2+]i concentrations (>300nM) have an 
inhibitory action upon the Ins(1,4,5)P3 receptor and inactivate the channel 
(Berridge et al., 2003). The RYR receptor, like the Ins(1,4,5)P3 receptor, has a 
varied response to Ca2+. At nM Ca2+ concentrations the RYR receptor is inactive, 
RYR receptors activate at µM Ca2+ FRQFHQWUDWLRQVDQGDUHLQDFWLYDWHGE\³KLJK´
Ca2+ concentrations within the mM range (Berridge et al., 2003, Bezprozvanny 
et al., 1991). 
Cytosolic Ca2+ binds to its effectors, initiating a cellular response. This accounts 
for a small proportion of cytosolic Ca2+, the remaining Ca2+ is either bound to 
Ca2+ binding proteins designated DV³&D2+ EXIIHUV´, re-sequestered or extruded. 
Buffers such as calbindin, D-28 and calrectin modulate short-lived intracellular 
Ca2+ signals by altering the amplitude and recovery time of Ca2+ transients 
(Schwaller, Berridge et al., 2003). The mitochondria can also propagate 
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intracellular Ca2+ signals by releasing Ca2+, replenishing intracellular stores 
(Demaurex et al., 2009). 
1.2.3  Cytosolic Ca2+ clearance mechanisms 
Following a Ca2+ signal event, there is a requirement for the [Ca2+]i to be 
restored to its resting level. Ca2+ clearance mechanisms that function to return 
[Ca2+]i to its basal state and/ or replenish the intracellular Ca
2+ stores comprise 
of the sodium calcium exchanger, (discussed in more detail in Chapter 3), and 
the plasma membrane Ca2+ ATPase. The plasma membrane Ca2+ ATPase 
functions as a cytosolic Ca2+ extrusion mechanism, whereas the SR/ER Ca2+ 
ATPase transports cytosolic Ca2+ into the ER/SR stores (Berridge et al., 2000). 
The mitochondria also sequester Ca2+, by way of proton extrusion, creating an 
electrochemical gradient that is used to drive Ca2+ uptake via the H+/Ca2+ 
uniporter (Demaurex et al., 2009). Reciprocal interactions are reported between 
the ER/SR and the mitochondria. The ER/SR is a source of Ca2+ for the 
mitochondria, which in turn modifies the Ca2+ feedback mechanisms that 
regulate Ca2+ release from the SR (Berridge et al., 2000). Additionally, the 
pumps and transporters mentioned above are active in different circumstances. 
The plasma membrane and SE/ER pumps have a high affinity for Ca2+ but a low 
rate of transport, whereas the NCX and mitochondrial uniporter transport Ca2+ 
quickly and are responsive to Ca2+ within the nM to µM range, although for fast 
mitochondrial Ca2+ uptake to be observed, [Ca2+]i must be higher than 400nM 
(Collins et al., 2001). 
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1.3 An overview of adipose tissue 
Two types of adipose tissue exist, brown, and white. This thesis is concerned 
with white adipose tissue. White adipose tissue comprises a variety of cell types 
including monocytes, stromal vascular cells, endothelial cells, with the major 
cellular constituent being white fat adipocytes (Kershaw and Flier, 2004). 
Adipose tissue deposits are classified as either subcutaneous or visceral 
(Giorgino et al., 2005). The physical functions of adipose tissue are summarised 
as providing thermal insulation and cushioning as protection against mechanical 
damage for the internal organs. The biochemical function of adipocytes is the 
management of the triglyceride energy stores. Adipocytes store energy in the 
form of triglycerides (TG) within lipid droplets during times of calorific excess 
(lipogenesis). During fasting or physical exercise free fatty acids (FFAs) are 
released from the adipocyte triglyceride stores into the circulation by lipolysis, 
the ester bonds in triglycerides are hydrolysed, releasing fatty acids and glycerol 
(Fruhbeck et al., 2001). The FFA are oxidised by other tissues such as skeletal 
muscle, liver, kidney and myocardium, to provide energy (Giorgino et al., 2005, 
Arner, 2003, Carmen and Victor, 2006). Lipolysis is discussed in more detail in 
Chapter 3, Section 3.1. 
Adipose tissue is a target tissue for the action of insulin, along with skeletal 
muscle, cardiac muscle (e.g. insulin-stimulated glucose uptake) (Purcell et al.) 
and liver (Cherrington et al., 2007). The actions of insulin upon adipocytes 
include stimulation of adipocyte lipogenesis (fatty acid synthesis), glucose 
uptake, inhibition of lipolysis. Insulin also regulates the synthesis and secretion 
of adipocyte secreted cytokines (see section 1.6), and stimulates the 
differentiation of pre-adipocytes into mature adipocytes (Arner, 2003). 
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1.3.1 Fat storage/utilisation by adipocytes 
Adipocytes vary in diameter between 20-200µM, depending on their lipid 
content,  with 95% of adipocyte volume comprising the lipid droplet (Arner, 
2005a). Fat accumulation within adipocytes depends on the balance between 
lipogenesis and lipolysis (Kersten, 2001). Excess fat accumulation results in 
obesity, which is associated with insulin resistance (IR) and type 2 diabetes 
(Kahn et al., 2006), indeed the majority of patients with type 2 diabetes are 
obese (Aulchenko et al., 2007). 
Obesity results from a prolonged imbalance between the storage and utilisation 
of TGs within adipose tissue. Adipose tissue expansion in obesity can arise due 
to either an expansion of adipocyte size, or an increased differentiation of pre-
adipocytes into adipocytes. Impairments of TG mobilisation in obesity could 
result from genetic variations, abnormal regulation of adrenoceptors or hormone 
sensitive lipase (HSL), resulting in a reduced lipolytic activity within adipocytes, 
or reductions in the oxidation of long chain fatty acids (Diraison et al., 2003). 
Total fat mass has been used as a determinant of obesity-related insulin 
resistance; however fat distribution is also an important factor which has been 
shown to influence IR (Aulchenko et al., 2007). It has been suggested that the 
location and type of adipose deposit (subcutaneous or visceral) influences the 
adipocytes response to regulatory factors involved in lipogenesis (Roberts et al., 
2009). Abdominal, particularly visceral, obesity is linked to insulin resistance, 
type 2 diabetes, hypertension and dyslipidaemia (Arner, 2003, Giorgino et al., 
2005). In humans, it has been shown that visceral adipocyte size was inversely 
related to insulin responsiveness (Lundgren et al., 2004), whereas, studies in 
insulin resistant rats demonstrated a significant improvement in glucose uptake 
following surgical removal of visceral fat (Gabriely et al., 2002). The rate of 
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lipolysis in visceral compartments is higher, as the visceral fat depot is less 
responsive to the antilipolytic effects of insulin. Rapid visceral fat metabolism 
results in high delivery of FFAs to the liver as the visceral fat depot connects to 
the portal vein. Increased FFA delivery to the liver stimulates gluconeogenesis 
and increased triglyceride synthesis (Arner, 2003). Additionally the increased 
levels of circulating FFA in the plasma causes ectopic accumulation of TG in 
skeletal muscle and liver. Eptopic deposition of triglycerides in skeletal muscle 
and liver are associated with the development of insulin resistance (Giorgino et 
al., 2005, Bays et al., 2004). Elevated plasma FFA caused by resistance to the 
anti-lipolytic properties of insulin in adipocytes can lead to elevated hepatic 
glucose production, diminished insuOLQVHFUHWLRQIURPSDQFUHDWLFǃ-cells (Bays et 
al., 2004) and a reduction in glucose uptake in skeletal muscle and liver (as 
discussed in section 1.5.2). Additionally in insulin resistant conditions, 
adipocytes secrete elevated amounts of insulin resistance inducing cytokines 
such as TNF-Į DQG ,/-6. A reduction in secretion of the insulin-sensitizing 
cytokine adiponectin has also been reported (Bays et al., 2004). Adipose-
derived cytokines are discussed in more detail in Section 1.6. 
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1.3.2 De novo lipogenesis 
FFAs in adipocyte lipogenesis can be derived from de novo lipogenesis, i.e. the 
synthesis of fatty acids from glucose or non-lipid precursors. This lipogenic 
pathway occurs in both the liver and the adipose tissue (Frayn, 2003). Fatty 
acid synthase (FAS) regulates de novo lipogenesis from acetyl-CoA, malonyl-
CoA and nicotinamide adenine dinucleotide phosphate oxidase (NADPH). FAS is 
highly expressed within the adipose tissue and liver (Ranganathan et al., 2006). 
It has, however, been suggested that de novo lipogenesis is not the prominent 
lipogenic pathway in humans (Diraison et al., 2003, Guo et al., 2000). 
Conversely, expression of acetyl-CoA, carboxylase A and FAS, which are 
involved in de novo lipogenesis, have all been reported in human adipose tissue 
(Frayn, 2001). Also the sterol regulatory element binding protein (SREBP) 
isoform SREBP-1c is a transcription factor which is highly expressed in adipose 
tissue that functions to regulate the expression of genes involved in de novo 
lipogenesis. Pathways of lipogenesis are summarised in Figure 1.2. 
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Figure 1.2. Pathways of lipogenesis in the white fat adipocyte adapted from Kersten (2000), 
Roberts (2009) and Vazquez-vela (2008). In lipoprotein lipase (LPL) lipogenesis, Insulin activates 
LPL on the surface of the vascular endothelium. Activated LPL hydrolyse TGs and release FA from 
the chylomicrons and VLDL, after which FA¶V are taken into the adipocytes via FA transporters FABP, 
FAT and FATP. FA are re-esterified with glycerol-3-phosphate to give rise to triglycerides. In de novo 
OLSRJHQHVLV)$¶s are synthesised from non-lipid precursors. Insulin binds the insulin-receptor on the 
adipocyte surface and promotes the translocation of GLUT4 to the cell membrane, facilitating cellular 
glucose uptake. High insulin levels activate pyruvate dehydrogenase, which forms acetyl-CoA. 
Acetyl-CoA carboxylase froms malonyl-CoA from acetyl CoA. LPL, lipoprotein lipase; FAT fatty acid 
transferase; FATP, fatty acid transport protein; FABP, fatty acid binding protein; TG, triglyceride; IR, 
Insulin receptor; FAS, fatty acid synthase; CM, chylomicron.  
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1.3.3 Uptake of fatty acids from the plasma 
Dietary FFA account for 30-40% of energy intake, comprising mostly of long 
chain fatty acids esterified in TGs; These TGs are too large to transition from the 
capillaries into the interstitial fluid, and as such they cannot be directly taken up 
by the adipocytes (Frayn, 2003). Fatty acids used for TG synthesis in adipocytes 
are derived from the plasma in the form of TG-rich lipoproteins (chylomicrons) 
and from very low density lipoproteins (VLDL) produced from fatty acids 
synthesised and secreted from the liver (Glatz et al., 2010). Fatty acids are 
released from the chylomicrons carrying exogenous lipids and VLDL lipoproteins 
via the lipoprotein lipase (LPL)-mediated hydrolysis of their TGs at the capillary 
endothelium (Glatz et al., 2010). This process generates non-esterified fatty 
acids for uptake by peripheral tissues (Ranganathan et al., 2006), see Figure 
1.2. 
In the fed state, LPL expression within adipose tissue is elevated. Fatty acid 
transporters facilitate and regulate FFA transport through the adipocyte plasma 
membrane. The fatty acid transporters are fatty acid translocase (Hao et al., 
2010) (or CD36 in humans) and the fatty acid transport protein (FATP), both of 
which are integral membrane proteins. FAT/CD36 is highly expressed in adipose 
tissue (Coburn et al., 2001), and has been shown to be an important mediator 
of fatty acid uptake. FAT/CD36-null mice exhibited a 50%-80% reduction in 
CD36 uptake within their adipose tissue (Coburn et al., 2001). FATP1 and FATP4 
isoforms of the fatty acid transport protein are highly expressed in adipocytes, 
and following differentiation of 3T3-L1 fibroblasts to adipocytes (Czech, 2002). 
The fatty acid binding protein (FABP) is a fatty acid transporter (Large et al., 
2004). FABPs expressed in adipose tissue are the adipocyte-lipid-binding-protein 
(ALBP) and the keratinocyte-lipid-binding-protein (KLBP) (Fisher et al., 2002). 
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The relative contribution of each of these transporters to fatty acid uptake is still 
under investigation, however it has been suggested that the relative 
contribution of each fatty acid transporter to fatty acid uptake may vary 
depending upon physiological conditions (Czech, 2002). Insulin has been 
suggested to be involved in the expression of ALBP/KLBP between subcutaneous 
and visceral fat depots. The protein ratio of each transporter type was related to 
fasting insulin concentrations in lean subjects but not in obese individuals, of 
which the latter group were insulin resistant (Fisher et al., 2001). The 
differences observed between lean and obese subjects are suggestive of adipose 
tissue ALBP/KLBP involvement in the pathogenesis of insulin resistance (Fisher 
et al., 2001). 
Following FFA entry into the adipocyte, re-esterification is necessary for the 
storage of TG. Insulin is an important hormonal factor influencing lipogenesis 
(Kersten, 2001). Insulin causes the translocation of fatty acid transporters from 
the intracellular stores to the plasma membrane in order to facilitate fatty acid 
uptake (Glatz et al., 2010); see Figure 1.2. In mature adipocytes and adipose 
tissue, insulin increases LPL mRNA levels, and also regulates the activity of LPL 
post-transcriptionally and post-translationally (Wang and Eckel, 2009). Insulin 
augments the expression of the genes encoding the enzymes involved in fatty 
acid biosynthesis, including fatty acid synthase and acetyl CoA (Diraison et al., 
2003) and, lipogenesis is also subject to regulation by transcription factors, 
namely the sterol regulatory element binding proteins (SREBPs) and the 
Peroxisome proliferator activated receptor-gamma (PPARJ). 
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1.4 Transcription factors involved in lipogenesis 
1.4.1 SREBP 
The sterol regulatory element binding proteins (SREBPs) are transcription 
factors involved in lipogenesis. SREBPs are a group of basic helix loop helix 
(bHLH) leucine zipper transcription factors (Yokoyama et al., 1993), consisting 
of the two isoforms of SREBP-1; SREBP-1a and SREBP-1c, (Kersten, 2001) and 
SREBP-2. SREBP-1c is the predominant isoform expressed in liver and adipose 
tissue (Yahagi et al., 2002). The stimulatory effect of insulin on fatty acid 
synthesis is mediated by an increase in SREBP-1c. Examples of genes involved 
adipocyte lipogenesis which are regulated by SREBPs are the low density 
lipoprotein receptor gene (Yokoyama et al., 1993), fatty acid synthase (Brown 
and Goldstein, 1997) and lipoprotein lipase genes (Kim and Spiegelman, 1996).  
1.4.2 PPARJ 
7KH33$5 IDPLO\RI WUDQVFULSWLRQ IDFWRUVFRPSULVHPHPEHUV33$5Į33$5ǃį
and PPARJWahli and Michalik. PPARJ is an important transcription factor in 
adipose tissue, commonly known to induce differentiation of pre adipocytes into 
mature fat cells (Kersten, 2001). PPARJ is activated by fatty acids and drugs of 
the thiazolidine class. To date it is known that PPARJ regulates genes encoding 
the fatty acid binding protein, lipoprotein lipase (Wang and Eckel, 2009), fatty 
acid transport protein (FATP), acyl-CoA synthetase, phosphor-enol pyruvate 
carboxykinase, the phosphor-enol pryuvate carboxykinase and the fasting 
induced adipose factor FIAF/ PPARJ angiopoietin related fasting induced adipose 
PGAR (Kersten, 2001). Both insulin and SREBP-1 stimulate PPARJ expression, 
this in conjunction with the observation that the majority of the known genes 
encoded by PPARJ are involved in the lipogenic pathway, implicating PPARJ¶V
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involvement in lipogenesis. The involvement of PPARJ in lipogenesis is supported 
by data from clinical studies, whereby subjects taking thiazolidinedione, PPARJ-
activating drugs, gain weight (Fuchtenbusch et al., 2000).  
It is reported that adipocytes from obese subjects are enlarged and have 
elevated basal levels of lipolysis (Large et al., 1999) and elevated levels of 
[Ca2+]i. It is possible that there are associations between obesity, elevated 
adipocyte [Ca2+]i, elevated lipolysis and peripheral insulin resistance. It seems 
reasonable to suggest that elevated levels of FFAs in the circulation would result 
in increased activation of the PPARs and SREBP transcription factors, therefore 
increasing transcription of the genes involved in lipogenesis, further 
exacerbating fat storage within the adipocyte and contributing to the 
development of insulin resistance. Indeed fatty acids are ligands for PPARs; 
additionally elevated circulating FFA cause numerous disruptions to the 
regulation of energy metabolism, examples of FFA disruptions to energy 
metabolism are presented in section 1.5.2. Contrary to this suggestion, 
correlations between adipocyte size and lipogenic gene expression (PPARJ-1 
PPARJ-2 and the fatty acid synthase gene (FASN)) are inverse, suggestive of a 
physiological mechanism which downregulates de novo lipogenesis as 
adipocytes expand to prevent uncontrolled expansion to a possibly detrimental 
phenotype (Roberts et al., 2009). 
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1.5 Adipocyte function 
1.5.1 The role of [Ca2+]i in dysregulated insulin-stimulated lipogenesis 
Food intake is not reported to be elevated in agouti mice, suggestive of altered 
energy homeostasis being accountable for their increased fat mass (Carroll et al., 
2004). Studies in obese visible yellow mice (Avy/a) have demonstrated that 
(Avy/a) mice exhibit both elevated [Ca2+]i, and elevated FAS activity (an enzyme 
involved in de novo lipogenesis) of ~7.2 fold in conjunction with their obesity 
when compared with lean controls (Kim et al., 1996). Elevations in [Ca2+]i are 
correlated with body weight, suggesting a link between [Ca2+]i and the 
mechanism of obesity in agouti mice (Zemel et al., 1995). Nifedipine is a 
dihydropryidine (DHP) Ca2+ channel blocker, reported to block L-type VGCCs 
(Lipscombe et al., 2004). (Avy/a) mice fed on a nifedipine diet exhibited reduced 
epididymal, perirenal and retroperitonal fat pad weights when compared to 
(Avy/a) mice fed on a nifedipine free diet. Nifedipine had no effect upon fat pad 
weights of control animals. Additionally, Ca2+ channel antagonism by nifedipine 
ameliorated the ~ 7 fold increase in FAS activity in subcutaneous adipose tissue, 
but only marginally in visceral adipose tissue of (Avy/a) (Kim et al., 1996). This 
is suggestive of Ca2+ action upon FAS, exacerbating de novo lipogenesis, 
contributing to the induction of the insulin resistant state and that there are 
variations in Ca2+ regulation of lipogenesis pathways between different murine 
fat depots. 
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1.5.2 Elevated plasma FFA concentrations in whole body insulin 
resistance 
Elevated plasma FFA are associated with the hepatic and peripheral insulin 
resistance. The Randle cycle is a model of elevated circulating FFAs in the onset 
of peripheral insulin resistance. Randle et al (1963) proposed a mechanism to 
explain how elevated plasma fatty acids inhibit glucose uptake. Randle et al 
(1963) demonstrated in both muscle and adipose tissue that FFA competes with 
glucose as an energy substrate. In response to elevated FFA concentrations, an 
increase in fatty acid oxidation occurs. In brief, increased levels of fatty acid 
oxidation results in an increase in cellular acetyl CoA, resulting in the inhibition 
of pyruvate dehydrogenase. The end-point is an elevation in intracellular 
glucose and glucose-6-phosphate concentrations, resulting in a reduction in 
glucose uptake (Randle et al., 1963). Boden et al (2002) investigated the 
mechanisms underlying FFA inhibition of insulin-stimulated glucose uptake in 
healthy subjects, (Boden et al., 1994) and in patients with type 2 diabetes 
(Boden and Chen, 1995). With normal subjects, fat infusions inhibited glucose 
uptake in a dose-dependent manner. Four to six hours post 750µM fat infusion 
resulted in elevated glucose-6-phosphate concentration. Intermediate 550µM fat 
infusion resulted in decreased muscle glucose-6-phosphate concentrations, as 
attributed to reduced glucose transport (Boden et al., 1994). Fat infusion 
reduced insulin-stimulated glucose uptake in the type 2 diabetic subjects by 40-
50%, this was accompanied by inhibition of glycogen synthesis and glycolysis 
(Boden and Shulman, 2002). Later studies by Roden et al (1996) also 
postulated an inhibitory effect of FFA on insulin-stimulated glucose transport in 
muscle by way of inhibited glucose transport/phosphorylation (Roden et al., 
1996).  
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There are several suggestions as to how FFA inhibit insulin-stimulated glucose 
transport, including direct effects upon GLUT-4 transporter activity, or FFA-
induced changes in the synthesis and trafficking of GLUT-4. Additionally Dresner 
et al (1999) examined the effect of elevated FFA concentrations on 
phosphatidylinositol 3-kinase (PI3K) activity (a regulator of GLUT-4 
translocation in muscle). In comparison to control subjects, FFA infusion 
abolished IRS-1 associated PI3K activity in response to insulin stimulation. It is 
possible that the effect of FFA could occur at the level of PI3K, or via alteration 
of another step in the insulin signalling pathway (Dresner et al., 1999).  
Elevated levels of circulating fatty acids give rise to reduced insulin stimulated 
glucose uptake in peripheral insulin responsive tissues, thus contributing to the 
development of insulin resistance. As [Ca2+]i is important to the biochemical 
functionality of adipocytes, the consequences of dysregulated [Ca2+]i in 
adipocytes could not only disrupt the biochemical functions of adipocytes, but 
also affect peripheral insulin responsive tissues and potentially be a crucial 
factor in the development of insulin resistance. Insulin resistance results in 
elevated levels of circulating insulin, which has also been reported to elevate 
adipocyte [Ca2+]i (Draznin et al., 1988). The role of [Ca
2+]i in adipocyte lipolysis 
is discussed herin. 
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1.5.3 The role of adipocyte [Ca2+]i in lipolysis 
The role of [Ca2+]i in adipocyte lipolysis is yet to be fully clarified. There is 
evidence in support of [Ca2+]i as both a positive (Allen and Beck, 1986, Katocs 
et al., 1974) and a negative regulator of lipolysis (Xue et al., 2001, Xue et al., 
1998). 
Stimulation of lipolysis by catecholamines is reported to be only partially 
dependent on [Ca2+]i
 (Allen and Beck, 1986, Schimmel, 1973). Stimulation of 
cAMP accumulation, by isoprenaline or forskolin was not affected by the 
presence or absence of [Ca2+]i, although the rates of lipolysis were reduced by 
~40% in the absence of extracellular Ca2+, indicative of a requirement for Ca2+ 
at a step in the lipolytic cascade distal to cAMP (Allen and Beck, 1986). 
Additionally Izawa and Komabayashi (1994) provided evidence for the 
requirement of Ca2+-calmodulin for the full activation of lipolysis, as lipolytic 
responses to noradrenaline and dibutyryl cAMP were blunted in the presence of 
calmodulin inhibitor W7 (Izawa and Komabayashi, 1994). Both Izawa and 
Komabayashi (1994) and Kawai (1985) suggest Ca2+ calmodulin activates cAMP 
dependent protein kinase (PKA) in primary adipocytes, and in fat cell extracts. 
In the lipolytic cascade PKA phosphorylates HSL, activating lipolysis (Kawai, 
1985). It has also been suggested that Ca2+ action on lipolysis in adipocytes is 
mediated by Ca2+-calmodulin, by stimulating the ERK/MAPK cascade, which then 
activates HSL (Della Rocca et al., 1997).  
To the contrary, work by Xue et al (2001) provided evidence of [Ca2+]i having 
an inhibitory effect upon lipolysis in human adipocytes. An increase in [Ca2+]i 
was attained by elevating [K+]o to 100mM. This treatment was found to inhibit 
agonist-stimulated lipolysis. Conversely, elevated conditions of [K+]o at 40mM to 
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60mM were shown not to affect basal or isoprenaline-stimulated lipolysis in 
either rabbit or mouse white fat adipocytes (Garcia-Barrado et al., 2001). This 
could be indicative of a species difference in the lipolytic responses to [Ca2+]i. In 
the study by Xue et al (2001), it was suggested that the ability of [Ca2+]i to 
inhibit lipolysis occurs via activation of phosphodiesterase 3B (PDE3B), the same 
PDE isoforms that mediates the antilipolytic effects of insulin. However, insulin 
and [Ca2+]i were suggested to activate PDE3B by different mechanisms but they 
both ultimately result in a reduction in cAMP, reducing HSL phosphorylation with 
subsequent inhibition of lipolysis (Xue et al., 2001). 
The recombinant murine agouti protein has also been demonstrated to cause 
elevations in [Ca2+]i in 3T3-L1 adipocytes (Kim et al., 1997). The recombinant 
agouti protein inhibited basal lipolysis by 60% in comparison to controls, and 
agonist (ACTH and forskolin) induced lipolysis (Xue et al., 1998). Additionally 
arginine vasopressin, (which is known to activate Ca2+ influx by way of 
phosphoinositide hydrolysis (Kondo et al., 1989)) and KCl-induced inhibition of 
forskolin stimulated lipolysis in recombinant agouti adipocyte samples by 56% 
and 50%, respectively. The anti-lipolytic effects of the agouti protein were 
revoked by treatment with nitrendipine (30 µM) (a Ca2+ channel blocker) 
indicative of extracellular Ca2+ influx in the involvement of the anti-lipolytic 
effects of agouti.  
Taken together, the role of Ca2+ on lipolysis and the mechanisms by which Ca2+ 
acts to mediate its effects, be they stimulatory or inhibitory, is not fully 
understood. It is apparent that there is a requirement for [Ca2+]i in lipolysis 
signalling pathway, however the consequences of abnormal [Ca2+]i and the 
influx pathway by which this is derived needs further investigation. 
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1.5.4 Insulin-stimulated glucose uptake 
Insulin is VHFUHWHGIURPǃ-cells in the islets of Langerhans of the pancreas, and 
is released into the circulation in response to elevated levels of plasma glucose. 
The liver, skeletal muscle and adipose tissue are the primary targets for the 
actions of insulin (Klip and Ramlal, 1987). The insulin receptor is a 
transmembrane glycoprotein with intrinsic tyrosine kinase activity (Gammeltoft 
and Van Obberghen, 1986). The insulin receptor (IR) is an Į2ǃ2-tetramer (Ding 
et al., 2002) 7KH Į-subunit pair comprise the insulin binding site, and is 
situated exterioUWRWKHSODVPDPHPEUDQH7KHǃ-subunits are transmembrane 
proteins which contain the tyrosine kinase domains. Upon insulin binding to the 
Į-subunits the tyrosine kinase activity of IR is stimulated. As such, the insulin 
receptor autophosphorylates tyrosinHUHVLGXHVZLWKLQWKHǃ-subunit. (Ding et al., 
2002). Initially, insulin receptor substrate (IRS) proteins are phosphorylated on 
tyrosine residues by the insulin receptor (Whitehead, Molero et al. 2001). The 
proteins which comprise the IRS family are as follows; IRS-1 and IRS-2 which 
are ubiquitously expressed IRS-3; which has been demonstrated in adipose 
tissue; IRS-4, which is so far only reported in cultured embryonic kidney cells; 
and Gab1, which is widely expressed also (Taha and Klip, 1999). The IRS 
proteins are not functionally interchangeable; mice deficient in IRS-1 show 50-
60% reduction in insulin-stimulated glucose uptake, even though there are 
other IRS substrate protein substrates for the insulin receptor (Bruning et al., 
1997).  
Following phosphorylation of IRS-1, IRS-1 is available to bind src-homology-2 
domain containing proteins such as phosphatidylinositol 3-kinase (PI3K) (Hering 
et al., 2008) and growth factor bound protein (GrB2) (Taha and Klip, 1999). 
PI3K interacts with IRS1/2 via its regulatory subunit P85, this interaction results 
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in PI3K activation and instigation of the phosphorylation cascade involving 
downstream effectors, such as protein kinase C (PKC) and protein kinase B 
(PKB), resulting in insulin-stimulated glucose uptake, glycogen synthesis, 
lipogenesis and inhibition of lipolysis. Also, interaction of IRS1/2 with Grb-2 
activates the mitogen-activated (MAP) protein kinase insulin signalling cascade. 
The MAP kinase insulin signalling cascade is reported not to be involved in the 
metabolic responses of insulin (Taha and Klip, 1999). 
The consequence of the IRS signalling cascade is the promotion of GLUT-4 
translocation from the intracellular stores to the plasma membrane (Giorgino et 
al., 2005, Taha and Klip, 1999). GLUT-4 transporters are sequestered within 
storage vesicles in the Golgi apparatus. The transporters are transported across 
the cytosol following receipt of the downstream signals produced by the insulin 
receptor (Whitehead et al., 2001). The effect of insulin on vesicle mobilisation is 
reversible; reductions in the level of circulating insulin results in removal of the 
plasma GLUT-4 receptors by endocytosis. A summary of the insulin signalling 
cascade is shown in Figure 1.3. 
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Figure 1.3. Insulin stimulated glucose uptake. ,QVXOLQELQGV WR WKH LQVXOLQUHFHSWRUĮVXEXQLW
stimulating the tyrosine kinase activity of the insulin receptor. The insulin receptor 
DXWRSKRVSKRU\ODWHVW\URVLQHUHVLGXHVZLWKLQLWVǃ-subunit. Insulin receptor substrate proteins (IRS) 
are phosphorylated. IRS-1 binds to PI3K via its regulatory subunit P85, activating PI3K. The 
activated PI3K initiates a complex phosphorylation cascade involving protein kinase C (PKC) and 
protein kinase B (PKB) resulting in GLUT-4 translocation from intracellular GLUT-4 storage vesicles 
to the adipocyte plasma membrane.  
Ca2+-GHSHQGHQW³FRQYHQWLRQDO´3.&VKDYHEHHQLPSOLFDWHGLQLQVXOLQ-stimulated 
glucose transport in 3T3-L1 adipocytes (Tsuru et al., 2002). Ca2+ channel 
opening either by receptor-mediated or voltage-dependent mechanisms is 
suggested to prolong PKC activation (Nishizuka, 1995), resulting in elevated 
GLUT-4 translocation to the adipocyte plasma membrane giving rise to elevated 
glucose uptake (Kohn et al., 1996). This may therefore contribute to the 
development of obesity by way of increased fat storage within the adipocyte.  
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1.5.5 The role of Ca2+ in adipocyte insulin resistance 
It has been suggested that dysregulated Ca2+ homeostasis contributes to 
reduced adipocyte responsiveness to insulin. Both experimental and clinical 
evidence pertaining to dysregulated Ca2+ influx by way of Cav1.2 / Cav1.3 VGCCs 
contributing to diminished insulin responsiveness, as defined by reduced insulin 
stimulated glucose uptake is reviewed in Chapter 3, Sections 3.7.2 and 3.7.3. 
Other aspects of [Ca2+]i involvement in insulin resistance is discussed herin. 
1.5.6 The role of Ca2+ in dysregulated insulin-stimulated glucose 
uptake 
Relationships between elevated [Ca2+]i and dysregulated insulin-stimulated 
glucose transport in adipocytes have been reported (Reusch et al., 1991, 
McCarty, 2006, Draznin et al., 1989, Begum et al., 1993). Furthermore, it has 
been suggested that an optimal range of [Ca2+]i for insulin-stimulated glucose 
transport in isolated rat adipocytes (Draznin et al., 1987b) of 140-370nM [Ca2+]i 
is required for normal adipocyte function, with extremes either side of this range 
resulting in a diminished response to insulin. 
Conversely some studies investigating the link between [Ca2+]i and insulin-
stimulated glucose uptake in primary adipocytes (Kelly et al., 1989) and in 3T3-
L1 adipocytes (Klip and Ramlal, 1987) do not describe an association between 
elevated Ca2+ and a reduction in insulin-stimulated glucose uptake. However in 
the studies that do report an association between [Ca2+]i and cellular 
responsiveness to insulin, elevations in [Ca2+]i have been suggested to cause 
resistance to insulin by way of reduced glucose uptake, using the 2-
deoxyglucose uptake assay (Reusch et al., 1993, Reusch et al., 1991, Begum et 
al., 1993). The reduction in insulin-stimulated glucose transport by elevated 
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[Ca2+]i was shown not to affect insulin binding to the insulin receptor, or the 
tyrosine kinase activity of the insulin receptor, thus implicating the involvement 
of elevated [Ca2+]i at a step in the insulin signalling cascade distal to the insulin 
receptor (Begum et al., 1992). 
Conditions of elevated extracellular K+ have been used to elevate [Ca2+]i in 
numerous cell types, including adipocytes (Pershadsingh et al., 1989, Haspel et 
al., 2005, Yaguchi and Nishizaki, 2010, Reusch et al., 1991). 
Reusch et al (1991) demonstrated that the consequences of elevated [Ca2+]i in 
adipocytes manifest as an increase in GLUT-4 phosphorylation and a reduction 
in insulin-stimulated glucose transport. The phosphorylation status of GLUT-4 
was shown by way of Western-blotting, not to affect the translocation of the 
GLUT-4 transporter to the adipocyte plasma membrane. Investigations into the 
mechanism underlying the elevated [Ca2+]i disruption to GLUT-4 
phosphporylation showed that elevated [Ca2+]i inhibited PP1 activity. Inhibition 
of PP1 was suggested to occur by a cAMP dependent mechanism. Adipocytes 
with elevated [Ca2+]i demonstrated a 2x elevation in [cAMP]i in comparison to 
controls. Later studies by Begum et al (1992) show elevated [Ca2+]i induces 
cAMP mediated phosphorylation and activation of inhibitor 1, resulting in an 
inhibition of PP1 activity and subsequent inactivation of GLUT-4. In support of 
cAMP in the diminished activity of GLUT-4 RPcAMP (a cAMP antagonist) 
prevented inhibitor-1 activation (Begum et al., 1992). In further support of the 
role of elevated [Ca2+]i in the phosphorylation of GLUT-4, treatment of 
adipocytes with nitrendipine (a Ca2+ channel blocker) restored GLUT-4 
phosphorylation (Reusch et al., 1993). 
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The observation that adipocytes from obese individuals exhibit elevated [Ca2+]i 
in comparison to gender and age matched lean controls (Byyny et al., 1992), is 
suggestive of Ca2+ involvement in insulin resistance in obese individuals, in part 
by reduced insulin-stimulated glucose uptake, possibly by way of inhibitor-1 
activation. 
As previously mentioned deficiencies in [Ca2+]i are also reported to have 
adverse effects on insulin signalling. In 3T3-L1 adipocytes chelation [Ca2+]i by 
calmodulin agonist W13 and 1,2-bis(2-aminophenoxy)ethane-N,N,N,N-
tetraacetic acid acetoxymethylester (BAPTA AM) inhibited insulin-stimulated 2-
deoxyglucose uptake by up to ~95%, which was later shown to occur as a result 
of diminished GLUT-4 translocation to the plasma membrane. BAPTA AM 
inhibited insulin-stimulated translocation of the GLUT-4 transporter to the 
plasma membrane by ~50% suggestive of a requirement of Ca2+ in the 
translocation of GLUT-4 from the intracellular vesicles to the plasma membrane 
(Whitehead et al., 2001). Treatment of BAPTA AM or W13 treated cells with 
ionophores A23187 or ionomycin prevented the inhibition of AKT (protein kinase 
B) phosphorylation and subsequent translocation of GLUT-4 by Ca2+ chelation, 
suggestive of a requirement for Ca2+ in the activation of protein kinase B 
(Whitehead et al., 2001). 
1.6 Adipokines in insulin sensitivity 
Until recently adipocytes were considered a somewhat inert energy store, 
however, it is now recognised as a major endocrine organ, secreting an 
expanding plethora of hormones, adipokines and other proteins with the 
capacity to impact upon energy metabolism (Antuna-Puente et al., 2008) 
Adiponectin and resistin are factors which are known to be produced only within 
Chapter 1 
28 
 
adipose tissue (Roth et al., 2004), see Figure 1.4. Other adipocyte secreted 
hormones are also shown in Figure 1.4. 
Among the expanding number of proteins that are secreted by adipocytes, only 
those that have a key role in energy metabolism and insulin resistance, will be 
discussed briefly herein, namely TNF-Į IL-6, resistin, and adiponectin. A brief 
summary of the sources, functions and interactions of these adipokines is shown 
in Table 1.1. 
Oestrogen
Resistin
TNF-Į
Leptin
IL-6, 8
Adiponectin
IGF-1
Angiotensinogen
FFA
Lipoprotein lipase
Triglycerides
FAA
ADIPOCYTE
Triglycerides
Visfastin
PAI-1
RANTES
VEGF
NGF
IL-1
 
Figure 1.4. A summary of adipose secreted factors, adapted from Gustafson et al (2010). 
Adipose secreted hormones and cytokines are shown. PPAR, peroxisome proliferator-activated 
receptor; regulated upon activation normal T-cell, RANTES; GH, growth hormone; Vascular 
endothelial growth factor, VEGF; Normal growth factor, NGF; IGF, insulin-like growth factor; 
Plasminogen activator inhibitor-1, PAI-1; TNF-ĮWXPRXUQHFURVLVIDFWRUDOSKD,/LQWHUOHXNLQ))$ 
free fatty acids. 
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Adipokine Primary Source Receptor Effects on other 
adipokines 
Action on 
adipose tissue 
(AT) 
Secretion in 
response to 
insulin 
Secretion in response 
to insulin resistance. 
Peripheral 
Function 
Leptin Adipocytes Leptin receptor Suppressed TNF-ĮDQG
IL-6 expression 
Stimulation of 
adiponectin expression 
Sensitises AT to 
the action of 
insulin. 
 
 
Increased 
production 
Increased leptin in 
circulation. 
(leptin resistance can 
occur with insulin 
resistance, despite more 
leptin is present, a 
response is not 
guaranteed). 
Regulates satiety (acts 
primarily at the level of 
the central nervous 
system to regulate 
energy intake and 
expenditure) 
Adiponectin Adipocytes AdipoR1, 
AdipoR2, T-
cadherin 
Suppressed TNF-ĮDQG
IL-6 expression 
Enhances insulin 
sensitivity. 
Involved in IR 
and IRS 
phosphorylation. 
Increased 
production 
(required for the 
normal action of 
insulin on the AT) 
Decreased Insulin sensitizer, anti-
inflammatory 
Decreases 
gluconeogenesis 
Increased glucose 
uptake 
Resistin 
 
Peripheral blood 
mononuclear 
cells (human), 
adipocytes 
(rodent) 
Unknown Stimulation of TNF-Į
and IL-6 expression 
Induces insulin 
resistance. 
Induces 
adipocyte 
differentiation. 
Decreased 
production 
Increased Promotes insulin 
resistance and 
inflammation through IL-
6 and TNF secretion from 
macrophages. 
IL-6 Adipocytes, 
stromal vascular 
fraction cells, 
liver, muscle 
IL-6R Stimulation of leptin 
and resistin expression. 
Suppression of 
adiponectin expression 
Elevated lipolysis,  Increased Reduction in insulin 
sensitivity 
TNF-Į Stromal vascular 
fraction cells, 
adipocytes 
TNFR Stimulation of leptin 
and resistin expression. 
Suppression of 
adiponectin expression 
Elevated lipolysis  Increased Inflammation, 
Antagonism of insulin 
signalling 
Table 1.1. Sources, functions and interactions of adipokines. Adapted from (Karlsson and Beck, Ouchi et al., Rabe et al., 2008, Lago et al., 2009) 
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1.6.1 TNF-Į 
TNF-Į LV DVVRFLDWHG ZLWK LQVXOLQ UHVLVWDQFH LQ ZKLWH DGLSRF\WHV as TNF-Į
mRNA and protein expression is elevated in adipose tissue from obese 
humans and rodents (Maeda et al., 2002). Adipocytes from obese subjects 
have been shown to have elevated [Ca2+]i, additionally, adipocytes with 
elevated [Ca2+]i have been demonstrated to have elevated [cAMP]i, 
therefore resulting in an elevated rate of basal lipolysis. A summary of the 
lipolytic cascade is presented in Chapter 2, Section 2.1. As TNF-ĮH[SUHVVLRQ
is elevated in obesity, it further enhances basal lipolysis via stimulation of 
MAP kinases which decrease the protein expression of perillipin (Carmen and 
Victor, 2006), resulting in enhanced lipolysis (Arner, 2005b). In 
macrophages it has been demonstrated that TNF-ĮSURGXFWLRQLVDVVRFLDWHG
with elevated [Ca2+]i (Seabra et al., 1998). As adipocytes in obese humans 
and rodents also exhibit elevated [Ca2+]i,  it seems reasonable to suggest 
that elevated adipocyte [Ca2+]i may also contribute to elevated basal 
lipolysis by stimulating TNF-ĮSURGXFWLRQ 
Additionally there are regional variations in TNF-Į SURGXFWLRQ, dependent 
upon the fat deposit from which it is produced. Adipose expression of TNF-Į
is greater in subcutaneous adipose compared with visceral adipose (Kershaw 
and Flier, 2004), BMI is also reported to affect regional differences in 
adipokine release as TNF-Į UHOHDVH ZDV JUHDWHU LQ VXEFXWDQHRXV DGLSRVH
tissue when obtained from obese women with a body mass index (BMI) of 
42, but not with a BMI of 32 (Fain et al., 2004). 
 
 
Chapter 1 
31 
 
1.6.2 IL-6 
Human white adipose tissue produces up to 30% of IL-6 present within the 
circulation (Guerre-Millo, 2004, Kershaw and Flier, 2004), the remaining IL-
6 is produced and secreted by other cell types present within the adipose 
tissue such as stromal vascular cells, endothelial cells and fibroblasts (Fain 
et al., 2004). Plasma IL-6 is positively correlated with body mass and 
inversely correlated to insulin sensitivity (Guerre-Millo, 2004). It is possible 
that there is an association between obesity, elevated adipocyte [Ca2+]i and 
elevated IL-6 secretion/ activity. As yet, this has not been directly studied in 
adipocytes. It is known, however, that IL-6 secretion from other cell types, 
e.g. mast cells, is a [Ca2+]i dependent process (Jeong et al., 2002). 
Insulin has been shown to both increase IL-6 mRNA expression and release 
in adipocyte cell lines (LaPensee et al., 2008), and elevate [Ca2+]i in primary 
adipocytes (Draznin, 1988). As IL-6 secretion is dependent on Ca2+ and 
stimulated by insulin, it is possible that elevated [Ca2+]i by insulin may 
upregulate IL-6 secretion. Adipocytes with elevated [Ca2+]i exhibited a 2X 
elevation in [cAMP]i. Studies in human fibroblasts, which are another IL-6 
secreting cell type, demonstrated that treatment with cAMP, cAMP 
analogues or cAMP activators all resulted in a sustained elevation of IL-6 
mRNA levels. cAMP activators were all shown to stimulate IL-6 secretion. 
Additionally treatment of cells with the Ca2+ ionophore A23187 also resulted 
in an increase in IL-6 expression.  
There are several means by which IL-6 can contribute to the induction of 
insulin resistance. IL-6 reduces insulin-stimulated glucose uptake by serine 
phosphorylation or IRS-1 and subsequent inhibition of the insulin receptor 
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kinase (Zhang et al., 1988). IL-6 increases hepatic triglyceride secretion 
(Nonogaki et al., 1995). In humans, infusion of IL-6 increases plasma 
fasting triglyceride and VLDL triglyceride levels (Stouthard et al., 1995), 
suggesting that IL-6 contributes to the development of 
hypertriglyceridaemia. However, there is evidence to suggest IL-6 may not 
always contribute to metabolic dysfunction. In vitro investigations have 
shown IL-6 to increase glucose uptake by increasing GLUT-4 translocation, 
additionally IL-6 can activate AMPK increasing fat oxidation in muscle and 
adipose cells (Allen and Febbraio, Galic et al., 2010). A complex interplay 
between different adipose secreted factors and cytokines may be 
responsible for the differences in the effects of IL-6 observed between 
studies  
1.6.3 Adiponectin 
Adiponectin is highly and specifically expressed in adipocytes, in particular 
subcutaneous adipose tissue (Kershaw and Flier, 2004). Circulating 
adiponectin levels are positively correlated with insulin sensitivity and 
negatively correlated with BMI (Smith, 2002) and insulin resistance (Guerre-
Millo, 2004). Adiponectin increases insulin sensitivity by increasing fatty acid 
oxidation in skeletal muscle by phosphorylation and activation of adenosine 
monophosphate activated protein kinase activity (AMPK) (Yamauchi et al., 
2002), resulting in a reduction in circulating FFAs and intracellular 
triglyceride deposition in muscle and liver (Diez and Iglesias, 2003). In mice, 
recombinant adiponectin administration by pancreatic euglycaemic clamp 
activates liver AMPK reducing hepatic glucose production by 65%, thereby 
also reducing plasma glucose concentrations (Combs et al., 2001, Yamauchi 
et al., 2002). 
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It has been demonstrated in both humans and mice that adiponectin 
formation is influenced by [Ca2+]i. Chelation of adipocyte [Ca
2+]i by EGTA 
resulted in a reduction in adiponectin secretion from adipocytes, whereas 
excess supplementation of Ca2+ (20mM) to the adipocyte incubation medium 
resulted in an elevation of adipocyte adiponectin (Banga et al., 2008). This 
could be suggestive of a protective mechanism to counteract the detrimental 
effects of elevated [Ca2+]i.. However a reduction in adiponectin expression is 
associated with obesity and insulin resistance (Diez and Iglesias, 2003). For 
example adiponectin mRNA levels in white adipocytes were lower in obese 
mice (~70 to 90% lower) and humans (~50-80% lower) in comparison to 
wild type mice and normal weight humans (Hu et al., 1996). It has been 
suggested that hypoadiponectinaemia is related to the development of 
insulin resistance (Hotta et al., 2001). Additionally adiponectin expression 
can influence and be influenced by adipokines. Adiponectin reduces the 
production and activity of TNF-Į (Fantuzzi, 2005). TNF-Į DQG ,/-6 inhibit 
adiponectin expression both cultured adipocytes and primary adipose tissue, 
indicative of TNF-ĮDQG,/-6 inhibition of adiponectin release having a role in 
insulin resistance. Interventions to reduce insulin resistance (weight loss, 
TZD treatment) increase adiponectin gene expression and plasma levels 
thereof in adipose tissue (Kershaw and Flier, 2004). 
1.6.4 Resistin 
In rodents resistin is expressed in adipocytes, whereas in humans resistin is 
expressed within macrophages (Galic et al., 2010). Resistin expression and 
secretion is increased in obesity, and is decreased by PPARJ ligands. 
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In mice infusion or over-expression of resistin results in hyperglycaemia, 
which has been attributed to elevations in hepatic glucose production. 
Reductions in serum resistin caused by infusion of resistin antibodies or by 
resistin gene deletions have been shown to restore hepatic responsiveness 
to insulin (Banerjee et al., 2004, Steppan et al., 2001). Additionally 
circulating resistin levels are reduced by rosiglitazone (an antidiabetic drug) 
(Steppan et al., 2001). The importance of resistin in humans is unclear as 
investigations into serum resistin levels in obese type 2 diabetics do not all 
report elevated serum resistin (Savage et al., 2001). To date the effects of 
elevated [Ca2+]i on resistin expression have not yet been studied in 
adipocytes. 
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1.7 Experimental Aims 
There is an increasing awareness of the role of white fat adipocytes in the 
regulation of energy metabolism. As [Ca2+]i is an important ubiquitous 
intracellular signalling molecule, it is possible that [Ca2+]i has a role in 
adipocyte function, with dysregulations in adipocyte [Ca2+]i and altered 
adipocyte function contribute to the metabolic derangements associated 
with obesity and hypertension.  
L-type Ca2+ channels have been suggested to be a functional Ca2+ influx 
pathway in adipocytes, which are activated upon plasma membrane 
depolarisation. As the ion species which regulate Vm are unknown, I aim to 
explore adipocyte Vm and the ion conductances which are responsible for 
this. 
Additionally as adipocyte plasma membrane Ca2+ influx pathways are poorly 
described, investigations presented within this thesis aims to identify the 
Ca2+ influx pathways present on the plasma membrane of the white fat 
adipocyte. This will be attempted by way of [Ca2+]i imaging in conjunction 
with known Ca2+ antagonists, patch clamp methods and Western blotting.
 .
36 
 
 
 Chapter 2 
The ionic control of membrane potential 
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2.1 Adipocyte Lipolysis 
One of the main roles of adipocytes is the storage of energy in the form of 
triglycerides (TG), particularly during times of surplus energy intake. When 
stored energy is required by other tissues, it is released in the form of non-
esterified fatty acids (Chaves et al., 2011). 95% of the total adipocyte volume is 
comprised of fat droplets (Arner, 2005a). Lipolysis is the stepwise hydrolysis of 
ester bonds in TG, resulting in the breakdown of diglycerides giving rise 
monoglycerides and glycerol (Ahmadian et al., 2009). The control of lipolysis 
comprises various signalling pathways. The cAMP dependent pathway is 
predominant and the best characterised pathway for the induction of lipolysis, 
this is summarised in Figure 2.1. 
Insulin and adrenaline/ noradrenaline are the main physiological regulators of 
lipolysis (Lafontan and Langin, 2009)$GUHQDOLQHDQGQRUDGUHQDOLQHELQG WRǃ-
adrenoceptors, stimulating lipolysis. ,VRSUHQDOLQHD V\QWKHWLFQRQVHOHFWLYHǃ-
adrenoceptor agonist can also be used to stimulate lipolysis. For an excellent 
UHYLHZRQWKHUROHRIǃDGUHQRFHSWRUVLQOLSRO\VLVVHH%DUWQHVVet al, 2010. 
,QVXOLQ LQKLELWV OLSRO\VLV ,QVXOLQ¶V LQKLELWLRQ RI FDWHFKRODPLQH-induced lipolysis 
can occur via multiple mechanisms, the cAMP degradation by its stimulation of 
cAMP phosphodiesterase being the most predominant (Engfeldt et al., 1988). 
Insulin can also inhibit lipolysis by a direct inhibitory effect on HSL, this has 
been shown in both human and in cultured 3T3-L1 adipocytes (Engfeldt et al., 
1988). 
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Figure 2.1. The cAMP dependent lipolytic pathway. Adapted from (Arner, 2005a)ǃ1,2,3, 
beta1,2,3-DGUHQHUJLFUHFHSWRUV$Į2 adrenoceptors, Gi,s,inhibitory (i) or stimulatory (s) G-proteins; 
AC, adenylate cyclise; cAMP, cyclic AMP; PKA, protein kinase A; AGTL, adipose tissue specific 
triglyceride lipase; HSL, hormone sensitive lipase; MGL, monoglyceride lipase; TG, triglycerides; DG, 
diglyceride, MG, monoglyceride; FA, Fatty acid; IR, insulin receptor; IRS-1,2, insulin receptor 
substrates 1 and 2; PI3K, phosphoinositide 3-kinase; PDE-3, phosphodiesterase 3. In short 
catecholamines bind to the ǃ-adrenoceptors, activating stimulatory G proteins (Gs). The alpha 
subunit of the activated Gs activates adenylate cyclise causing increased cAMP. The increase in cAMP 
activates PKA, which then goes on to phosphorylate HSL, initiating triglyceride hydrolysis.  
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2.2 The effects of insulin and catecholamines upon the 
electrophysiological properties of adipocytes. 
Isoprenaline is reported to hyperpolarise the plasma membrane of mouse 
skeletal muscle fibres (van Mil et al., 1995). The hyperpolarising effect of 
isoprenaline was attributed to membrane voltage (Vm) alterations caused by 
stimulation of the Na+-K+ pump, Na+ conductance, and an increase in outward 
K+ conductance. Insulin also causes membrane potential alterations in insulin 
responsive tissues. Zierler (1966) studied the effect of insulin on the resting 
membrane potential of the rat extensor digitorium longus muscle. High insulin 
concentrations (0.1 units/ml) caused hyperpolarisation of the RMP of every 
muscle fibre investigated. The authors suggest a difference in membrane 
permeability to K+ and accumulation of [K+]i observed was not due to the 
actions of insulin, but more likely due to the resultant membrane 
hyperpolarisation that occurred as a result of insulin exposure. The 
hyperpolarisation observed was attributed to reduced membrane permeability to 
Na+ or increased permeability to Cl-. It is already well characterised that nerve, 
cardiac and pancreatic beta cell functions depend upon, or are accompanied by, 
alterations in transmembrane ion gradients. It is possible that the RMP of the 
white fat adipocyte may play a significant role in its basal function. Inhibition of 
lipolysis in adipocytes by Ca2+ was reported to result following KCl depolarisation 
of the plasma membrane, inducing opening of VGCCs. The resultant Ca2+ influx 
caused activation of PDE-3, reducing intracellular cAMP, leading to reduced HSL 
and subsequent inhibition of lipolysis (Xue et al., 2001). Furthermore, 
modulations in membrane potential induced by hormonal changes may influence 
the metabolic activity of adipose tissue or even contribute to the development of 
a dysregulated state. Insulin inhibits lipolysis by PDE-3 activation (see Figure 
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2.1). Conversely it is also possible, that if indeed insulin does hyperpolarise the 
plasma membrane of the white fat adipocyte, that this hyperpolarisation could 
counteract/ prevent the opening of VGCCs, therefore inhibiting Ca2+ influx, 
removing the inhibitory action of Ca2+ on lipolysis. Ion channel 
agonists/antagonists may be used to mimic the regulatory effect of hormones or 
signalling molecules on the adipocyte. For example, sulphonylurea drugs such 
as tolbutamide and glibenclamide are used as insulin secretalogues in the 
treatment of type 2 diabetes, as they cause KATP channel closure in pancreatic 
beta cells, mimicking the effect of ATP (Pearson et al., 2006). Understanding 
adipocyte membrane potential in the basal state and how disease states alter 
the types of ion channels involved and how they are regulated, may prove to be 
clinically useful. At present very little is known about the electrophysiological 
properties of adipocytes and how these may influence adipocyte function.  
The electrophysiological characteristics of adipocytes, such as resting membrane 
potential (RMP), have not been comprehensively studied when compared to the 
plethora of information available pertaining to other tissue types. As the K+ ion 
is a determinant of membrane potential in many cell types it would be 
interesting to determine if the K+ ion is involved in adipocyte RMP. The 
importance of K+ in RMP is discussed in Section 2.3.1. Initial investigations into 
white adipose tissue RMP were made using the sharp electrode technique. RMP 
values obtained from different studies using this method were inconsistent 
ranging from -21mV to -46mV (Ramirez-Ponce et al., 1990, Stark et al., 1980, 
Akiyama et al., 1990, Kamei et al., 1992). Other investigations into adipocyte 
RMP utilised Rb+ distribution ratio and voltage-sensitive dyes also provided 
varied RMP values (Davis et al., 1981, Cheng et al., 1980). No investigations 
into adipocyte RMP within the literature have utilised the whole-cell or 
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perforated patch clamp techniques, which are reported to be less damaging to 
the cell membrane and thus better suited to the maintenance of the intracellular 
ionic mileau (see Section 2.5.4.3). 
To date, studies utilising singe-channel patch clamp and molecular biological 
methods, such as RT-PCR and Western Blot, have indicated that isolated 
adipocytes of rat and human origin contain voltage-gated potassium channels of 
the delayed rectifier type. Channel properties were reported to be similar 
between both species indicative that it could be the same Kv channel, (which 
had suggested involvement in the regulation of Vm) in adipose tissue from both 
species.  
Hormones influencing adipocyte metabolic activity have been reported to 
influence transmembrane ionic gradient and membrane potential (Ramirez-
Ponce et al., 1991). Insulin and noradrenaline have been shown to modify the 
resting membrane potential of the white fat adipocyte. Insulin is reported to 
hyperpolarise adipocyte RMP (Ramirez-Ponce et al., 1991, Beigelman and 
Hollander, 1962)7KHH[WHQWRILQVXOLQ¶VK\SHUSRODULVLQJHIIHFWZDVIRXQGWREH
more pronounced in adipocytes sourced from younger lighter rats (<330g), 
although RMP of adipocytes from older heavier rats >330g was also modulated 
by insulin (Beigelman and Hollander, 1963). The effects of insulin are reversible. 
Conversely catecholamines reversibly depolarise the plasma membrane of 
adipocytes (Ramirez-Ponce et al., 1991). In contrast to the hyperpolarisation by 
catecholamines reported in mouse skeletal muscle (Zemkova et al., 1985), and 
rat mesenteric artery (Goto et al., 2000). 
Changes in intracellular cAMP levels via adenylate cyclase 
(activation/inactivation) are also suggested to be a consequence of the 
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hormones modulation of membrane properties. Insulin also exerts its inhibitory 
effect upon lipolysis by activation of Gi proteins which are implicated in Ca
2+ 
dependent K+ channel regulation and in the regulation of inwardly rectifying K+ 
channels (Lishko et al.) (Karschin, 1999). Although KIR channels have not yet 
been confirmed on the plasma membrane of primary adipocytes, small inward 
currents K+ have been determined in 3T3-L1s (Straub et al., 2011) 3T3-L1s are 
also reported to undergo lipolysis (Zhou et al., 2011). Gi proteins inhibit 
adenylate cyclase and therefore attenuate cAMP accumulation. Thus, evidence 
indicates that insulin has the potential to alter membrane properties via 
modulation of either the K+ channel directly, or indirectly via action upon 
regulators of this channel type. More insight can be gained in the effects of 
catecholamines in white adipocytes by looking at brown adipocytes. 
As with white fat adipocytes, catecholamines are known to depolarise the brown 
DGLSRF\WHSODVPDPHPEUDQHǃ-adrenergic stimulation of brown adipocytes by 
noradrenaline results in elevated intracellular cAMP. cAMP can modulate a 
variety ionic currents in other cell types, however this is predominantly via the 
inactivation of K+ channels and removal of the outwards K+ gradient. However 
membrane input resistance in brown fat cells decreased following noradrenaline 
stimulation and depolarisation, indicative of an increase in channel activity 
(Horwitz et al., 1969).  
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2.3 Resting membrane potential 
The basis for the resting membrane potential (RMP) are the permeabilities and 
the equilibrium potentials for the major ion species involved in RMP, typically K+, 
Na+ and Cl- ions. Physiologically, the cellular permeabilities to K+ and Cl- are 
high, thus the resting membrane potential of many cells, (see Table 2.1) is close 
to the equilibrium potential of Cl- and K+ ions. Table 2.2 shows the ionic 
concentrations and equilibrium potentials as calculated for each ion involved in 
RMP in a typical mammalian cell. The equilibrium potential for any particular ion 
is given by the Nernst equation (see Equation 2.1). 
Ion Ion 
concentration in 
plasma (mM) 
Ion concentration 
in cytoplasm (mM) 
Reversal Potential 
(mV) 
Na+ 145 12 +67 
K+ 4 140 -95 
Cl- 115 4 -90 
Table 2.1. Ionic concentrations and Nernst Potentials in a typical mammalian cell as 
determined at 20oC, taken from Stanfield (1996). The values presented here should be taken 
as a rough guideline as every cell type is different and ion concentration and permeability for any 
given cell varies depending upon cellular physiological status. 
However as shown in Table 2.2 not all RMPs are close to that of K+ or Cl-. In the 
physiological situation where multiple ion gradients control the resting 
membrane potential of the cell, the equilibrium potential of the cell (Nernst 
potential) depends on the relative permeability of the ions. Ion permeability is 
GHSHQGHQWRQWKHLRQ¶VVL]HDQGPRELOLW\DQGDOVRWKHDFWLYLW\RIPHPEUDQHLRQ
channels for that ion. It is the membrane permeability of the cell to other ions 
such as Na+ and Cl- that prevent the cell interior reaching the Nernst potential 
for K+ (Wright, 2004). 
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Tissue/Cell Membrane 
Potential 
(mV) 
Major ion 
involved in 
membrane 
potential 
References 
Pancreatic Beta cell -62 K+ (Manning Fox et al., 2006) 
Bovine pulmonary 
artery endotheilial 
cells 
Range from -88mV 
and 5mV with a 
mean of -26±3mV 
K+ , Cl- and Na+ (Voets et al., 1996) 
Rabbit articular 
chondrocytes 
-42 Cl- (Tsuga et al., 2002) 
The red blood cell -8 Cl- (Jay and Burton, 1969) 
Neuron -60 K+ (Doan and Kunze, 1999) 
Skeletal muscle -95 K+ (Hille, 2001) 
Smooth muscle -50 K+ (Hille, 2001) 
Astrocyte -80 K+ (McKhann et al., 1997) 
Adipocyte ~-30 Unconfirmed (Ramirez-Ponce et al., 1990) 
Table 2.2. Resting membrane potentials of various cell types. 
Drugs and hormones can affect ion permeabilities and therefore membrane 
potential by multiple mechanisms, including reduction in the number of ion 
channels, closure of ion channels, and altered exchanger activity. For example, 
insulin is reported to affect ion permeabilities in skeletal muscle resulting in 
membrane hyperpolarisation. Application of insulin caused the rate of active Na+ 
/K+ exchange in skeletal muscle to increase by 60-120%, resulting in a decrease 
in [Na+]i leading to membrane hyperpolarisation (Clausen, 1996).  
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Equation 2.0-1. The Nernst equation. E= equilibrium potential for the ion under consideration, 
R= the universal gas constant (8.31j mol-1 K-1), Z= the oxidation state of the ion under 
consideration, T=temperature in Kelvin. [ion]o and [ion]i represent extracellular and intracellular ion 
concentrations. The Nernst equation can be simplified and represented as equation B, at room 
temperature. 
inClPCloutNaPNaoutKPK
outClPClinNaPNainKPK
F
RTVm ][][][
][][][ln 
  
Equation 2.0-2. The Goldman-Hodgkin-Katz equation. Vm is the potential difference that exists 
across the plasma membrane of the cell. , R= the universal gas constant (8.31j mol-1 K-1), Z= the 
oxidation state of the ion under consideration, T=temperature in Kelvin. P is the relative 
permeability of the ion given in cm/s. 
2.3.1 K+ channels regulate resting membrane potential  
Resting membrane potential is an important ubiquitous property of all cells. K+ 
channels stabilise the resting membrane potential of both excitable and non 
excitable cell types (Sanguinetti and Spector, 1997, Chilton et al., 2005). 
Generally, transmembrane K+ -selective leak channels allow the diffusion of K+ 
ions down the concentration gradient (the K+ concentration gradient is 
established by the activity of ATPases). This creates a charge separation and 
also a voltage across the membrane. Other examples of K+ channels involved in 
the generation of resting membrane potential are discussed briefly heirn. 
Delayed rectifier K+ channels set RMP in feline smooth muscle. Opening of the 
ATP sensitive K+ channel (KATP) contributes to RMP in large, cultured primary rat 
neurons (Kawano et al., 2009)DQGLQSDQFUHDWLFǃ-cells. In excitable cells, K+ 
channels regulate RMP during the quiescent period between action potentials, 
A 
B 
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and also govern the return of membrane potential back to the resting state. In 
cell types expressing outwardly rectifying K+ channels, K+ channel closure 
results in depolarisation of the plasma membrane and subsequent cell specific 
DFWLYLW\ VXFK DV WKH VHFUHWLRQ RI LQVXOLQ IURP SDQFUHDWLF ǃ-cells or muscle 
contraction. Generally, activation of K+ channels (Kv and KATP) resulting in an 
increase in outward K+ permeability results in a shift in the transmembrane 
potential towards the Nernst potential for K+, i.e. membrane hyperpolarisation. 
K+ channel regulators such as G proteins (Yamada et al., 1998), and 
intracellular ATP, (Terzic et al., 1995) can alter channel properties such as 
subunit assembly, conductance, activation and inactivation. Consequences of 
such modulation can result in membrane potential changes, or altered 
intracellular ionic activity due to the induction of voltage-gated ion channel 
conductance arising from the activation of other voltage-regulated channels that 
are permeable to other ions.  
A large number of genes encode channel subunits, giving rise to a very diverse 
range of K+ channel subtypes (Coetzee et al., 1999). The number of K+ channel 
phenotypes is even greater. The functional diversity of K+ channels is extended 
due to additional processes such as alternative splicing, post-translational 
modification and the heterologous assembly of pore-forming subunits. This 
diversity is attenuated by K+ channel interactions between accessory subunits or 
regulatory proteins. As the multitude of K+ channels is vast and beyond the 
scope of this brief introduction see (Miller, 2000) for a brief and generalised 
summary of K+ channels and their characteristics. 
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2.4 Experimental aims 
To date information pertaining to the Vm of adipocytes is limited, additionally 
the ion species that determine adipocyte Vm are unknown. In this chapter I aim 
to measure adipocyte Vm and determine the ion conductances that underlie this. 
6LQFHLQVXOLQDQGǃ-adrenoceptors are key regulators of adipocyte function I also 
aim to explore their effect on adipocyte Vm. 
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2.5 Methods 
2.5.1 3T3-L1 adipocyte culture 
Cells in culture were kept at 37oC in a humidified atmosphere of 5% CO2/ 95% 
air. 3T3-L1 fibroblasts were cultured in maintenance medium comprising 
'XOEHFFR¶V 0RGLILHG (DJOH 0HGLXP '0(0 6LJPD ' VXSSOHPHQWHG ZLWK
Newborn Calf Serum (NCS Sigma N4637, 10% (v/v)), antibiotic/anitmycotic mix 
(Sigma A5955, 5 ml/500 ml medium), gentamycin (Sigma G1272, 2.5 ml/500 
ml medium) and L-glutamine. The 3T3-L1 fibroblasts were grown to 60% 
confluence in T75 flasks prior to trypsinisation with trypsin and subcultured at a 
1:3 split twice a week. To prevent the occurrence of spontaneous differentiation 
of the 3T3-L1 fibroblasts all maintenance flasks were regularly checked and 
subcultured at 50-60% confluence (Green and Meuth, 1974). 
 
3T3-L1 fibroblasts intended for differentiation to 3T3-L1 adipocytes seeded in 
35mm culture dishes (Corning) and were grown to confluency. Two days post 
confluency differentiation of the 3T3-L1 fibroblasts was initiated using a series of 
DMEM based media comprising of 3T3-L1 fibroblast maintenance medium, with 
foetal calf serum instead of newborn calf serum, with supplementation of 
porcine insulin (Sigma I5523, 1mg/ml stock in dH2O:acetic acid (100:1) 200 µl/ 
200 ml), IBMX (Sigma I-7018, 0.5 mM), dexamethasone (Sigma D1756, 0.25 
µM).  
Substitution of the fibroblast maintenance medium for differentiation medium 
RFFXUUHG RQ µGD\ ¶ DQG ZDV OHIW IRU  KRXUV 2Q GD\  WKH PHGLXP ZDV
exchanged for differentiation medium, excluding dexamethasone and IBMX. 
Cells were kept in this for a further period of 48 hours, days 2-4. On day 4 this 
medium was removed and replaced with differentiation medium with the 
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exclusion of insulin, IBMX and dexamethasone. At this stage, differentiation is 
apparent as the cells lose their fibroblastic appearance and adopt a round, 
adipocyte like morphology. During the early stages of differentiation the cells 
contain multiple small fat droplets. As differentiation progresses the multiple 
droplets coalesce into a singular large droplet and the cells become macroscopic. 
The 3T3-L1s were used when the majority of cells in a dish were observed at a 
later stage of differentiation. The medium was changed every 48 hours. The 
cells were used within 5 days.  
2.5.2 3T3-L1 Oil Red O hematoxylin counter stain 
To confirm the presence and accumulation of lipid droplets following cell 
differentiation, dishes of cells were taken for Oil Red O and hematoxylin counter 
staining. Oil Red O is a fat soluble dye commonly used for the staining of 
triglycerides and neutral lipids (Ramirez-Zacarias et al., 1992, Sung et al.). 
Tissue culture dishes containing cultures were gently rinsed with 2mls sterile 
'XOEHFFR¶VSKRVSKDWH-buffered saline (DPBS) (pre-warmed to 37oC so as not to 
shock the cells). Following aspiration of the DPBS, each culture dish was 
incubated in 2ml 10% (v/v) formalin in dH2O for 30 minutes.  
Stock solution of Oil Red O (300mg Oil Red O in 100mls 99% (v/v) isopropanol 
was used to prepare a working solution. Three parts Oil Red O stock (30ml) 
were mixed with two parts (20ml) dH2O. This was allowed to sit for ten minutes 
and filtered prior to use. 
Following formalin incubation, and each plate rinsed in 2 ml sterile dH2O, and 
then incubated in 2ml of 60% (v/v) isopropanol for 5 minutes. The isopropanol 
was poured away and 2 ml of Oil Red O working solution was added and left to 
stand at room temperature for 5 minutes. Warm tap water, applied using a 
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pipette, was used to rinse each dish multiple times over until the water ran clear. 
To visualise the cells nuclei, each plate was counter-stained with hematoxylin 
(Jensen et al., 2004). Each dish was incubated for 1 minute in 2ml hematoxylin 
(stock solution composition 5g hemotoxylin, 50ml absolute ethanol, 100g 
ammonium sulphate, 100ml dH2O, 30g sodium iodate; Working solution 
composition: 100ml filtered stock solution and 4ml glacial acetic acid), and 
rinsed with warm water as described above. To maintain staining, dishes were 
kept wet with water. Cells were observed and images taken using a phase 
contrast microscope at x10 magnification. 
2.5.3 Rhodamine 123 staining of primary adipocytes 
Within suspensions of primary adipocyte preparations, both adipocytes and fat 
droplets (as a result of lipolysis) are present. The adipocyte nucleus nub was 
used as a morphological indicator to distinguish between adipocytes and fat 
droplets. If the nucleus nub of a primary adipRF\WH LV DWWDFKHG LQ WKH ³IDFH
GRZQ´ RULHQWDWLRQ WR WKH JODVV FRYHU VOLS (plating is described in Chapter 3, 
Section 3.9.2) it can be difficult to distinguish a primary adipocyte from a lipid 
droplet. To improve the likelihood of patching a mature adipocyte it is necessary 
to visualise them; to facilitate this, intact cells can be loaded with lipophillic dyes. 
For this purpose Rhodamine 123 was chosen. 
 
The adipocytes were loaded with 10-20µg/ml Rhodamine 123 in Ca2+ +DQN¶V
buffer. Rhodamine 123 was prepared from a 2mg/ml stock solution in DMSO. 
The adipocytes were loaded with dye for 5 minutes in the dark at 22oC and then 
visualised under a fluorescent microscope. Cells were illuminated with an 
excitation wavelength of 450-490nm. Emitted light was filtered using a long-
pass barrier filter at 510nm (Karl Zeiss filter set 10 488010-9901-000). The 
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emitted light was detected using a photonics ISIS camera. A typical view of a 
group of adipocytes stained with rhodamine 123 is shown in Figure 2.2. Of the 
five adipocytes present in the image, the protruding nucleus is only visible in 
two of the adipocytes shown; without the presence of rhodamine 123, it would 
have been difficult to distinguish the other adipocytes from fat droplets. No fat 
droplets are seen within this image. 
 
 
Figure 2.2. A fluorescent image of primary adipocytes loaded with 10-20µg of Rhodamine 
123, viewed at X20. The grey / white colouration is indicative of the presence of the Rhodamine 
123 within the adipocyte. Fat droplets fail to fluoresce and are not visible following fluorescent 
illumination. 
2.5.4 Patch clamp 
2.5.4.1 Patch clamp pipettes (perforated patch) 
Patch clamp pipettes were pulled from thin-walled borosilicate capillaries 
(GC150TF, Harvard apparatus) using a two-stage vertical pipette puller 
(Narishige, Japan). The diameter of the patch pipette tip of each batch of 
pipettes pulled was assessed using the bubble number method. Patch clamp 
pipettes with bubble numbers of 7 were used. The tips of the patch pipettes 
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were coated close to their tips with Sylgard (Dow Corning Corp) to reduce their 
electrical capacitance. (Sakmann, 2009). The pipettes were fire-polished before 
use. Pipette resistances were typicall\EHWZHHQDQG0 
 
Pipettes were assembled in a standard polycarbonate pipette holder. Electrical 
coupling was provided by using an Ag/AgCl wire. The adipocytes were washed 
ZLWK +DQN¶V VROXWLRQ SULRU WR REVHUYDWLRQ $ FRDUVH WKUHH-way, mechanical 
manipulator was used to bring the pipette close to the cell, such that both the 
pipette and the cell could be visualised within the same field. A fine three-way 
hydraulic micromanipulator was used to position the tip of the pipette onto the 
cell.  
 
The bath was electrically grounded via a salt bridge comprising 150mM KCl in 
2% (v/v) agar. On contact with the batch solution, the pipette current was 
adjusted to zero by application of an offset voltage. The offset voltage was 
taken as the zero reference potential for all experimental measurements. 
Posteriori corrections were made for liquid junction potentials, these are 
discussed in Chapter 4, Section 4.3.3.  
 
Membrane voltages (perforated patch) and membrane currents (cell-attached 
patch) were recorded using an Axopatch-1D patch clamp amplifier (Axon 
instruments).  
2.5.4.2 Microscope set up 
The 35mm dishes containing 3T3-L1 cells were mounted directly onto the stage 
of the inverted microscope. To reduce the volume of the petri dishes, and permit 
a more rapid solution change, a perspex insert was used. The volume of the 
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dish was reduced from 2.5ml to 500µl. With the insert, complete solution 
changeover could occur within 60 seconds. Primary adipocytes were attached to 
a glass coverslip as described in Chapter 3, Section 3.9.2. To image these cells 
prior to patching, a bespoke perspex chamber was used with a glass floor. Again, 
solutions could be changed within 60 seconds.  
 
To perifuse the microscope chamber, solutions were gravity fed, through 
polythene tubing, all drug additions were made via bath perifusion. Solutions 
were removed via aspiration by a vacuum pump. To exchange the perifusion 
solutions electrically controlled two-way valves were utilised. Solutions were 
warmed to the desired temperature by passing through a heated electrical 
resistor that was controlled by a feedback circuit (designed by Dr P.A. Smith). A 
thermocouple was used to monitor and set the temperature of the perifusion 
solution.  
 
To form a seal, the microelectrode was gently brought to the surface of the cell 
until contact was made, gentle suction was applied as necessary by application 
of negative pressure via a syringe connected to the pipette holder by polythene 
tubing. Seal formation was monitored by applying short positive voltage pulses 
to the cell membrane. Contact with the cell and seal formation is indicated by a 
reduction in the test pulse current response, indicative of increased resistance at 
the pipette tip, caused by occlusion of the pipette tip by the cell. Seals >2*
were considered acceptable. Following gigaseal formation, the appropriate patch 
clamp configuration was carried out. 
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2.5.4.3 The perforated patch, whole-cell configuration of the patch 
clamp technique. 
 
Figure 2.3. The formation of the perforated patch, patch-clamp configuration. In this 
configuration, amphotericin B, a pore forming antibiotic is added to the pipette solution and this is 
back filled. The pipette tip does not contain amphotericin. The amphotericin B migrates to the 
pipette tip and incorporates with the membrane patch. A low resistance pathway formed between 
the interior of the cell and the patch pipette. Adapted from (Molleman, 2003). 
Resting membrane potentials were recorded from primary epididymal white fat 
adipocytes and 3T3-L1 adipocytes using a variant of the whole-cell patch clamp 
technique, the perforated patch configuration. The perforated patch technique is 
shown in Figure 2.3. The advantage of this method is that the patch of the cell 
membrane is not disrupted, and as the pores produced by amphotericin are 
permeable to monovalent cations only, anions and multivalent ions do not 
permeate through the pores due to the absence of dialysis. Moreover, 
intracellular constituents and signalling molecules essential for normal cell 
function are not exchanged with the pipette solution. The maintenance of the 
intracellular milleu in this configuration also prevents channel run-down, giving 
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this configuration a distinct advantage over the traditional whole-cell patch 
configuration (Carrier, 1995).  
 
Membrane voltages were recorded using an Axopatch 1D patch clamp amplifier 
(Axon instruments) at both room temperature (22oC) and at 32oC. The pipette 
solution comprised (in mM) 76K2SO4, 10KCl, 10NaCl, 10 HEPES. The solution 
was adjusted to pH 7.4 with NaOH. A stock solution of amphotericin B in DMSO 
(50mg/ml) was prepared, protected from exposure to light and stored at -200C 
for a period of one week. To induce perforation of the adipocyte cell membrane, 
0.1 µg/ml of amphotericin B was applied to the pipette filling solution. The tip of 
the patch pipette was filled with amphotericin B free solution by capillary action, 
DQG WKH UHPDLQGHU RI WKH SLSHWWH µEDFN-ILOOHG¶ ZLWK DPSKRWHULFLQ % FRQWDLQLQJ
solution. Normal Hank¶V VROXWLRQ see Appendicies) was perifused in the bath 
containing adipocytes during seal formation. This was to reduce amphotericin B 
build-up at the tip of the pipette and subsequently improve the likelihood of 
obtaining a high resistance seal in the cell-attached configuration before 
perforation of the adipocyte cell membrane occurred. Following the formation of 
the high resistance seal, the holding potential of the pipette tip was set at -
30mV. Test pulses of 0.2mV were repetitively applied to monitor changes in the 
access resistance. As the amphotericin B diffused to the pipette tip and 
incorporated with the membrane patch, it resulted in subsequent perforation of 
the adipocyte membrane. The resistance of the patch decreased and cell 
capacitive currents in the form of capacity current transients appeared. When 
the whole-cell configuration was ascertained as determined by the development 
of capacitance transients (Figure 2.4), the capacitive transients were 
compensated, the current clamp applied and the membrane potential measured.  
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Figure 2.4. Seal formation with subsequent development of capacitance transients as 
observed during establishment of a perforated patch protocol. (A) Current response as the 
pipette is immersed in the bath solution. (B) Increase in resistance at the pipette tip as it makes 
contact with the cell surface as manifest by a reduction in current response. (C) Gigaseal formation. 
(D) Development of the capacitive transients as access resistance decreases during perforation. (E & 
F) Compensation for the capacitive transient.  
One of the limitations of the perforated patch configuration is that the voltage of 
the pipette is not necessarily the same as the voltage of the clamped cell 
membrane. Such an error is introduced by a high series access resistance can 
be problematic, (series resistance arises as a result of anything in series with 
the cell such as the patch pipette; perforation; clogging of the pipette tip). 
 
The series resistance and membrane resistance acts as a voltage divider to all 
imposed voltages. Voltage error is at a minimum in instances when the series 
resistance is small in comparison to the membrane resistance. Typically, series 
resistance has to be two orders of magnitude smaller than the membrane 
resistance to keep the voltage error low.  
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The mean series resistance of the 3T3-L1 adipocytes was 32±10 DQG WKH
mean capacitance was 15.6±13.9pF (n=100) as determined by electronic 
capacitance compensation. The capacitance of the primary adipocytes could not 
be compensated, as the cells were too large. The mean diameter of the primary 
adipocytes was 78.18µM±0.5 (n=634). The diameter of the differentiated 3T3-
L1s was not measured.  
 
Ccell=specific capacitance X cell area 
 
Ccell=1Fcm-2 x Area(cm2) 
 
2.5.4.4 Measurement of RMP 
For this, the P-clamp amplifier was used in current clamp mode (Figure 2.5). In 
current clamS PRGH WKH SDWFK FODPS DPSOLILHU µPHDVXUHV¶ 9P RI WKH FHOO E\
varying the voltage command to maintain a constant current, Iout, of zero. 
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Figure 2.5. A simplified diagram of the perforated patch circuit and patch clamp amplifier. Rf: feedback resistor, Vcom: command voltage, Vpip: pipette potential, Iout: output current.
59 
2.5.4.5 Prediction of [ion]i 
The Nernst equation can be transformed to give [ion]i on the basis of known 
membrane potential responses (as observed experimentally) to a given 
extracellular ion concentration. The Nernst equation was used to predict 
values for adipocyte [K+]i, [Na
+]i and [Cl
-]i.  
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Equation 2.3. The Nernst equation (A). (B) is the Nernst equation, fully transformed to 
give an estimate of [Cl-]i. 
2.5.4.6 Input resistance measurements 
Plasma membrane input resistances for primary and 3T3-L1 adipocytes in 
both 138mM Cl- and 5mM Cl- bath solutions were calculated by measuring the 
changes in membrane potential during the application of current pulses. The 
calculation used to determine input resistance is shown in Equation 2.4. 
 
Equation 2.4. The calculation used to determine input resistance. V=voltage, I=current. 
2.5.4.7 Statistical analysis 
Membrane potential data are expressed as box and whisker representations 
showing the median Vm, the 25 and 75% confidence intervals and the 
A 
B 
Chapter 2 
60 
 
maximum and minimum membrane potential values observed for each cell 
type. Statistical analysis was performed using Graphpad PRISM version 5 
(graphpad software, San Diego, California USA). All statistics are expressed 
as described within each figure legend. 
2.5.5 Microscopic demonstration of differentiated 3T3-L1 adipocytes 
To confirm 3T3-fibroblast differentiation into 3T3-L1 adipocytes, lipid 
accumulation was monitored by staining with Oil Red O, throughout the 
differentiation process. 
 
Figure 2.6. Oil Red O stain with the haematoxylin counter stain. All images are at X20 
mag. Image A shows 3T3 fibroblasts prior to the induction of differentiation. Image B was taken 
96 hours (day 4) into the differentiation process, image C shows a heterogeneous population of 
3T3 fibroblasts and 3T3-L1 adipocytes following completion of the differentiation protocol. 
Adipocytes selected for patching are shown by arrows. 3T3-L1 adipocytes were stained at 
passage 15. 
The differentiation of 3T3-L1 fibroblasts to adipocytes is characterised by the 
accumulation of lipid droplets, which is visible in some cells by the presence 
of red stain (Figure 2.6C). As the cells accumulate lipid, they become less flat 
and adopt a rounded shape. 3T3-L1 fibroblasts at an intermediate stage of 
differentiation show multiple lipid droplets and a centralised nucleus. Fully-
differentiated 3T3-L1 adipocytes are spherical in shape and contain a 
coalesced fat droplet, (as indicated by the blue arrow (Figure 2.6C)). Some 
cells within the population failed to differentiate. The presence of non-
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differentiated cells within the differentiated population of adipocytes is due to 
the proliferation of fibroblasts that have lost their capacity to differentiate 
(Green and Meuth, 1974). Figure 2.7 illustrates the typical patch clamp 
arrangement for both primary (Figure 2.7A) and 3T3-L1 (Figure 2.7B) 
adipocytes. 
100µM 100µM
A B
 
Figure 2.7. A typical image of a group of A) primary adipocytes and B) differentiated 
3T3-L1 adipocytes. Cells were viewed at x20 under an air objective lens. The shadow of the 
cell-attached patch pipette is highlighted with an arrow in both cases. In B, the adipocyte chosen 
for study was spherical in shape indicative of the cell being in a late stage of differentiation. In B, 
there are cells at various stages of the differentiation process, cells at an intermediate stage of 
differentiation have multiple fat droplets as in Figure 2.7C. Cells that have not differentiated are 
visible in the background (flattened fibroblasts). 
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2.5.6 Ionic basis of adipocyte resting membrane potential 
 
Figure 2.8. Comparison of the data spread of RMPs. (A) and distribution of RMPs (B) of 
primary adipocytes (n-68) and 3T3-L1 adipocytes (n=88). In (A) the data are shown as Median 
± 25% and 75% confidence intervals, with the maximum and minimum values for data shown. 
Figure 2.8 shows the distribution of membrane potentials of primary white fat 
adipocytes and differentiated 3T3-L1 adipocytes, measured in the absence of 
insulin with the perforated patch clamp configuration. 
The median resting membrane potentials of the primary adipocytes and the 
differentiated 3T3-L1s were not significantly different (Mann-Whitney, 
P>0.05). Figure 2.8A, with a similar distribution of values Figure 2.8B. These 
data suggest that the two adipocyte models used in this study may have 
similar ionic mechanisms of resting membrane potential.  
7KH ODEKDVH[WHQVLYHH[SHULHQFHZLWK WKHXVHRIPRXVH LVOHWǃ-cells. Islets 
were prepared and supplied by Dr P.A Smith. To confirm the accuracy and 
validity of the perforated patch clamp technique used in this study, the 
membrane potential of the mouse isOHWǃ-cells was measured in the absence 
RIJOXFRVHLQERWKP0DQG³HOHYDWHG´P0H[WUDFHOOXODU.+ (Figure 2.9). 
Chapter 2 
63 
 
The mean series resistance and cell capacitance were 32.9±1M and 
12.6±4.4pF respectively (n=8).  
The concentration of extracellular K+ was altered by equimolar substitution of 
bath Na+. In physiological [K+]o P0WKH9PRIWKHǃ-cell was ~-71mV 
(n=8), which was significantly depolarised to ~-21mV in elevated (50mM) 
[K+]o )ULHGPDQ¶VP<0.001) Figure 2.9.  
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Figure 2.9 Membrane potential of primary mouse beta cells. Membrane potentials were 
measured in the absence of glucose in 5.6mM K+ (control), in 50mM K+ and then recovery in 
5.6mM (n 3)ULHGPDQ¶V 
I assume the mouse beta cells possess [K+]i of 140mM, and [Na
+]i of 10mM   
as per a generic cell, (see Table 2.2). On the basis of the membrane potential 
responses observed experimentally (Figure 2.9) the GHK equation (Equation 
2.2) was used to determine the permeability ratio of Na+ to K+ (assuming 
PCl- is negligible) : 0.02. 
Since K+ is the major ion involved in controlling the membrane potential of 
most cell types (Hille, 2001), conditions of 50mM [K+]o
 were applied to 
adipocytes to investigate the role of the K+ ion, if any in adipocyte RMP. 
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If we assume that the adipocyte Vm is solely dependent on K+, and the 
median adipocyte Vm in Figure 2.10 being -41mV in 5.6mM [K+]o, the 
predicted [K+]i is 26mM as per the Nernst equation (Equation 2.3). On the 
basis of the predicted [K+]i value, and assuming exclusive involvement of K
+ 
in adipocyte Vm, elevation of [K+]o to 50mM would result in a membrane 
depolarisation to +17mV.  
However elevation in extracellular K+ by equimolar substitution of Na+ with 
K+ from 5.6mM to 50mM did not affect membrane potential of either primary 
(Figure 2.10A) or 3T3-L1 (Figure 2.10B) adipocytes. Furthermore addition of 
known L-type Ca2+ channel blocker verapamil at 20µM failed to block any 
voltage-gated or passive Ca2+ current. Addition of verapamil did not affect 
membrane potential in either adipocyte model. 
 
Figure 2.10. The effect of elevation of extracellular K+ from 5.6mM to 50mM on the 
membrane potential in the absence and presence of 20µM verapamil (V). (A) primary 
adipocytes (n=8) and (B) differentiated 3T3-/DGLSRF\WHVQ )ULHGPDQ¶V 
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Figure 2.11. The effect on membrane potential of extracellular Ca2+ removal by 
equimolar substitution with Mg2+. In (A) primary adipocytes (n=8) and (B) differentiated 
3T3-/DGLSRF\WHVQ )ULHGPDQ¶V 
Equimolar substitution of extracellular Ca2+ with Mg2+ did not have an effect 
on membrane potential in either primary or differentiated 3T3-L1 adipocytes 
(Figure 2.11). 
Since [K+]o appeared not to be involved in controlling Vm, another ion 
capable of generation of a negative membrane potential was sought; the 
involvement of Cl- in the generation of the resting membrane potential in 
both adipocyte models was explored. The effect of removal of extracellular 
chloride was initially explored by equimolar substitution of Cl- with Aspartate 
(Asp-). 
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Figure 2.12. Representative trace, of the effect of perifusion of decreasing 
concentrations of extracellular chloride on membrane potential in the primary white 
adipocyte. Extracellular chloride was removed by direct equimolar substitution with sodium 
aspartate from 138mM extracellular chloride to 5mM extracellular chloride. Extracellular chloride 
substitution with aspartate caused a partially reversible hyperpolarisation of the plasma 
membrane in the primary adipocyte. Junction potentials were determined experimentally, and 
membrane potential measurements corrected. Black triangles represent raw data. Junction 
potential corrected membrane potentials are shown as red circles (n=5). 
Incremental substitution of extracellular Cl- from 138mM to 80mM by 
replacement with aspartate resulted in a concentration dependent 
hyperpolarisation of the primary adipocyte. (Figure 2.12). Initially Na-
Aspartate was used as a substitute for extracellular chloride. It was 
hypothesised that the net Cl- current would be outward resulting in 
depolarisation of the adipocyte plasma membrane. However, as the opposite 
was observed it is suspected that, aspartate was entering the adipocyte 
causing membrane hyperpolarisation. To test this hypothesis, another Cl- 
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substitute, gluconate, was utilised and similar experiments carried out (Figure 
2.13).  
Having determined that the Cl- ion is involved in the regulation of resting 
membrane potential in 3T3-L1 cells, the incremental substitution protocol 
was repeated in primary white fat adipocytes. Membrane potential values 
were taken after stabilization of the membrane potential value shortly 
following exchange of the extracellular solution. The effect of extracellular 
chloride removal on membrane potential recorded in 3T3-L1 and primary 
adipocytes was similar, with maximal depolarisation of the plasma membrane 
from a median of ~-30 to -40mV to a median of -7mV (Figure 2.14). Junction 
potentials were measured for each chloride solution tested. Junction 
potentials were measured as follows. The patch pipette was filled with 3M KCl 
solution. The pipette was immersed in the perifusion medium in 138mM Cl- 
solution, ZLWK WKH YROWDJH ]HUR¶G 7KH SHULIXVLRQ PHGLD ZDV H[FKDQJHG IRU
one containing 5mM Cl-, and the potential change (if any) was measured. 
Following each junction potential measurement the pipette containing 3mM 
KCl was changed. The voltage offset caused by the junction potential 
increased with every decreasing concentration of chloride, most notably from 
40mM [Cl-]o onwards. Junction potentials have been subsequently 
compensated in all figures depicting experimental data. Figure 2.15 illustrates 
a typical experiment using this protocol. The effect on membrane potential of 
extracellular chloride removal suggests the presence of chloride channels on 
the plasma membrane of both adipocytes and 3T3-L1 adipocytes. This will be 
discussed further in Chapter 4. 
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Figure 2.13. Representative traces, of the effect of decreasing concentrations of 
extracellular chloride on adipocyte membrane potential. Extracellular chloride removal 
causes a reversible depolarisation of the plasma membrane of both the primary adipocyte (A) 
from -35mV to ±10mV, (n=9) and the 3T3-L1 adipocyte (B) from -40mV to -10mV, (n=14). Due 
to Cl- ions leaving the cell, ECl- becomes more +ve. Membrane potential measurements were 
corrected for junction potentials, n=9. The input resistance of the primary adipocyte (A) in 
138mM extracellular Cl- ZDV*LQP0H[WUDFHOOXODU&O- WKHLQSXWUHVLVWDQFHZDV* 
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Figure 2.14. Membrane potential change of primary adipocytes in 5mM [Cl-]o. Pooled 
membrane potentials, as were recorded in 138mM [Cl-]o , and 5mM [Cl
-]o, n=9. *P<0.05 
)ULHGPDQ¶V 
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Figure 2.15. A representative trace showing the effect of removal of extracellular Cl- by 
substitution with gluconate on the membrane potential of 3T3-L1 cells. The 
concentration of extracellular Cl- present in the extracellular medium is represented by the blue 
line. The change in Vm (mV) arising as a result of buffer substitution is represented in black. The 
staircase changes in voltage (labelled as IR) input resistance are a result of incremental stepwise 
current injection from -9pA to +9pA. To measure input resistance, the slope of the voltage 
values obtained at each step were noted. There is no correction for junction potentials in this 
figure. Note recovery of Vm on return to 138mM [Cl-]o.. 
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Figure 2.16. A representative determination of input resistance. This measurement was 
taken from a primary adipocyte in 138mM Cl-. To measure input resistance current was injected 
in 10pA increments from -90pA to +90pA and the corresponding change in membrane voltage 
noted for each current injection step. The values for current and voltage were plotted and in 
accordance with Ohms law, V=I/R and therefore the slope was taken as the input resistance 
YDOXH7KHLQSXWUHVLVWDQFHLQWKLVH[DPSOHLV* 
In addition to measuring changes in membrane potential, the input resistance 
of the adipocyte plasma membrane was measured as both an indicator of cell 
integrity and as an indicator of ion channel activation. A low resistance, i.e. 
high conductance would suggest open channels and vice versa. A 
representative trace showing a membrane potential experiment with input 
resistance determination is shown in Figure 2.16. To measure the input 
resistance of the primary adipocyte plasma membrane, current was injected 
in an incremental and stepwise manner. This is indicated by the triangular 
peaks in the Vm record (Figure 2.15) showing negative deflection for the 
injection of negative currents and positive deflection for the injection of 
positive currents. After the first input resistance measurement in 138mM Cl-, 
the extracellular Cl- was dropped to 5mM. A rapid depolarisation from ~-
20mV to ~0mV was observed. After the measurement of input resistance, 
bath Cl- was switched to 10mM, 20mM, 40mM 80mM, 100mM, 120mM back 
to 138mM. Hyperpolarisation resulted with each increment in extracellular Cl- 
I 
V (mV) 
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concentration. The start and end membrane potential values in 138mM 
extracellular chloride solution used in this illustrative trace were similar at -
28mV and -27mV respectively. The ability of extracellular Cl- removal to 
reversibly depolarise the 3T3-L1 adipocyte plasma membrane suggests that 
Cl- has a role in the generation of resting membrane potential in these cells. 
The basal input resistances of primary white fat adipocytes with resting 
membrane potential values between -20 and -P9UDQJHGIURP*DQG
*$VWKHSODVPDPHPEUDQHK\SHUSRODULVHVZLWKLQFUHDVLQJ>&O-]o the input 
resistance increases (P<0.05, Pearson). There was no significant correlation 
between input resistance and membrane potential in 5mM extracellular Cl- for 
either the primary (Figure 2.17) or 3T3-L1 adipocytes (Figure 2.18). 
 
Figure 2.17. Correlation analyses between input resistance and membrane potential in 
primary white fat adipocytes. (A) 138mM extracellular chloride and (B) in 5mM extracellular 
chloride. In 138mM extracellular chloride the input resistance is significantly correlated with 
PHPEUDQHSRWHQWLDO33HDUVRQRXWRIDGLSRF\WHVWHVWHGKDG503¶VRIEHWZHHQ-20 
and -45mV. All of these adipocytes KDG LQSXW UHVLVWDQFHV RI EHWZHHQ  DQG * ,Q P0
extracellular Cl- ,there was no correlation between Vm and input resistance. 
Chapter 2 
72 
 
 
Figure 2.18. Correlation analysis between input resistance and membrane potential in 
differentiated 3T3-L1 adipocytes.  (A) 138mM extracellular Cl- n=10 (B) and 5mM 
extracellular Cl- (n=11). 
For primary adipocytes, the pooled input resistance in 138mM Cl- was 
0.8±* Q  DQG LQ P0 &O- 0.7±* Q  2QH GDWD VHW ZDV
excluded on the basis of non-linearity. For the 3T3-L1, the input resistance in 
138mM Cl- was 0.6±*Q ZKHUHDV LQP0&O-, it was 0.5±*
(n=11). A parametric paired t test was conducted for analysis involving both 
adipocyte models.  
Although the input resistance appears high, values reported here are lower 
than those reported for other cell types such as smooth muscle cHOOV*
DQGQHXURQV*). (Klockner and Isenberg, 1985, Pixley and Pun, 1990). 
The greater the input resistance, the less conductance there is across the 
membrane, and the less likely it is that ion channels will be open. Conversely, 
it is possible that if fewer ion channels are open, the ions that transition 
through these may have a more significant effect on the membrane 
responses of the cell.  
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Additionally measurements of input resistance in single cells are high, both 
isolated smooth muscle + rabbit portal vein are reported to have IR values 
a*ƥDWUHVWLQJPHPEUDQHSRWHQWLDOVRIa-50mV (Wilde and Lee, 1989). 
2.5.7 Determination of [Cl-]i 
On the basis of [Cl-]o being 135mM and ECl
- being -30mV (the median 
membrane potential of adipocytes). If we assume only Cl- is involvement in 
adipocyte RMP then we can calculate from the Nernst equation (See Equation 
2.3) a value for [Cl-]i of 42mM. As such, on reduction of [Cl
-]o to 5mM the Vm 
would be expected to depolarize to +52mV. Such a membrane potential 
response was not observed, this supports the role of an additional ion 
involved in adipocyte Vm. 
2.5.8 The effect of Na+ on adipocyte Vm 
When two or more ions contribute to the cells resting membrane potential, 
the membrane potential will not be at the equilibrium potential for either ion. 
To test the hypothesis that Na+ has a role in adipocyte resting membrane 
potential, RMP, extracellular Na+ was removed from the bath solution by 
equimolar substitution with NMG. NMG is a cationic compound which cannot 
permeate cation channels (Clifford et al., 1998). 
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Figure 2.19. The effect of removal of extracellular Na+ on adipocyte membrane 
potential. (A) primary adipocytes, n=7 and (B) 3T3-L1 adipocytes, n=7. Removal of 
extracellular Na+ caused a significant and reversible hyperpolarisation of the adipocyte plasma 
PHPEUDQH3)ULHGPDQ¶VLQERWKDGLSRF\WHPRGHOV 
Input resistances were measured to determine any changes in membrane 
permeability that may result as a consequence of ion channel activity. Data 
are presented as Mean ± SEM. For the primary adipocytes the input 
resistance in Na+ was 0.4±0.5G, in NMG Cl 1±0.7* and upon return to 
Na+ reversed back to 0.6±0.4*, with a significant difference in input 
resistance between Na+ and NMG Cl-, P<0.05 (Friedman¶V). For the 3T3-L1 
adipocytes, the input resistance in Na+ was 0.5±0.2*, in NMG Cl- 
0.4±0.1*, and upon return to Na+ 0.2±0.1*)ULHGPDQ¶V. 
Removal of Na+ from the bath solution resulted in a reversible & significant 
hyperpolarisation of both the primary and the 3T3-L1 adipocyte plasma 
membrane of 10mV 3 )ULHGPDQ¶V (Figure 2.19). Since these 
experiments suggest an involvement of Na+ on RMP. 2-APB a blocker of non-
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selective ion channels was used to investigate the channel types which may 
underlie this permeability (Figure 2.20).  
 
Figure 2.20. The effect of 100µM 2-APB on adipocyte membrane potential. (A) primary 
adipocytes n=5, and (B) 3T3-L1 adipocytes, n=7. 100µM 2-APB did not have any significant 
HIIHFWRQPHPEUDQHSRWHQWLDOLQHLWKHURIWKHDGLSRF\WHPRGHOVWHVWHG)ULHGPDQ¶V 
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Figure 2.21. The effect of the DMSO vehicle control on membrane potential in 
differentiated 3T3-L1 adipocytes. Perifusion of 1% (v/v) DMSO in the perifusion media did 
not cause any significant change in membrane potential, n=5 )ULHGPDQ¶V 
Neither 2-APB or its vehicle DMSO (Figures 2.20 and 2.21) affected Vm of 
either adipocyte model. See appendicies for an investigation into the effects 
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of 2-APB in rat dorsal root ganglions. Dorsal root ganglions are reported to 
express non selective cation channels (Elg et al., 2007). 
2.5.9 The effect of insulin and isoprenaline on adipocyte membrane 
potential 
Isporenaline and insulin have been reported to alter membrane potential of 
both adipocytes and in other target tissues (Section 2.2). To explore the 
possibility that these hormones may change membrane potential of 
adipocytes the effect of insulin and isoprenaline on the resting membrane 
potential of primary (A) and 3T3-L1 (B) adipocytes was investigated.  
 
Figure 2.22. The effect of 100nM insulin and the acetic acid vehicle control on 
membrane potential. (A) primary adipocytes (n=12) and (B) differentiated 3T3-L1 adipocytes 
at 320C (n=3, note the lack of 25%/75% quartiles due to the small n). Neither insulin nor acetic 
acid haG D VLJQLILFDQW HIIHFW RQ PHPEUDQH SRWHQWLDO )ULHGPDQ¶V LQ HLWKHU DGLSRF\WH PRGHO
tested. 
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Figure 2.23.The effect of perifusion of 10µM isoprenaline on the membrane potential of 
differentiated 3T3-L1 adipocytes. Of the total population (n=12) 64% of the 3T3-L1 
depolarise as a result of isoprenaline perifusion at 32oC. This effect on Vm is not statistically 
VLJQLILFDQW)ULHGPDQ¶V  
Figure 2.22 shows that neither 100nM insulin or the vehicle control for insulin, 
acetic acid, have no significant effect on membrane potential in either 
primary (A) or differentiated 3T3-L1 adipocytes (B). Figure 2.23 shows that 
10µM isoprenaline does not have an effect on the membrane potential of 
3T3-L1 adipocytes. The vehicle for isoprenaline, DMSO, did not have an effect 
on 3T3-L1 RMP (Figure 2.21).  
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2.6 Discussion 
2.6.1 Tissue culture 
Differentiation of 3T3 fibroblasts to 3T3-L1 adipocytes occurs only after 
cessation of cell proliferation. At this point, the cells incorporate an increased 
amount of fatty acid precursors into triglycerides, as visualised by the 
formation of multiple small fat droplets, which over time incorporate into 
large fat droplets. Differentiated 3T3-L1 adipocytes adopt an appearance 
which is similar to, but not identical to that of the mature adipocytes (Figure 
2.6 and Figure 2.7). 3T3-L1 adipocytes express markers of adipocyte 
GLIIHUHQWLDWLRQ VXFKDV 33$5ǻDQG&(%3Į (Ntambi and Young-Cheul, 2000, 
Guo and Liao, 2000), incorporate glucose into triglyceride in response to 
insulin (Green and Kehinde, 1975, Mehra et al., 2007, Straub et al., 2011), 
and secrete adipose specific adipokines such as adiponectin and resistin 
(Soares et al., 2005, Kershaw and Flier, 2004, Kamigaki et al., 2006). To 
confirm that the 3T3-L1s were successfully accumulating lipids during the 
differentiation process and adopting an adipocyte phenotype, Oil Red O was 
used to monitor lipid accumulation within the 3T3 fibroblasts during the 
differentiation time-course. The differentiation end point (Figure 2.6C) was a 
heterogenous population of 3T3-L1 adipocytes at varying stages of the 
differentiation process; this is not uncommon as others also do not observe 
100% differentiation (Green and Meuth, 1974, Green and Kehinde, 1975). It 
is possible that the cells are not asynchronous with regard to the time-frame 
and extent of lipid accumulation. It is also likely that not all cells are capable 
of differentiation, and that the non-differentiating cells continue to proliferate 
maintaining the monolayer during the differentiation time-course. The 
presence of non-differentiated adipocytes within our culture is not 
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problematic with regard to this study as only fully-differentiated single 
adipocytes were selected and utilised for patching, as indicated in Figure 2.6C. 
2.6.2 Comparison of RMP in primary adipocytes, 3T3-L1 adipocytes 
and fibroblasts 
Primary adipocytes and differentiated 3T3-L1 cells are both widely used 
adipocyte experimental models, each with their respective advantages and 
disadvantages. Primary adipocytes are considered the most physiological 
adipocyte model. Their large lipid droplet and increased buoyancy render 
conventional tissue culture methods and experimental manipulations 
ineffective (Poulos et al., Ailhaud, 2001). Primary adipocytes cannot 
proliferate and as such cannot be maintained and utilised experimentally over 
extended periods of time unlike their 3T3-L1 counterparts (Ntambi and 
Young-Cheul, 2000). The quality of the cell preparation and indeed the 
variability between different preparations can also determine experimental 
success. Over-digestion with collagenase can potentially increase membrane 
permeability and increase membrane fragility. A need to repeatedly source 
and prepare tissue can introduce variability due to the differences between 
donors; however, this can also be considered a favourable trait as the 
heterogeneity between different rat donors and also individual adipose cells 
within a preparation is more representative of physiological diversity. 
There are very few published electrophysiological studies on adipocytes. So 
far there is no direct experimental comparison of the electrophysiology of 
primary and 3T3-L1 adipocytes, the results presented here are the first. The 
resting membrane potential of primary white fat adipocytes has previously 
been determined. See Table 2.3 for a summary.  
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Vm 
(mV) 
Technique used 
to observe 
membrane 
potential 
Species Tissue 
Preparation 
References 
-28.7 Cl- distribution ratio Rat       
(120-140g) 
Isolated cells 
from epididymal 
fat pads. 
Perry and Hales, 1969 
-46 Microelectrode Rat Epididymal fat 
pad tissue 
explant 
Stark et al., 1980 
-75 Rb+ distribution Rat       
(130-180g) 
Epididymal fat 
pad tissue 
explant 
Davis et al., 1981 
-21 Microelectrode Rat        
(400-500g) 
Mesenterial fat 
pad tissue 
explant 
Akiyama et al., 1990 
-34 Microelectrode Rat       
(120-180g) 
Epididymal fat 
pad tissue 
explant 
Ramirez-Ponce et al., 
1990 
-58 Voltage sensitive 
dye 
Rat                
(150-200g) 
Isolated cells 
from epididymal 
fat pads. 
Cheng et al., 1980 
-34 ZnO nanoelectrodes Human Isolated cells Al-Hilli and Willander, 
2009 
-17 to  
-69 
Microelectrode Rat        
(110-405g) 
Epididymal fat 
pad tissue 
explants 
Beigelman and 
Hollander, 1962 
-27 to  
-29 
Microelectrode Rat (210g) Epididymal fat 
pad tissue 
explants 
Beigelman and Shu, 
1972 
-21 Microelectrode Rat        
(400-500g) 
Mesenterial fat 
pad tissue 
explants 
Kamei et al., 1992 
-22 Microelectrode Rat        
(400-500g) 
Epididymal fat 
pad tissue 
explants 
Kamei et al., 1992 
-22 Microelectrode Guinea Pig 
(600-700g) 
Mesenterial fat 
pad tissue 
explants 
Kamei et al., 1992 
-23 Microelectrode Guinea Pig 
(600-700g) 
Epididymal fat 
pad tissue 
explants 
Kamei et al., 1992 
Table 2.3. A comparison of the techniques used and the resting membrane potentials 
for white fat adipocytes sourced from different species. 
The most commonly reported adipocyte RMP values fall within the range of     
-20 and -46mV, with discrepancies occurring between the RMP obtained via 
Rb+ distribution and the values obtained by the sharp microelectrode 
technique. Rb+ permeates K+ channels and mimics the distribution of K+ 
across the plasma membrane. Through using this technique it is already 
assumed that K+ is the predominant contributor to membrane potential. A 
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problem with ion distribution determinations is that is difficult to determine if 
a singular ion, and which ion determines membrane potential. Accurate 
estimations of intracellular water space also need to be determined and 
shown to be constant throughout. Determining intracellular water space in 
adipocytes is difficult (Cheng et al., 1980, Ailhaud, 2001). Impaling a tissue 
segment or a cell with a microelectrode can cause severe ionic leaks at the 
junction between the electrode and the cell membrane. This can compromise 
the certainty and reproducibility of potentials derived by this method. In 
particular, methods involving repeated electrode contact on agitated tissue 
segments such that multiple perforations occurred, the leakiness of the 
membrane increases giving rise to variable membrane potential 
measurements (Beigelman and Hollander, 1962). Difficulties arise when using 
adipocytes as they comprise predominantly of lipid and only have a thin rim 
of cytoplasm. Microelectrode impalement can be interfered by the clogging of 
the electrode tip with fat. The whole-cell patch configuration is believed to be 
less damaging to the cell, and thus give rise to more accurate recordings of a 
FHOO¶VHOHFWULFDOVLJQDOV(Li et al., 2004). Attempts at ascertaining the whole-
cell configuration of the patch clamp technique within this study on primary 
adipocytes were unfortunately unsuccessful due to persistent clogging of the 
patch pipette tip with lipid. Even less detrimental to the integrity of the cell 
membrane is the perforated patch configuration of the whole-cell technique. 
The integrity of the cytoplasmic components are maintained as electrical 
contact to the interior of the cell is established via perforation using pore-
forming antibiotics, such as amphotericin or nystatin. It is likely that 
variations between primary tissue explants, adipocyte preparations, and the 
methods used to study adipocyte RMP are accountable for the variation in 
adipocyte RMPs reported. Generally the RMP of white adipocytes is notably 
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more depolarised than that of brown adipocytes, as determined by 
microelectrode impalement at 29oC, -50mV to -60mV (Nedergaard, 1981, 
Girardier et al., 1968) DQGRI³excitable´FHOOVVXFKDVQHXURQVZKLFK have a 
resting membrane potential of ~-60mV (Doan and Kunze, 1999). In this 
study, the mean RMP for both the 3T3-L1 (-28±1.23mV, n=88) and the 
primary adipocytes (-31±1.57mV, n=68) as shown in Figure 2.8 are similar 
to the RMP values most commonly reported in the literature for this cell type 
(Table 2.3). 
2.6.3 The involvement of K+ in RMP of 3T3-L1 adipocytes or primary 
adipocytes 
The lack of change in adipocyte membrane potential in response to elevated 
extracellular K+ (50mM), suggest K+ ions are not involved in the RMP of 
either primary epididymal white fat adipocytes or differentiated 3T3-L1 
adipocytes.  
Increasing [K+]o to 80mM depolarised adipocyte resting membrane potentials, 
from -24mV to -12mV, when compared to the RMP in the absence of 
extracellular K+(Beigelman and Shu, 1972). Earlier studies suggested that 
the adipocyte responses to changes in [K+]o
 were only observed in white fat 
adipocytes in rats weighing less than 215g (Beigelman and Hollander, 1964). 
This could be an explanation as to why no membrane potential effects were 
seen in adipocytes in this study, as rats used to source tissue weighed 
between 250-340g. Adipocyte size influences basal and insulin-stimulated 
lipid synthesis, the basal rate of lipolysis and how the cell responds to insulin 
in an antilipolytic capacity (Jacobsson and Smith, 1972). Large cells are less 
likely to take up glucose and exogenous fatty acids in response to insulin 
(Smith, 1971, Lonn et al., 2010). Adipose tissue deposits sourced from 
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heavy/ overweight rats contain larger cells, the increase in adipocyte size 
may influence the electrophysiological properties of the plasma membrane, 
however no report as yet has investigated the differences in plasma 
membrane properties, e.g. ion channel density between obese and lean 
tissues.  
If only K+ ions were involved in setting adipocyte resting membrane potential, 
we would expect the resting membrane potential of adipocytes to be 
approximately -90mV, assuming [K+]i to be 135mM with [K
+]o to be 5.6mM 
where elevation of [K+]o to 50mM would depolarise the adipocyte plasma 
membrane to approximately -26mV. The theoretical adipocyte resting 
membrane potential based on the Nernst potential for K+ was not observed. 
Additionally 50mM [K+]o did not significantly depolarise the plasma 
membrane of the adipocyte. The K+ gradient would make no contribution to 
RMP if it was membrane impermeable. However, the presence of K+ channels 
in the plasma membrane of adipocytes has been recorded. Initially, an 
outwardly rectifying K+ conductance was described by microelectrode 
recording in rat white adipose tissue (Ramirez-Ponce et al., 1991). Studies 
using inside-out patches and whole cell patch configuration have provided 
evidence of the existence of voltage-dependent K+ channels in isolated white 
fat adipocytes from rat, (Ringer et al., 2000, Lee and Pappone, 1997). 
Whole-cell patch clamp studies also describe a voltage-dependent K+ 
conductance in subcutaneous and visceral preadipocytes (Ramirez-Ponce et 
al., 2003) and in mature white fat adipocytes differentiated from epididymal 
pre-adipocytes. (Ramirez-Ponce et al., 1996, Lee and Pappone, 1997). 
A practical limitation of applying the whole-cell configuration to adipocytes is 
persistent clogging of the patch pipette tip due to the high lipid content of 
adipocytes, as was experienced during whole-cell patch clamp attempts upon 
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primary adipocytes within this laboratory. The risk of washout of channel 
regulators in whole cell configuration has also been reported as the electrode 
solution dialyzes that of the cell interior. The size of the cell under study 
determines the likelihood of dialysis of pipette solution with the cell interior, 
with smaller cells more likely to undergo dialysis in comparison to larger cells. 
Ramirez ponce et al (1996) reported adipocyte diameters of 20-60 µM. 
Images of adipocytes in studies conducted by Lee and Pappone (1997) and 
Ramirez Ponce et al (1996) are inclusive of scale bars. The diameters of the 
adipocytes under study within the investigation conducted by Ramirez Ponce 
et al (1996) were varied in size, with an approximate diameter of 30µM. The 
diameter of the adipocytes studies in the literature is generally 2-3 times 
larger than that reported for islet cells (12µM diameter). Islet cells are a 
prominent cell type used in patch clamp investigations (Perez-Armendariz et 
al., 1991), so it is likely that washout of intracellular constituents when 
conducting whole cell investigations with adipocytes, may be less of a 
technical issue, than with other smaller cell types. Despite the observed 
technical difficulties in applying the whole-cell configuration to adipocytes, in 
the study by Lee and Pappone (1997) whole-cell findings were re-enforced by 
replicate investigations in the perforated patch configuration, no difference in 
observations utilising the two techniques was reported (Lee and Pappone, 
1997). Ramirez ponce et al (2003) utilised human pre-adipocytes 
differentiated into mature adipocytes in culture. The adipocyte morphology 
resembled that of the 3T3-L1 cells used in this study at an intermediate stage 
of differentiation (Figure 2.6B). In the study by Ramirez ponce et al (2003), 
differentiation was assessed by eye on the basis of lipid droplet accumulation, 
however lipid stains such as Oil Red O or Sudan black were not utilised to 
confirm the inclusions seen as being lipid, although in earlier studies by the 
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same group utilising rat pre-adipocytes differentiated in culture, did confirm 
lipid accumulation with Oil Red O (Ramirez-Ponce et al., 1996). The K+ 
currents observed in the 1996 and 2003 studies by Ramirez ponce between 
differentiated adipose cells of rat and human origin were not dissimilar. A 
voltage-gated outward current with sigmoidal activation kinetics, and an 
activation threshold of ~-30mV was demonstrated in white adipocytes (Lee 
and Pappone, 1997, Ramirez-Ponce et al., 1996). Macroscopic current 
amplitudes ranged between 0.5nA to 6nA (Ramirez-Ponce et al., 1996). In 
white adipose tissue, the single channel conductance of these channels was 
reported to be 16.4pS (Ringer et al., 2000), whereas in brown adipose tissue 
it was 17pS (Russ et al., 1993). The channels responsible for this current 
were highly selective for K+ with a selectivity sequence of K+>NH4
+>Cs+>Na+. 
This sequence did not differ between adipocytes of rat or human origin 
(Ramirez-Ponce et al., 1996, Ramirez-Ponce et al., 2003). Pharmacological 
K+ channel blockers (tetraethylammonium (TEA), 4-aminopyridine (4-AP), 
barium and cobalt) were used to confirm the identity of these channels as K+. 
In white rat adipocytes, the IC50 for TEA blockade was 1.5mM (Ringer et al., 
2000), similar to the IC50 of TEA blockade in brown adipose tissue of 1.8mM 
(Russ et al., 1993). No difference in K+ channel properties were observed 
between isolated white adipocytes sourced from Sprague Dawley, Zucker 
lean and Zucker obese rats (Lee and Pappone, 1997).  
Similarities between the observations of different investigators, and across 
differing primary tissue sources suggests that voltage-gated K+ conductance 
is a universal property of primary adipose tissue, including brown adipose 
tissue (Russ et al., 1993, Lucero and Pappone, 1989). It was proposed that 
the voltage-gated K+ channel observed in brown adipose tissue was similar to 
the delayed rectifier channel found in nerve. If this is the case, it would 
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suggest that the activity of these channels in brown cells is dependent upon 
depolarisation/excitability (Lucero and Pappone, 1989). 
Regarding the reported differences in RMP between white adipose tissue and 
brown adipose tissue, ~-30mV for white adipose tissue, (see Table 2.3) and -
51mV for brown adipose tissue (Girardier et al., 1968), a non-voltage 
dependent K+ channel was identified in brown adipocytes but not in white 
adipocytes (Russ et al., 1993). It is possible that this channel contributes to 
steady state RMP in brown adipose tissue and is not expressed in WAT.  
As an addition to the current work, it would be of interest to determine the 
presence of K+ channels on the plasma membrane surface of our primary and 
3T3-L1 adipocytes. It is possible that K+ channels are present on the 
adipocyte plasma membrane, however they may be non functional or 
inactivated. cAMP is known to inactivate delayed rectifier K+ channels when 
applied directly (Chung and Kaczmarek, 1995), or via pharmacological 
induction of elevated cAMP (Garber et al., 1990). cAMP is involved in a 
variety of adipocyte functions, differentiation, adipokine secretion (Path et al., 
2001) and lipolysis (see Chapter 2, Section 2.1). Our adipocytes were not 
stimulated by catecholamines to undergo lipolysis or subject to 
pharmacological elevation in cAMP by agents such as dibutyryl adenosine 
3',5'-cyclic monophosphate (DBcAMP, a cAMP analogue), aminophylline or 
pentoxifylline (PDE inhibitors). It is a possibility that the rats would be 
exhibiting a sympathetic nervous system response prior to culling, which may 
result in adipose tissue lipolysis, however there was no membrane potential 
response to elevated extracellular K+ in either the primary or 3T3-L1 
adipocyte model, therefore the likelihood of inhibition of delayed rectifier K+ 
channels by elevated cAMP is unlikely. 
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Since K+ lacked a contribution to adipocyte RMP, the role of Cl- and Na+ on 
adipocyte RMP were investigated.  
2.6.4 Membrane potential of beta cells 
It is well established that K+ ions are the major determinant of resting 
membrane potential in pancreatic beta cells. Eradication of the outward K+ 
gradient either by closure of the K+ ATP channel or elevations in extracellular 
K+ gives rise to membrane depolarisation of the pancreatic beta cell (Smith et 
al., 1990, Manning Fox et al., 2006, Antunes et al., 2000). The resting 
membrane potential values obtained here for mouse beta cells (as shown in 
Figure 2.9) are similar to those previously reported in the literature, ~-62mV 
(Smith et al., 1990, Manning Fox et al., 2006) with depolarisation of Vm in 
50mM extracellular K+ going to ~-20mV. This indicates that our membrane 
voltage measurements by the perforated patch method are comparable to 
membrane voltage measurements previously made by others using either the 
whole-cell patch configuration or the perforated patch configuration (Manning 
Fox et al., 2006, Smith et al., 1990). The observation of membrane 
depolarisation in elevated extracellular K+ is indicative that our perforated 
patch method is valid and confirms suitability of the experimental method 
utilised. It also confirms that K+ is not a determinant of adipocyte RMP.  
2.6.5 Cl- ions are involved in adipocyte RMP 
Cl- is generally present at lower intracellular concentrations than extracellular 
levels (see Table 2.2). Generally, the transmembrane Cl- gradient carries an 
inward negative charge, which either contributes to a hyperpolarised RMP or 
it is in equilibrium with Vm. Our adipocytes do not have a hyperpolarised RMP 
when compared to brown adipocytes or neurons, however, reduction of [Cl-]o 
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from 138mM to 5mM depolarized the plasma membrane, a finding that 
indicates Cl- ions have a role in adipocyte RMP, and the presence of Cl- 
channels (This is further investigated in Chapter 4) (see Figure 2.14). 
Radioisotopic determination of rates of K+, Na+ and Cl- efflux and intracellular 
concentrations in isolated fat cells support the hypothesis that Cl- is a major 
determinant of adipocyte resting membrane potential (Perry and Hales, 
1969). The membrane potential we observed for primary adipocytes (-28mV) 
is identical to the membrane potential reported by Perry et al (1969) as 
determined by radioisotopic methods. Microelectrode studies by Biegelman et 
al (1972) also suggested a role of Cl- in the resting membrane potential of 
primary adipocytes, although this was in conjunction with K+ (Beigelman and 
Shu, 1972). 
It is not entirely uncommon for Cl- ions to be a major determinant of RMP. Cl- 
ions determine the resting membrane potential of the red blood cell, which 
has a resting membrane potential of -8mV. The plasma membrane of the red 
blood cell is thousands of times more permeable to Cl- ions than Na+ or K+ 
ions (Jay and Burton, 1969). The calculated Nernst potential for Cl- ions in 
the red blood cell matches experimental observations of resting membrane 
potential made by investigators Jay and Burton (Jay and Burton, 1969). Cl- 
ions are also implicated in the resting membrane potential of bovine 
pulmonary artery cells. When the Cl- ion component is eliminated the cell 
hyperpolarises from -26mV towards the Nernst potential for K+ ions, -62mV 
(Voets et al., 1996). The resting membrane potential of rabbit articular 
chondrocytes, -42mV, has also been reported to be maintained by Cl- ion 
conductance (Tsuga et al., 2002). It seems reasonable to conclude that Cl- 
ion conductance contributes to the resting membrane potential of adipocytes. 
Multiple ion conductances often determine membrane potential at rest. We 
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suggest that the other ion conductance involved in adipocyte RMP is that of 
the Na+ ion. 
Input resistances were calculated prior to and post extracellular Cl- removal, 
(1) to eliminate the possibility that the adipocyte plasma membrane was 
leaky, and (Hulme et al.) to investigate the hypothesis that an increase in 
channel activity would increase the permeability and hence decrease the 
resistance of the adipocyte plasma membrane. If the plasma membrane of 
the cell was leaky, a low input resistance would result regardless of ion 
channel activity due to high membrane permeability. It would be expected 
WKDW DGLSRF\WHVZLWK ³OHDN\´PHPEUDQHVZRXOG EH XQDEOH WRPDLQWDLQ WKHLU
ionic mileau, and as such it is expected they would have resting membrane 
potentials in 138mM Cl- of close to 0mV. Conversely, regarding channel 
activity, a decrease in ion channel activity would decrease the permeability 
and hence increase the input resistance of the adipocyte plasma membrane. 
There was no significant difference in mean input resistance in either primary 
or 3T3-L1 adipocytes between 138mM Cl- and 5mM Cl- bath solutions. 
2.6.6 Na+ ions contribute to adipocyte RMP 
The data presented Figure 2.19 suggest that Na+ has a role in the RMP of 
both the primary adipocyte, and 3T3-L1 adipocyte. It is known that Na+ 
conductance contributes to RMP in brown adipocytes (Girardier et al., 1968). 
For Na+ to contribute to RMP, a Na+ selective pathway in the plasma 
membrane is required. Na+ currents are carried by a number of channel types 
and transporters including ligand-gated sodium channels, voltage-gated 
sodium channels, non-selective cation channels. It is unlikely that voltage-
gated Na+ channels contribute to adipocyte RMP. No evidence of an inward 
current that would be indicative of an inward voltage-gated Na+ or Ca2+ 
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conductance has been reported (Lee and Pappone, 1997, Ramirez-Ponce et 
al., 2002). Secondly, I-V relationships for estimation of RIN were linear 
(Figure 2.16) and did not indicate any voltage-dependent components. Store-
operated calcium channels (SOCs) are also Na+ permeable (Arnon et al., 
2000); it is unlikely that Na+ permeable SOCs are involved in adipocyte RMP, 
as their main role is regulation of store-operated calcium entry and are only 
active in response to internal Ca2+ store emptying (Parekh and Putney, 2005). 
It was hypothesised that the Na+ currents carried by non selective cation 
channels are involved in the membrane potential responses observed. Na+ 
conductance via non-selective cation channels are suggested to be involved 
in the generation of resting membrane potentials in bovine pulmonary artery 
cells (Voets et al., 1996) and in rabbit arterial smooth muscle cells, where the 
non-selective cation channel conductance is twice that of the K+ channel 
conductance (Bae et al., 1999). Single channel data has provided evidence 
for the presence of non-selective cation channels in both primary white 
adipocytes and brown adipocytes (Halonen and Nedergaard, 2002, Ringer et 
al., 2000, Weber and Siemen, 1989). In the current investigations, buffer 
substitution of Na+ for K+ had no effect on adipocyte membrane potential, 
however removal of extracellular Na+ by equimolar substitution with NMG Cl- 
caused a hyperpolarisation of the adipocyte plasma membrane. As NMGCl 
FDQ¶W SHUPHDWH QRQ VHOHFWLYH FDWLRQ FKDQQHOV WKLV LV LQGLFDWLYH RI QRQ-
selective cation channel conductance (Figure 2.19). 
Currently, the channel selectivity for non-selective cation channel antagonists 
is poor. To ascertain in a general context, the presence of non selective 
cation channels on the plasma membrane of our adipocytes, 2-
Amioethoxydiphenylborate (2-APB), a TRP channel inhibitor, was utilised (See 
Table 2.6). The consensus is that maximal block of non-selective cation 
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channels by 2-APB occurs a concentration of ~100uM. If this is the case, it 
would be expected that 2-APB inhibits Na+ influx causing hyperpolarisation of 
plasma membrane. In experiments presented here, there was no membrane 
potential effect of 2-APB in either adipocyte model (Figure 2.20).  
Table 2.6 summarises the TRP channel types blocked by 2-APB, and the 
inhibitory concentration. TRPC and TRPCM channels are the predominant TRP 
channel types that are blocked by 2-APB. To confirm the effects of 2-APB 
blockade on non-selective cation channels, rat DRG neurons were sourced as 
a positive control. In rat DRG neurons, single cell RT PCR identified TRPC1 & 
TRPC6 mRNA (Alessandri-Haber et al., 2009). DRGs from mouse had an 
abundant expression of TRPC1, TRPC3 and TRPC6 mRNA, with lower levels of 
expression of TRPC2, TRPC4 and TRPC5 mRNA (Elg et al., 2007). Expression 
of multiple TRPC channel types within one tissue is not uncommon 
(Abramowitz and Birnbaumer, 2009), this may complicate my interpretation 
of the observed 2-APB effect.  
Proteins  Concentration/ IC50*  
TRPC1  >80% inhibition @80µM  
TRPC3  >90% inhibition @ 90µM  
TRPC5  19µM*  
TRPC6  10.4uM*  
TRPM2  >95% inhibition 30µM  
TRPM3  87.5% inhibition @ 100µM  
TRPM7  178µM*  
TRPM8    
Voltage 
operated K+ 
channel  
5µM  
Table 2.6. A Comparison of the potencies of 2-APB in inhibiting a range of channels and 
proteins from (Togashi et al., 2008). Note, 2-APB was used at 100µM within this 
investigation. 
Chapter 2 
92 
 
Using the perforated patch clamp technique, 20mM OAG (synthetic cell 
permeable diacyl glycerol analogue) was used with primary rat DRG neurons 
to activate the TRPC channels, (Vazquez et al., 2003, Hofmann et al., 1999, 
Venkatachalam and Montell, 2007). It was hypothesised, that this would 
result in a cellular influx of Na+ resulting in membrane depolarisation, which 
would then be ameliorated following application of 100µM inhibitory 
concentration of 2-APB in the presence of 20mM OAG. Unfortunately due to 
time constraints it was not possible to fully optimise seal formation on the 
DRGs within these patch clamp investigations. As most TRP channels are 
permeant to Ca2+ ions (Hofmann et al., 1999, Nilius and Voets, 2005), 
calcium imaging was used as an alternative approach utilising the same 
method as described in Chapter 3, Section 3.9.3. The results and discussion 
of this experiment are presented in appendicies. In short the findings in this 
study were inconclusive; as such the presence of NSCC on the plasma 
membrane of white adipocytes is yet to be fully ascertained. 
2.6.7 The effect of insulin on adipocyte membrane potential 
Insulin and the catecholamines, adrenaline, noradrenaline and isoprenaline 
are known to modulate metabolic activity in white fat adipocytes. Insulin was 
originally reported to hyperpolarise the resting membrane potential of the 
insulin responsive tissue, skeletal muscle (Zierler, 1966). This was proposed 
to be via accelerated Na+ efflux activated by insulin. An increase in 
permeability, and inward flux of Cl- ions was also considered a potential 
consequence of insulin. In contrast to published observations in adipocytes, 
insulin was not reported to increase permeability of the plasma membrane to 
K+ (Zierler, 1966),  
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In adipocytes, insulin is antilipolytic (Ahmadian et al., 2009, Jacobsson and 
Smith, 1972). As insulin is membrane impermeable, it is likely that its 
membrane potential effects occur due to altered ion flux via modulation in ion 
channel function, or via altered trafficking and channel expression. It has 
been suggested that the functional effect of insulin occurs via modulation in 
membrane potential. Intracellular recording demonstrated that insulin 
hyperpolarised the RMP of white adipocytes by 13.5mV, potentially by 
reducing intracellular cAMP concentrations and increasing outward K+ 
conductance (Ramirez-Ponce et al., 1991, Ramirez-Ponce et al., 1998). K+ 
channel current density in differentiated adipocytes was larger in the 
presence of insulin when compared to non-insulin exposed cells, indicating 
that insulin may also modulate K+ currents by up-regulation of K+ channel 
trafficking to the plasma membrane (Ramirez-Ponce et al., 2002). Rb+ fluxes 
suggested that insulin caused a 9mV hyperpolarisation of the white adipocyte 
plasma membrane (Davis et al., 1981). The hyperpolarisation of white 
adipocytes observed in insulin by Davis  et al (1981) is identical to the mean 
change from RMP of -9mV in the presence of insulin, as determined by 
microelectrode impalement (Beigelman and Hollander, 1962). In the case of 
Beigelman and Hollander et al (1962), there was a large distribution of 
resting RMP values (-17 to -69mV) and membrane potential change in the 
presence of insulin. Such a large spread of data, may mask any significance. 
In our adipocytes, insulin caused a 5mV depolarisation in median resting 
membrane potential (Figure 2.22), however this effect was not statistically 
significant, a finding in agreement with observations by Stark et al (1980). 
The reasons for the difference in the reported effects of insulin and those 
shown here are unknown.  
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2.6.8 The effect of isoprenaline on adipocyte membrane potential 
There was no membrane potential effect of isoprenaline this is unlikely to be 
due to DQ DEVHQFH RI ǃ-adrenoceptors since their functional presence has 
already been shown in differentiated 3T3-L1 cells within our laboratory 
(Pulbutr, 2009). 
The lack of a membrane potential effect observed with isoprenaline is in 
contrast to that reported by others. Noradrenaline causes depolarisation of 
the white adipocyte RMP by ~8.5mV (Ramirez-Ponce et al., 1991). Brown 
adipose tissue segments also depolarised  from -50mV to ~-30mV following 
adrenoceptor stimulation with noradrenaline (Schneider-Picard et al., 1985). 
Based on observations by Hamida et al (2011) demonstrating the functional 
effect of depolarisation on the stimulation of lipolysis, the lack of membrane 
potential effect of isoprenaline in 3T3-L1 cells could indicate that lipolysis was 
not stimulated as catecholamine resistance has been demonstrated in human 
adipocytes sourced from populations of normal healthy individuals (Lonnqvist 
et al., 1992). Hamida et al (2011) also demonstrated resistance to 
isoprenaline-induced lipolysis in human abdominal subcutaneous adipocytes, 
however the BMI and health status of the donors was unknown (Hamida et 
al., 2011). Although not demonstrated here, previous work within this 
laboratory has demonstrated that application of 10µM isoprenaline is suitable 
for the induction of lipolysis of adipocytes (Pulbutr, 2009). The EC50 of 
isoprenaline for the induction of lipolysis, as consistently reported by others, 
is 0.1µM (Langin et al., 2005, Tebar et al., 1993). Inhibition of lipolysis under 
HOHYDWHG FRQFHQWUDWLRQV RI LVRSUHQDOLQH 0 DQG LWV ELQGLQJ WR Į-
adrenoceptors has been reported (Skomedal et al., 1984). The concentrations 
of isoprenaline used in this study were sufficiently lower, also previous 
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VWXGLHV LQ RXU ODERUDWRU\ GLG QRW VKRZ Į-adrenoceptor involvement in 
isoprenaline-stimulated lipolysis (Pulbutr, 2009)&RQYHUVHO\Į-adrenoceptor 
involvement is implicated in the membrane depolarisation of brown adipose 
tissue (Schneider-Picard et al., 1985) partly mediating K+  efflux (Weber and 
Siemen, 1989). 
2.6.9 The involvement of cAMP in the mediation of the membrane 
potential effects of insulin and isoprenaline 
The existence of K+ currents reported in adipocytes has lead to the 
hypothesis that, as with brown adipocyte (Girardier et al., 1968, Horwitz et 
al., 1969, Lucero and Pappone, 1990), both insulin and noradrenaline act by 
modulating K+ conductances. Elevating intracellular cAMP (reported to block 
K+ channels) indirectly by addition of forskolin (50µM), or directly, in addition 
with phosphodiesterase inhibitor IBMX, reduced voltage rectification in 
adipocytes. It was suggested that noradrenaline induced increases in [cAMP]i, 
and blocked outward K+ conductance resulting in depolarisation. This effect in 
white adipose tissue may depend on the adipocyte source. Mesenterial 
adipocytes did not show a membrane potential effect of isoprenaline (50nM) 
(Akiyama et al., 1990), however the membrane potential response was 
significantly depolarised in the presence of theophylline, an agent known to 
elevate cAMP (Stefanovich, 1979), again confirming a requirement for cAMP 
involvement in the membrane responses seen (Akiyama et al., 1990).  
If the membrane potential effects of insulin and isoprenaline are dependent 
on a functional K+ conductance, this could explain the absence of any 
membrane potential effect in our adipocyte models as they are not 
responsive to modulations in K+. Functional studies assessing lipolysis in 
brown adipocytes investigated the effect of ouabain (an Na+/K+ ATPase 
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inhibitor) and theophylline (inhibitor of cyclic AMP breakdown). The authors 
observed no effect of theophylline on noradrenaline-stimulated lipolysis, 
suggesting that the effect of noradrenaline may be independent of adenylate 
cyclise activation and subsequent augmentation of intracellular cAMP levels. 
However there was a requirement for inward K+ conductance through the 
Na+/K+ ATPase. Removal of extracellular K+ by substitution with choline, an 
impermanent cation, impaired free fatty acid release to a similar extent as 
ouabain (Herd et al., 1973). K+ channel inhibition may not be the only 
mechanism involved in the induction of lipolysis, however it is possible that 
the mechanism of regulation of lipolysis differs between brown and white 
adipocytes.  
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2.6.10 Summary 
Data show that the K+ conductance through K+ ion channels, is not a 
determinant of membrane potential in either primary adipocytes or in 
differentiated 3T3-L1 cells. The membrane potential of both primary 
adipocytes and differentiated 3T3-L1 adipocytes is ~-30mV. The major ion 
involved in adipocyte membrane potential is Cl-, with a minor role of Na+. 
Data also suggest a role of non selective cation channels as a cellular Na+ 
entry pathway in adipocytes. Neither insulin nor isoprenaline had an effect on 
the Vm of either adipocyte model, as such, any functional effects of insulin or 
ǃ-adrenoceptor stimulation on adipocytes are unlikely to be modulated by 
alterations in membrane potential. Additionally, membrane responses were 
similar between the 2 adipocyte models for all investigations within this 
chapter; suggesting a similar mechanism for the regulation of Vm between 
primary and differentiated 3T3-L1 adipocytes.  
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3.1 Introduction 
Ca2+ is a ubiquitous second messenger that is involved in signal transduction 
within numerous cell types. Changes in the concentration of intracellular Ca2+ 
([Ca2+]i) instigate a range of cellular functions from muscle contraction, 
neurotransmitter release, exocytotic release from endocrine cells and gene 
expression (Catterall et al., 2003b). [Ca2+]i needs to be tightly controlled to 
maintain appropriate cellular homeostasis and function. Dysregulated Ca2+ 
signalling can result in abhorrent cell function and the development of a disease 
state. Examples include dysregulations in the inositol triphosphate (IP3) pathway 
in nHXURQV LQWKHGHYHORSPHQWRI$O]KHLPHU¶VGLVHDVH (Stutzmann et al., 2004), 
dysregulated Ca2+ signalling by L-type VGCCs in muscle disorders (MacLennan, 
2000) and dysregulated Ca2+ handling by the ryanodine receptor (RYR) Ca2+ 
channel in the control of sarcoplasmic Ca2+ release in cardiomyopathies (Kranias 
and Bers, 2007). In the non-excitable smooth muscle, a switch in expression of L-
type VGCCs to T-type channels contributes to the development of vascular 
disease (House et al., 2008).  
Sources of Ca2+ are derived from Ca2+ release from the intracellular stores, or via 
extracellular Ca2+ influx. There are numerous Ca2+ influx pathways (see Chapter 1, 
Section, 1.2.1) including ligand-gated ion channels, store-operated ion channels, 
and, as discussed herein, voltage-gated Ca2+ channels and the sodium calcium 
exchanger. 
 
 
Chapter 3 
103 
 
3.1.1 Voltage-gated calcium channels 
Voltage-gated calcium channels (VGCCs) are multi-subunit, transmembrane 
proteins which mediate Ca2+ entry in a variety of cell types in response to 
depolarized membrane potentials (Arikkath and Campbell, 2003). The presence 
and function of VGCCs in excitable cell types such as neurons, muscle cells, and 
cardiac muscle cells is well established (Ertel et al., 2000). VGCCs are 
increasingly being reported in non-excitable cell types, regulating functions such 
as endocrine secretion and gene expression (Catterall et al., 2003b, Tsien et al., 
1991). There is increasing evidence for the contribution of L-type Ca2+ channels 
in insulin action. L-type Ca2+ currents in both primary, and islet cell lines are 
implicated in insulin secretion (Satin et al., 1995, Jung et al., 2009). It is possible 
that L-type Ca2+ currents have a role in insulin signalling as they have been 
described in insulin target tissues such as the liver and skeletal muscle, although 
characterisation of their role is needed. Adipose tissue is a target tissue for insulin 
action. Ca2+ influx by VGCCs is suggested to influence insulin responsiveness in 
white adipose tissue, however to date evidence is limited; this point is expanded 
upon in Section 3.7. 
3.1.2 The sodium calcium exchanger 
The Na+/Ca2+ exchanger (NCX) is regarded as an essential Ca2+ signalling 
component which is present on the plasma membrane of many cell types, in 
particular the heart (Philipson and Nicoll, 2000). The NCX is a bi-directional 
exchanger which can operate as a means of both Ca2+ efflux or influx. The NCX 
utilises the electrochemical gradient of Na+ to mediate the counter transport of 
3Na+ ions for 1Ca2+ ion (Reuter et al., 2005). The stoichiometry of the NCX is the 
exchange of 3Na+ ions to 1Ca2+ ion (3:1), although exchange ratios of 1:1 and 
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4:1 have been suggested (Iwamoto and Kita, 2004, Dong et al., 2002). The 
calcium efflux mode of NCX LVUHIHUUHGWRDVWKH³IRUZDUGPRGH´, whereby NCX 
extrudes Ca2+ from the cytoplasm. It is generally accepted that under normal 
physiological conditions, the NCX works as a Ca2+ extrusion mechanism. Net Ca2+ 
efflux via the NCX is accomplished using energy derived from the Na+ gradient 
set up by the ATP-dependent Na+ pump (Li et al., 1994).  
Plasm
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Figure 3.1. The sodium-calcium exchanger, a representation of Ca2+ efflux and Ca2+ influx 
modes.  
Alterations in membrane potential or in Na+ and Ca2+ gradients can initiate the 
³UHYHUVHPRGH´RI exchange such that Ca2+ is transported into the cell, with Na+ 
being extruded (Altimimi and Schnetkamp, 2007). Elevated [Na+]i or reductions 
in [Na+]o are reported to alter the mode of exchange from the forward to the 
reverse mode (Rathi et al., 2004). The NCX is also reported to operate in the 
reverse mode at membrane potentials of ~-40mV, however this is dependent 
upon Ca2+ and Na+ FRQFHQWUDWLRQ JUDGLHQWV $ YLVXDO RYHUYLHZRI WKH ³IRUZDUG´
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DQG³UHYHUVH´PRGHVRI1&;LVVKRZQLQFigure 3.1. The structure of the NCX is 
shown in Figure 3.2. 
The physiological role of the forward mode of the NCX has been well 
characterised in heart muscle. During cardiac excitation-contraction coupling, 
Ca2+ enters cardio myocytes upon membrane depolarisation through Cav1. VGCCs 
(Quednau et al., 1997); or via Ca2+ induced Ca2+ release. Following each cardiac 
contraction, Ca2+ is extruded via the NCX, ensuring cardiac relaxation and 
maintaining Ca2+ homeostasis (Reuter et al., 2005). The physiological role of the 
reverse mode of the NCX is less well characterised. Leblanc and Hulme (1990) 
proposed that Ca2+ influx via the NCX is involved in cardiac action potentials 
(Leblanc and Hume, 1990), however the function of the reverse mode of the NCX 
is well characterised under pathological conditions. For example, in ischemia 
associated reperfusion injury, there is an increase in cardiomyocyte [Na+]i. This is 
suggested to induce [Ca2+]i overload by the reverse mode of the NCX (Iwamoto 
et al., 1996b). Additionally platelets from diabetic patients exhibit abnormal Ca2+ 
homeostasis, which has also been suggested to occur as a result of Ca2+ influx via 
the reverse mode of the NCX (Li et al., 2001). 
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Figure 3.2. Model of the Na+/Ca2+ exchanger, (adapted from Philipson and Nicoll (2000)). 
The NCX is modelled to comprise 9 segments. The N-terminus is glcosylated and located 
H[WUDFHOOXODUO\7KHĮ-repeat regions in transmembrane segments 2, 3 and 7 are represented by blue 
shading. Segment 6 has previously been suggested to be a transmembrane segment, however it is 
also suggested to be part of the large intracellular loop region (as represented by the shaded triangle). 
The XIP region, Ca2+ binding site and the region where alternative splicing occurs are all shown on the 
large intracellular loop. GIG represents a Glycine, Leucine, Glycine segment. 
3.1.3  Voltage-gated Ca2+ channel structure 
Structural knowledge of a protein aids supported hypothesis of biochemical 
function or molecular binding partners and their mode of interaction with the 
protein. Understanding protein interactions with its subunits, substrates, and 
regulators aids the identification of physiological function and cellular role of the 
protein, how it is regulated, and how expression and function may alter in a 
disease state. Structure prediction methods such as homology searches (Hanlon 
et al., 1999), hydropathy profiles and for some subunits, electron microscopy 
(Wang et al., 2004) and x-ray crystallography have been utilised to establish the 
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structure of VGCCs (Opatowsky et al., 2004, Van Petegem et al., 2004). Excellent 
general reviews on the structure and classification of VGCCs are available 
(Lipscombe et al., 2004, Catterall, 2000, Catterall et al., 2003a, Ertel et al., 2000) 
as only a brief summary will be presented in this introduction.  
Multiple systems of classification exist for VGCCs. The first system of classification 
split the Ca2+ channels into two groups, high voltage activated (HVA) and low 
voltage activated (LVA). This system based on observations made through the 
utilisation of electrophysiological and pharmacological techniques. When Barium 
(~100mM) was used as a charge carrier in single-channel studies HVA channels 
activate at membrane potentials positive to ~-20mV and thus need to be subject 
to greater levels of depolarisation to activate (Catterall et al., 2003b, Jones, 
1998). Members of the HVA channel family were first discovered in skeletal, 
smooth and cardiac muscles. HVA channels were named L-type channels as they 
had a LARGE and LONG-LASTING current, comprising a large single-channel Ca2+ 
conductance (~25pS) with slow current decay (Fox et al., 1987). 
The next system of classification was based on the type of Į1 subunit the channel 
FRPSULVHGRI7KHQRPHQFODWXUHRIWKHĮ1 gene products was based on their order 
RIGLVFRYHU\Į1s was the first channel isoform to be cloned within a laboratory, 
WKLV ZDV GHULYHG IURP VNHOHWDO PXVFOH Į1A- Į1I are subsequently discovered 
subunits, however this system of nomenclature was found to cause confusion as 
no identification of channel properties or structure is given (Catterall et al., 2003b, 
Catterall et al., 2003a). In 2000, Ertel et al (2000) suggested a system of 
nomenclature for VGCCs that was based on the channels structural relationships 
as well as conforming to the system of nomenclature used for other VGCC 
families, (i.e. Na+ and K+). Ca2+ channels were renamed such that the chemical 
symbol of the permeating ion was used in conjunction with the channels primary 
Chapter 3 
108 
 
regulator (e.g. voltage), denoted in subscript. The first numerical indicator 
LGHQWLILHV WKHRUGHURIGLVFRYHU\RI WKHĮ1 VXEXQLWZLWKLQ WKDWĮ1 gene family. In 
the instance where a splice variant of a particular channel needs to be identified, 
lower case letters are used (Ertel et al., 2000). An overview of Ca2+ channel 
nomenclature/classification is shown in Table 3.1, additionally the structure of 
VGCCs is shown in Figure 3.3. 
Current 
Nomenclature 
Former 
Nomenclature 
Ca2+ channel 
Classification 
Generic Ca2+ 
channel 
classification 
Cav1.1 Į1S  
L-type 
 
 
HVA 
Cav1.2 Į1C 
Cav1.3 Į1D 
Cav1.4 Į1F 
Cav2.1 Į1A P/Q-type 
Cav2.2 Į1B N-type 
Cav2.3 Į1E R-type  
LVA Cav3.1 Į1G  
T-type 
Cav3.2 Į1H 
Cav3.3 Į1I 
Table 3.1. An overview of Ca2+ channel nomenclature and classification. High voltage 
activated, HVA; Low voltage activated, LVA. 
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Figure 3.3. The subunit structure of VGCC channels, reproduced with permission (Catterall et al., 
2005). The illustrated model depicts the subunit composition and structure of a skeletal muscle Ca2+ 
FKDQQHO&\OLQGHUVDUH UHSUHVHQWDWLYHRIĮKHOLFHV. VGCCs are comprised of a transmembrane alpha 
subunit (190-250kDa), a regulatory cytoplasmic beta ǃ subunit (52-62kDa), with gamma, delta and 
J-subunits completing the complex, however the J subunit is omitted in neuronal VGCCs (Catterall, 
2000). 7KHĮ1-subunits incorporate the conduction pore, voltage sensor and gating apparatus, as well 
as the sites of regulation by drugs, toxins, and second messengers (Catterall et al., 2005). The VGCC 
protein is organised into 4 homologous domains (I-IV) with 6 transmembrane segments (S1-S6) 
within each domain. The membrane-spanning S4 segments of each domain are highly-conserved 
amphipathic helices, comprising of positively charged residues at every 3rd or 4th position (Catterall et 
al., 2005, Hui et al., 1991). The S4 segment of VGCC is the voltage sensor. 
6ROHH[SUHVVLRQRIWKHĮ1-subunit is sufficient for Ca2+ channel activity, however 
co-H[SUHVVLRQ RI WKH Į1-VXEXQLW ZLWK WKH Į2į-subunit increases the surface 
expression of the channel, macroscopic current amplitude, and alters the voltage-
dependence of channel activation/inactivation (Felix et al., 1997). More recently a 
UROHRIWKHĮ2į-subunit in regulating the surface distribution of VGCCs in response 
to epigenetic cues has been suggested, also that these subunits aid association of 
the channel complex with lipid rafts, pertaining to areas of elevated VGCCs 
H[SUHVVLRQ RU ³KRW-VSRWV´ (Robinson et al., 2010). Lipid rafts are increasingly 
reported to be involved in protein compartmentalisation (Chini and Parenti, 2004, 
Hardie and Muallem, 2009). Lipid rafts are specialised microdomains which 
compartmentalise cellular signals by acting as a central point for the organisation 
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of signalling molecules. Į2į GLUHFWLRQ RI FKDQQHOV WR KRWVSRWV VHUYHV WR DPSOLI\
calcium signalling in accordance with local demand, as well as drive the VGCCs 
towards raft-associated proteins known to regulate channel activity, such as G-
proteins and kinases (Robinson et al., 2010). However the role RI Į2į LQ
PHPEUDQHWDUJHWLQJLVFRQWURYHUVLDODVVRPHVWXGLHVZKHUHĮ2įZDVFR-expressed 
ZLWK Į1 failed to yield channel expression on the cell membrane. Discrepancies 
PD\EHDWWULEXWHGWRWKHH[SUHVVLRQV\VWHPXVHGKRZHYHULWLVOLNHO\WKDWWKHĮ2į
subunit FRRSHUDWHVZLWKWKHǃ-subunit to ensure expression of the mature channel 
complex on the cell membrane surface (Herlitze et al., 2003).  
ǃ-VXEXQLWVDVVRFLDWHZLWKWKHĮ1-subunit via a high affinity interaction between a 
highly conserved motif of the I-,,F\WRSODVPLF OLQNHURIWKHĮ1-subunit known as 
the alpha interaction domain (AID) and the guanylate kinase (GK) domain of the 
ǃ-subunit (Pragnell et al., 1994, Karunasekara et al., 2009). The AID is located in 
the intracellular loop joining the first and second UHSHDWV RI WKH Į1-subunit. ǃ-
VXEXQLW DVVRFLDWLRQ ZLWK WKH $,' ZLWKLQ WKH Į1-subunit aids trafficking of the 
membrane protein to the cytoplasm (Jarvis and Zamponi, 2007) by binding to 
and antagonising an endoplasmic reticulum retention signal present on the 
intracellular loop I-,, RI WKH Į-subunit (Herlitze et al., 2003). Functional CavǃV
increase whole-cell current by increasing the number of channels expressed on 
the plasma membrane and by increasing their open probability (Po) (Dalton et al., 
2005). Ca2+ channels expressed in Xenopus oocytes show greater whole-cell 
current amplitude and an increased number of drug binding sites when the Į1-
subunit is co-expressed with the E-subunit (Herlitze et al., 2003). Rabbit CHO 
WUDQVIRUPDQWVFRPSULVLQJWKHĮ1-suEXQLWLQFRQMXQFWLRQZLWKWKHǃ-subunit show a 
100-fold increase in current amplitude and an increase in the number of DHP 
binding sites as well as improved DHP binding capacity (Nishimura et al., 1993). 
7KHLQWHUDFWLRQEHWZHHQWKHĮ1 DQGǃ-subunits is reYHUVLEOHLQGLFDWLQJWKDWWKHǃ-
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subunit acts as a regulatory protein rather than a subunit. TKH ǃ-subunit is 
unique in comparison to other auxiliary subunits by way of it being located 
entirely within the cytoplasm (Karunasekara et al., 2009).  
Site-directed mutagenesis studies identified three essential residues within the 
$,' UHTXLUHG IRU WKH VXFFHVVIXO LQWHUDFWLRQ RI WKH Į1-VXEXQLWZLWK WKH ǃ-subunit 
(Hui et al., 1991). The mutations showed abolition RIWKHFRXSOLQJEHWZHHQĮ1 and 
ǃDQGDVDUHVXOWDOVRWKH ǃ-VXEXQLWUHJXODWLRQRIWUDIILFNLQJRIĮ1 to the plasma 
membrane.  
To summarise, VGCCs are a diverse group of channels, their structural and 
function diversity is owed not only by the numerous genes and splice isoforms of 
WKH Į1-subunit, but also the association of auxiliary subunits. Post-translational 
modifications have a role in mediating channel function, adding further to the 
functional diversity of the channel by influencing its tertiary structure. 
Dysregulations in gene transcription and translation into VGCC channel protein 
can give rise to a disease state, as can altered regulation by substrates.  
3.2  Regulation of voltage-gated Ca2+ channels 
3.2.1 Regulation of voltage-gated Ca2+ channels by phosphorylation 
Calcium current through VGCC channels is regulated by numerous hormones and 
substrates by way of second messenger induced channel phosphorylation. The 
most characterised second messenger system of VGCC phosphorylation is that of 
cAMP-dependent phosphorylation by protein kinase A (PKA), although 
phosphorylation by protein kinase C (PKC) and, more recently protein kinase D 
(PKD), have roles in the regulation of VGCCs. 
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The cardiac Cav1.2 channel is regulated by phosphorylation by PKA (Dai et al., 
2009). Stimulation of this channel occurs via PKA and cyclic adenosine 
monophosphate (cAMP)-dependent mechanisms, as such this channel is heavily 
involved in the response to E adrenergic stimulation in the ³fight or flight´ 
response (Dai et al., 2009). Cav1.2 assembles with the Eadrenoceptor into a 
signalling complex with Gs protein, adenylate cyclase, PKA and PP2A. G-protein 
coupled receptors in the heart activate G-proteins which act as either stimulatory 
Gs or inhibitory Gi signals for adenylate cyclase (AC). Increased AC activity gives 
rise to elevated intracellular cAMP. cAMP binds to the regulatory subunits of PKA. 
cAMP binding to PKA releases the catalytic subunits which are then free to 
phosphorylate their channel substrates. PKA phosphorylation sites of functional 
importance as determined by observing a reduction in current upon mutation of 
said residues (serine to alanine) are located on both the DFSer1928) and E(Ser 
459, Ser478, Ser 479) subunits. Not all E subunits have PKA phosphorylation sites; 
the PKA phosphorylation sites are conserved in Esplice variants with the 
exception of EEEEF. Phosphodiesterase regulates the phosphorylation cascade 
via the degradation of cAMP to 5-AMP (Kamp and Hell, 2000). 
PKA stimulation of VGCCs also occurs as a result of strong depolarisation. The 
voltage-dependent conformational change is suggested to expose phosphorylation 
sites coupling voltage-gating and phosphorylation of the Ca2+ channel (Catterall, 
2000). Facilitation of this regulation requires PKA to be located in close proximity 
to the channel. In skeletal muscle, PKA is associated with the channel by an A-
Kinase anchor protein (AKAP). AKAPs anchor cAMP-dependent protein kinase to 
specific substrates and cellular compartments, targeting kinases to intracellular 
sites, facilitating phosphorylation events close to their substrates. AKAPs 
comprise of a targeting domain, enabling direction to the appropriate cellular 
location, and a kinase-anchoring domain comprising an D-helix which binds to the 
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regulatory subunit of PKA. This regulatory mechanism is important in the 
regulation of the contractile force in skeletal muscle (Catterall, 2000). The 
association of AK$3 LV UHTXLUHG IRU WKH ǃ-AR regulation of Cav1.2 channels in 
cardiac myocytes (Gao et al., 1997). 
Cardiac Cav1.2 channels are also regulated by the PKC kinases (classical cPKCs, 
novel nPKCs and atypical aPKCs) (Tafti and Hantash, 2008). PKC is stimulated by 
numerous pathways including; various Gq protein coupled receptors; Į1 
adrenoceptors intracellular and extracellular ATP; glucocorticoids; arginine-
vasopressin (McHugh et al., 2000); phospholipase C; and occasionally Ca2+ 
(Kamp and Hell, 2000). 
Both the D and E-subunits are substrates for PKC phosphorylation. PKC 
phosphorylation sites on the Dc-subunits are on the N-terminal domain at 
Threonine 27 and Threonine 31(Kamp and Hell, 2000). Mutation studies, 
whereby threonine residues 27 and 31 were singly converted to alanine abolished 
the channels sensitivity to modulation by PKC, suggestive of a requirement for 
both sites to be phosphorylated in the regulation of channel activity (McHugh et 
al., 2000). Conversely threonines 27 and 31 are not involved in the regulation of 
the brain isoform of Cav1.2. Cav1.2 activity in rat myoblast L6 cells is shown to be 
both up-regulated and down-regulated by PKC activity depending on the isoform 
activated; nPKC isoforms are reported to enhance activity in the basal state whilst 
cPKCs are reported to inhibit basal channel activity (Tafti and Hantash, 2008). 
Recently, PKD was shown to regulate the human cardiac Cav1.2 channel. Single-
channel activity in HEK234 cells stably expressing Cav1.2 was observed in the 
presence of an active mutant of PKD. Current amplitude was unaltered in 
comparison to the control. Expression of the dominant-negative mutant of PKD 
saw significant reduction of calcium channel currents. Mutation studies identified 
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the functional target residues of PKD as being Ser1884 on the C-terminal domain 
of human Cav1.2. As currents were neither enhanced or reduced by PKD activity, 
a role of PKD regulation of channel activity in the basal state was suggested (Aita 
et al., 2011). 
3.2.2 Regulation of voltage-gated Ca2+ channel by lipids 
Lipids are increasingly being recognised as signalling molecules in their own right. 
However, in comparison to signalling proteins, lipids are harder to study due to 
technical difficulties (Hardie and Muallem, 2009). Lipid regulation of VGCCs is not 
fully understood, although there is growing evidence that phosphatidylinositol 
4,5-bisphosphate (PIP2) and free fatty acids regulate the activity of VGCCs. 
ArachiGRQLF DFLG $$ SRO\XQVDWXUDWHG IDWW\ DFLG UHJXODWHV WKH DFWLYLW\ RI Į1 
VGCCs (Hardie and Muallem, 2009). 
External application of AA inhibits VGCC current at both the single-channel and 
the whole-cell current level with IC50s ranging from 1-10µM. Inhibition of  channel 
activity in the presence of AA has been reported in skeletal (Cav1.1), smooth 
muscle and rat cardiac myocytes (Cav1.2) (Xiao et al., 1997), SCG neurons 
(Cav1.3), and recombinant Cav1.3 channel currents in HEK 293 cells. It has been 
suggested that AA maintains VGCCs in a closed state as opposed to an 
inactivated state (Roberts-Crowley et al., 2009). 
3.3 Regulation of the NCX 
3.3.1 Regulation of the NCX by Ca2+ and Na+ 
In addition to its role as a transport substrate for the NCX, Ca2+ also has a 
regulatory role in the activation of the NCX. Regulatory Ca2+ binds to a high 
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affinity binding site within the intracellular loop region (Matsuoka et al., 1997) 
which contains 2 Ca2+-binding domains. Conversely, high levels of cytosolic [Na+] 
inhibits the NCX by facilitating Na+-dependent inactivation (Iwamoto et al., 2004b, 
Dong et al., 2002, Lytton, 2007). Excised patch-clamp investigations 
demonstrated a time-dependent change in exchange currents when elevated 
(~100mM) Na+ was applied to the cytosolic side of the membrane surface. 
Initially, a rapid outward Ca2+ current was observed which declined over a 20 
second period to a steady state value amounting to ~10% of the original peak 
current amplitude. This time-dependent decline in outward current was attributed 
to Na+-dependent inactivation (Chernysh et al., 2008). Amelioration of Na+-
dependent inhibition of the exchanger can be achieved by elevated concentrations 
of Ca2+ although the site of Ca2+ action is unclear. Additionally, ATP is also known 
to prevent Na+-dependent inactivation of the NCX (Hilgemann and Ball, 1996). 
Different models of inactivation have been proposed, including exchanger 
inactivation following the binding of Na+ to the intracellular transport site of the 
NCX. Alternatively, Na+ has also been suggested to bind to a regulatory site distal 
from the Na+ binding site (Lytton, 2007).  
As mentioned above, ATP protects against Na+-dependent inactivation, the 
proposed mechanism is by stimulating phosphatidylinositol-4,5-bisphosphate 
(PIP2) synthesis (Hilgemann and Ball, 1996). PIP2 is reported to bind to the 
exchanger inhibitory peptide (XIP) region of the exchanger (Figure 3.2). The XIP 
region is suggested to exert an auto-inhibitory function on exchanger activity 
following its interaction with a binding site located elsewhere on the exchanger. 
The precise location of the XIP binding site is not yet known, however it has been 
suggested to be situated within the central hydrophilic domain (Maack et al., 
2005). PIP2, through binding to the XIP region of the exchange protein, prevents 
the auto-inhibitory action from occurring. In support of this hypothesis, mutation 
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studies conducted within the XIP region of the exchanger have demonstrated 
both enhanced and reduced susceptibility to Na+-dependent inactivation 
(Matsuoka et al., 1997). When compared to the wild type NCX, an NCX mutant 
with an XIP corresponding to the mutant with increased susceptibility to Na+-
dependent inactivation was shown to bind PIP2 with low affinity (He et al., 2000).  
3.3.2 Regulation of the NCX by phosphorylation 
NCX1 on rat smooth and cardiac muscle is phosphorylated by protein kinase C 
(Linck, 1998). PKC activation is reported to stimulate the NCX (Ballard and 
Schaffer, 1996, Zhang et al., 2006, Iwamoto et al., 1996a). Site-directed 
mutagenesis studies identified three phosphorylation sites for the regulation of 
NCX1 by PKC: Ser-249, Ser-250 and Ser-357. Additionally, deletion of the 
cytoplasmic loop in NCX3 mutants abolished responsiveness to phorbol 12-
myristate 13-acetate (PMA), a potent PKC activator, implicating the cytoplasmic 
loop in PKC regulation of the exchanger (Iwamoto et al., 1998, Zhang and 
Hancox, 2009). 
The involvement of PKA in the regulation of NCX is unclear. It has been 
established that that NCX plays an important role in the maintenance of Ca2+ 
homeostasis in the heart (Ballard and Schaffer, 1996) ZLWK ǃ-adrenoceptor 
activation stimulating myocardial contraction and relaxation, which is suggestive 
of a role of PKA in the regulation of NCX1 (Zhang and Hancox, 2009). Conversely, 
D QXPEHU RI LQYHVWLJDWRUV DOVR UHSRUW D ODFN RI ǃ-adrenoceptor stimulation of 
NCX1 by isoprenaline, abrogating a role of PKA in NCX1 regulation (Main et al., 
1997, Lin et al., 2006, Ginsburg and Bers, 2005). Discrepancies between 
investigations could be indicative of either a minor role of PKA in the regulation of 
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NCX1, or a secondary effect upon NCX regulation by way of alterations in [Ca2+]i 
or [Na+]i management (Ginsburg and Bers, 2005) 
3.4  Inactivation of voltage-gated Ca2+Channels 
3.4.1 Ca2+-dependent inactivation of voltage-gated Ca2+Channels 
Ca2+ is a ubiquitous second messenger, as such Ca2+-dependent inactivation is an 
essential regulatory mechanism ensuring optimal [Ca2+]i. Ca
2+-dependent 
inactivation was discovered following the finding that Ca2+ channel inactivation is 
faster in the presence of Ca2+ than in the presence of Ba2+ or any other 
monovalent/divalent cation (Hering et al., 2000). Ca2+ dependent inactivation is 
considered as a means of negative feedback control, preventing excessive Ca2+ 
entry (Hofer et al., 1997). Cardiac Cav1.2 channels predominantly inactivate by 
Ca2+-dependent inactivation, although they can also undergo voltage-dependent 
inactivation (Cens et al., 2006). Ca2+-dependent inactivation determines the 
duration of Ca2+ current in Cav1.1-Cav1.4 channels (Catterall, 2000). These VGCC 
channels are usually subjected to fast Ca2+-dependent inactivation and slow 
voltage-dependent inactivation (McDonald et al., 1994). 
3.4.1.1 Time course of Ca2+ dependent inactivation 
Ca2+-dependent inactivation is a common property of Cav1.2, Cav1.3 and Cav2.2 
channels (Liang et al., 2003). Ca2+ dependent inactivation can be induced by 
elevations in [Ca2+]i of only a few micromoles. Ca
2+ entry during a maintained 
depolarisation enhances Ca2+ channel closure. In instances of long-lasting 
membrane depolarisation (~1 second), channel inactivation follows a biphasic 
WLPH FRXUVH FRPSULVLQJ RI ERWK ³IDVW´ DQG ³VORZ´ FRPSRQHQWV ,Q PXOWLSOH
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investigations the fast component of Ca2+ channel inactivation was significantly 
reduced in external Ba2+. The slow component remained unaltered, suggesting 
that the fast component of inactivation is Ca2+ mediated (Lin et al., 2012). The 
fast component of Ca2+ GHSHQGHQWLQDFWLYDWLRQRFFXUVZLWKLQ¶VRIPLOOLVHFRQGV
(Brehm and Eckert, 1978), (Neely et al., 1994). It has been proposed that the 
rate of Ca2+-dependent inactivation is limited by the rate at which channel 
conformational changes can take place within the channel protein (Sherman et al., 
1990). 
Following Ca2+-dependent inactivation channels are subject to additional closure 
by slow voltage-dependent inactivation (Hering et al., 2000), this occurs within 
a¶VPLOOLVHFRQGV. Prior to opening channels have to recover from inactivation, 
if a pulse arrives before completion of inactivation, there will be a reduction in 
Ca2+ entry.  
3.4.1.2 Mechanism of Ca2+ dependent inactivation 
The majority of Ca2+-dependent inactivation of a channel occurs via a reduction in 
the open probability of available channels (Po) (Hofer et al., 1997) with only a 
small proportion of Ca2+-dependent inactivation occurring via an alteration to the 
open channel. Studies investigating Cav1.2 channels in HEK293 cells indicate that 
[Ca2+]i inactivates 80% of this channel type (Lacinová and Hofmann, 2005). The 
remaining 20% of Cav1.2 channels available for opening were inactivated by 
Ca2+-dependent and voltage-dependent mechanisms (Lacinová and Hofmann, 
2005). The suggested Ca2+ site responsible for Ca2+-dependent inactivation is an 
()PRWLIORFDWHGLQWKHĮ1 subunit of the channel (Bernatchez et al., 1998). Ca2+ is 
suggested to bind with an interaction of 1:1 Ca2+ to binding site, with a reported 
Ki of ~4µM (Hofer et al., 1997). The helix loop helix (EF) Ca
2+-binding motif has 
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EHHQORFDWHGFORVHWRWKH,96UHJLRQRIWKHĮ1-subunit. In cardiac VGCC channels, 
it is suggested that this motif is responsible for Ca2+-dependent inactivation 
(Hofer et al., 1997). Studies on the role of the S6 segment in Cav1.2 channel 
blockade by drugs by point substitution mutations in segments IIIS6 and IVS6 
(from valine to alanine) show altered drug sensitivity to phenylalkylamines and 
1,4 dihydropryidines along with altered inactivation kinetics in comparison to wild 
type Cav1.2. Ca
2+ inactivation is susceptible to alterations in the composition of 
the intracellular domain linkers, highlighting the importance of the IIIS6 and IVS6 
segments in Ca2+-dependent inactivation. Ca2+ entry is determined by the 
following factors: membrane potential, the kinetics of Ca2+ channel opening, the 
kinetics of inactivation processes, and the kinetics of recovery form inactivation 
(Hering et al., 2000). Development and recovery from inactivation in Ca2+ 
FKDQQHOV DUH DIIHFWHG E\ VWUXFWXUDO FKDQJHV LQ WKH Į1-subunit pore forming 
segments, intracellular loops and carboxyl (C) terminus. Auxiliary subunits and 
intracellular proteins also influence the inactivation process, in partLFXODU WKHǃ-
subunit. In VGCCs ǃ-subunits 1-4 produce different channel inactivation 
behaviours. ǃ2 produces slow inactivation ǃ1 and ǃ4 produce intermediate 
inactivation behaviour with ǃ3 producing fast inactivation. The modulatory effect 
RI WKHǃ-subunit upon channel inactivation is dependent upon the alpha subunit 
LVRIRUPDVǃ-subunit modulations in channel inactivation characteristics have not 
yet been observed in Cav1. Ca
2+ channels (Walker et al., 1998). 
It has been demonstrated that stimulatiRQRIǃ-adrenoceptors which instigate the 
phosphorylation of Ca2+-dependent channels in a cAMP-dependent manner as a 
result of PKA activation, significantly reduces Cav1. Ca
2+ channel inactivation. 
Inhibition of channel dephosphorylation also reduced Ca2+-dependent inactivation 
(Rankovic et al., 2011). These findings indicate that phosphorylation of Cav1.x 
Ca2+ channels maintain the channels in a state of high open probability and that 
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dephosphorylation of the channels may be involved in Ca2+-dependent 
inactivation. Ca2+ can also activate the Ca2+-dependent protein phosphatase 
calcineurin, which itself is regulated by the Ca2+ binding protein calmodulin. 
Calcineurin activation results in dephosphorylation and therefore inactivation of 
the Ca2+ channel (Armstrong, 1989). Other potential contributors/ mechanisms 
involved in Ca2+-dependent inactivation are Ca2+ binding to an EF motif in the C 
terminal domain, Ca2+ binding to calmodulin a Ca2+ binding protein and Ca2+ 
binding directly to the channel (de Leon et al., 1995). Although as discussed 
above, the various motifs involved in Ca2+-dependent inactivation have been 
identified, the structural rearrangement of the channel protein that occurs during 
the inactivation process is yet to be elucidated. 
3.4.2  Voltage-dependent inactivation (VDI) of voltage-Gated Ca2+ 
channels 
Channel inactivation by way of voltage is defined as the current decay that occurs 
during prolonged periods of depolarisation. Voltage-dependent inactivation 
regulates Ca2+ entry, preventing toxic Ca2+ overload under these circumstances 
(Cens et al., 2006). Neuronal Cav2.1 channels inactivate primarily by voltage-
dependent inactivation although they can also inactivate by Ca2+-dependent 
means. The kinetics of VGCC channel inactivation as studied using barium as a 
charge carrier in heterologous expression systems, have been investigated and 
compared across different channel subtypes (Hering et al., 2000). The 
inactivation sequence for VGCCs is as follows, from the fastest to the slowest: 
Cav3.1> Cav2.3>Cav2.2>Cav2.1>Cav1.1-Cav1.4 (Hering et al., 2000). 
As with Ca2+-dependent inactivation, the kinetics of Ca2+ channels are determined 
E\ WKH SURSHUWLHV RI ERWK WKHLU Į1-VXEXQLWV DQG WKH Į1-subunit interactions with 
Chapter 3 
121 
 
RWKHU FKDQQHO VXEXQLWV ,QWHUDFWLRQ RI WKH Į1-VXEXQLW ZLWK WKH ǃ-subunit, also 
influence inactivation properties. Chimeras created between non-inactivating 
Cav1.x and fast-inactivating R-type rat brain Ca
2+ channels have demonstrated 
that multiple structural domains are involved in voltage-dependent inactivation; 
substitution of linker region I-II and domain II &III S6 regions of Cav2.3 with 
Cav1.2 sequence, abolished inactivation implicating these regions II and III in 
voltage-dependent inactivation. A model of inactivation was proposed whereby 
the I-II linker forms a hinged lid which docks at domains II and III of the S6 
region (Stotz et al., 2000), a similar mechanism to that observed during voltage-
dependent inactivation in K+ (Armstrong and Bezanilla, 1973, Murrell-Lagnado 
and Aldrich, 1993) and Na+ channels (Kass, 2004). 
Regulation of activatLRQ DQG LQDFWLYDWLRQ RI Į1 E\ WKH ǃ-subunits are separate 
events (Olcese et al., 1994). The N-WHUPLQXV RI WKH ǃ-subunit is one of the 
VWUXFWXUDO GHWHUPLQDQWV LPSRUWDQW IRU VHWWLQJ WKH UDWH DQG YROWDJH DW ZKLFK Į1 
inactivates. One hypothesis is that thHǃ-subunit interacts with a highly conserved 
VHTXHQFHPRWLILQWKHLQWUDFHOOXODUORRSRIĮ1,  that connects the first and second 
of the four repeat domains (Olcese et al., 1994). Another hypothesis is that the N 
WHUPLQXV RI WKH ǃ-subunit may not inteUDFW ZLWK Į1, but rather set the special 
FRQIRUPDWLRQRIǃVRWKDWRWKHUǃ-VXEXQLWPRWLIVLQWHUDFWZLWKĮ1 (Pragnell et al., 
1994) $V ZLWK ǃ-VXEXQLW DFWLYDWLRQ RI Į1 WKH UDWH DW ZKLFK Į1 inactivates is 
GHSHQGHQWRQWKHǃ-subunit subtype (Ellinor et al., 1993).  
Ca2+ channels undergo more than one conformational change during 
activation/inactivation. There is a slight delay prior to channel opening, with a 
sigmoidal time-course for the development of inward current upon depolarisation. 
The channel must pass through multiple closed states prior to opening (Jones, 
1998). 
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3.5  Calcium channel / Exchanger pharmacology 
3.5.1 Voltage-gated calcium channel pharmacology 
Multiple VGCC channel types are present in mammalian cells. VGCCs differ in 
their voltage dependence, kinetics, and single-channel properties, they also differ 
in their pharmacology. Drugs and toxins are essential research tools for 
distinguishing between different classes of Ca2+ channel, especially in tissues 
which comprise more than one VGCC channel type, such as the neuron (Cena, 
1998). A summary of current VGCC channel ligands is shown in Table 3.2. VGCC 
agonists and antagonists used in particular areas of research are summarised 
briefly in Table 3.3 
  
Peptide voltage-gated Ca2+ channel ligands 
Blocker Derived from Block Mode of action Binding site Reversibility Reference 
Ǚ-Aga-IVA African Funnel Web 
spider (Agenelopsis 
aperta) 
Cav2.2 Gating modifier 
Antagonism of 
voltage sensor 
movement 
 S3-S4 OLQNHURIĮ1 Poor reversibility, 
channel activity can 
be recovered 
following repetitive 
depolarisation 
(Mynlieff and 
Beam, 1992, 
Aosaki and Kasai, 
1989) 
GVIA 
Ǚ-conotoxin 
 
Marine snail venom 
(Conus geographus) 
Cav2.1 
Cav2.3 
Cav3.1, 3.2, 3.3 
Occlusion of 
channel pore 
3RUH UHJLRQ RI Į1 
subunit 
 
Inorganic voltage-gated Ca2+ channel ligands 
Lead 
Copper 
Zinc 
Aluminium 
Cobalt 
Cadmium 
 Non-selective 
 
 
 
 
Cav1.2 IC50 4µM 
Physical Pore 
occlusion or 
surface charge 
screening altering 
gating properties 
 
 
  
 
 
 
 
 
(Busselberg et al., 
1994).  
 
 
 
(Lory et al., 1990) 
 
Organic voltage-gated Ca2+ channel ligands 
Ligand Classification Blocks Mode of action Binding site Reversibility Reference 
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Nifedipine DHP 
Antagonist 
Cav1.2 DHP antagonists bind with 
high affinity to the 
inactivated state of the 
channel at depolarised 
membrane potentials 
(~Kd<1nM) than at 
hyperpolarised membrane 
potentials (~Kd 10nM to 
1µM). 
The 
transmembrane 
segments IIIS5, 
IIIS6 and IVS6 of 
WKH Į1 subunit. 
Within these 
segments, single 
amino acid 
residues 
responsible for 
high affinity drug 
binding have 
been identified 
for the DHPs, 
PAAs and BZPs. 
It has been 
suggested that 
DHP and BZP 
binding sites are 
located in close 
proximity. 
Yes  
Amlodipine DHP 
Antagonist 
Cav1.2 Yes  
Nitrendipine DHP 
Antagonist 
Cav1.2, Cav1.3 Yes (Xu and 
Lipscombe, 2001) 
Nimodipine DHP 
Antagonist 
Cav1.2 IC50 
139nM, Cav1.3 
IC50 2.7µM 
Yes (Xu and 
Lipscombe, 2001) 
Bay K DHP Agonist Used as a 
research tool to 
enhance single 
channel activity 
of Cav1. , thus 
improving their 
detection 
Stabilises the open 
conformation of the 
channel. No change in the 
IV relationship 
Yes (Fox et al., 1987) 
Verapamil PAA Antagonist Cav1.3 Pore block from the 
intracellular side. 
Yes (Hockerman et al., 
1997) 
Desmethoxyverapamil PAA Antagonist   Yes 
Methoxyverapamil PAA Antagonist   Yes 
Diltiazem BZPs 
Antagonist 
  Yes  
Table 3.2. A brief overview of Ca2+ channel ligands used in research 
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Ca2+ 
Channel 
Tissue expression of 
Ca2+ channel 
Ca2+ Channel 
blockers used in 
research 
Used in research for the 
following conditions: 
Cav1.1, 
Cav1.2, 
Cav1.3,  
Cav1.4 
Neurons, endocrine, 
skeletal muscle, cardio 
vascular system 
Dihydropyridines 
Phenylalkylamines, 
Benzothiazepines 
Cardiac disorders 
Cav2.1 Neurons w-agatoxin IVA from 
spider, w-conotoxin 
MVIIC from marine 
cone snail. 
Epilepsy, migrane symptoms 
Cav2.2 Neurons w-conotoxin MVIIA 
from marine cone 
snail, CVID from 
marine cone snail. 
Pain 
Cav2.3 Neurons SNX-482 from 
tarantula 
Diabetes symptoms 
Cav3.1, 
Cav3.2, 
Cav3.3 
Neurons, Smooth muscle, 
sinoatrial node 
Nickel Ethosuximide, 
Zonisamide 
Arrhythmias, epilepsy, pain 
Table 3.3. Outline of Ca2+ channel blockers, the channels they are effective against and the areas of research in which they are used. Adapted 
from Mohan and Gandhi (2000).
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3.6 Pharmacology of the NCX 
Unlike VGCCs where selective inhibitors for various channel types have been 
identified (see Section 3.5.1), many NCX inhibitors used in research are not 
sufficiently selective to allow exchanger characterisation in intact cells. This is 
due to non-specific effects of NCX antagonists upon other transporter types 
(Annunziato et al., 2004). The NCX also operates in both Ca2+-influx and 
Ca2+-efflux modes, as such, blockade of the reverse mode of exchange may 
not confirm the presence of the NCX if it is operating in the forward mode. A 
summary of NCX inhibitors used in research is presented within Table 3.4 
Inhibition of the reverse mode of the NCX does represent a novel potential 
therapeutic strategy to treat conditions of dysregulated Ca2+ influx, e.g. 
ischaemia-reperfusion injury, as demonstrated by preliminary investigations 
in animal models and primary tissue preparations of brain (Annunziato et al., 
2004), heart (Feng et al., 2006, Takahashi et al., 2003, Magee et al., 2003) 
and kidney (Matsuda et al., 2005, Ogata et al., 2003). Clinical trials are 
currently not possible with NCX inhibitors, as currently available reverse-
mode NCX inhibitors do not exhibit the required levels of selectivity and 
efficacy to permit such investigations (Toth et al., 2009). If the NCX is a Ca2+ 
influx pathway in white adipocytes, it is possible that dysregulated Ca2+ influx 
could occur by the reverse mode of the NCX. Inhibition of Ca2+ entry by NCX 
could also have applications in adipocytes. SN-6 and KBR-7943 were used in 
the current study to investigate the presence of NCX1 and NCX3 within 
primary white fat adipocytes. 
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Classification of 
NCX inhibitor 
NCX inhibitor used 
in research 
Isoform 
selectivity 
IC50 Inhibition upon 
mode of 
exchange 
Reported inhibition upon 
other channel types 
References 
Inorganic Cation Ld3+, Mn2+, Cd2+, Ni2+ NCX1 
NCX2 
  VGCC (Annunziato et al., 2004) 
Amilioride Analogue Amilioride No isoform 
selectivity 
reported 
1mM Ca2+ efflux and 
Ca2+influx modes 
Na+/H+ exchange 
VGCC 
Na+ channels 
(Alvarez de la Rosa et al., 2000, 
Blaustein and Lederer, 1999, 
Annunziato et al., 2004) 
Amilioride Analogue Benzamil No isoform 
selectivity 
reported 
100µM Ca2+efflux and Ca2+ 
influx modes 
Na+/H+ exchange (Watano et al., 1996) 
Amilioride Analogue 3,4-dichlorobenzamil NCX1 17-30µM Ca2= efflux and Ca2+ 
influx modes 
Cav1.1-Cav1.4 VGCCs 
T-Type VGCCs 
(Watano et al., 1996) 
Peptide XIP  Ki 0.1 to 
1.0µM 
 Calmodulin (Li et al., 1991, Annunziato et al., 
2004) 
Benzyloxyphenyl SN-6 NCX1 
NCX2 
NCX3 
2.9µM 
16µM 
8.6µM 
Ca2+ influx 
Ca2+ influx 
Ca2+ influx 
Non reported at concentrations 
up to 30µM. 
(Iwamoto et al., 2004b, Iwamoto, 
2004, Iwamoto et al., 2004a, 
Matsuda et al., 2001) 
 
Benzyloxyphenyl SEA0400 NCX1 
NCX2 
56nM 
980nM 
Ca2+ influx 
Ca2+ influx 
Inhibition of Ca2+ influx 
observed in hepatocyte NCX 
knockouts. 
(Reuter et al., 2002, Iwamoto et 
al., 2004a) 
Benzyloxyphenyl YN-244769 NCX3 18nM Ca2+ influx  (Iwamoto et al., 1996b, Iwamoto 
and Kita, 2006) 
Benzyloxyphenyl KBR-7943 NCX3 
NCX1 
 
NCX3 
NCX1 
1.2-2.4nM 
 
 
>30µM 
Ca2+ influx 
 
 
Ca2+ efflux 
Inhibition of Ca2+ influx 
observed in hepatocyte NCX 
knockouts. 
@~30µM, Cav1.1-Cav1.4 
VGCCs, Na+ pump, voltage-
dependent Na+ channels, NCKX 
(Reuter et al., 2002, Iwamoto and 
Kita, 2004, Iwamoto et al., 1996b) 
Table 3.4. Brief overview of Na+/Ca2+( NCX) inhibitors used in research. VGCC, voltage gated calcium channel; XIP, exchanger inhibitory 
peptide; (2-[2-[4-(-nitrobenzyloxy)phenyl]-ethyl]isothiourea methanesulfonate), KBR-7943
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3.7 Evidence for voltage-gated Ca2+ channels in white adipocytes 
3.7.1 Experimental evidence for voltage-gated Ca2+ channels in 
white adipocytes 
The presence and role of VGCCs in excitable cells is well-characterised, 
however to date the evidence for their existence in adipocytes is limited. 
There is no direct electrophysiological evidence for the presence VGCCs on 
the membrane surface of the white fat adipocyte. Elucidation of the presence 
of VGCCs on the membrane surface of the white adipocyte has been 
determined indirectly through the utilisation of intracellular fluorescent Ca2+ 
indicators such as aqueorin (Pershadsingh et al., 1989) or Fura 2 in 
conjunction with conditions of elevated extracellular K+ (~30mM or higher). 
Conditions of elevated extracellular K+ are used to probe for the presence of 
VGCCs, in a variety of cell types (Yaguchi and Nishizaki, 2010), including 
adipocytes. Elevations in extracellular K+ depolarize the plasma membrane 
(Beigelman and Shu, 1972) by eradicating the outward K+ gradient resulting 
in opening of the VGCCs and subsequent cellular Ca2+ influx. Reversal of any 
K+-induced increase in [Ca2+]i by VGCC specific antagonists such as nifedipine 
or nitrendipine ~10µM is also indicative of VGCC on the plasma membrane 
surface. 
Initially, Draznin et al (1987) demonstrated that addition of 40mM K+ to 
Fura-2 loaded primary adipocytes resulted in a significant increase in [Ca2+]i 
which was ameliorated following addition of Cav1.2 Ca
2+ channel blocker 
nitrendipine (25µM) (Draznin et al., 1987a). Subsequent studies by other 
groups in primary adipocytes confirmed these findings. Elevation of 
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extracellular K+ from ~5.6mM to 30mM resulted in a significant increase of 
[Ca2+]i (Gaur et al., 1996b, Kelly et al., 1989). A similar Ca
2+ response to 
that induced by 30mM [K+]o was observed upon addition of Bay K 8644 
indicative of Ca2+ by VGCCs. The increase in [Ca2+]i produced by 30mM K
+ 
was blocked upon addition of dihydropryidine VGCC antagonist nimodipine 
(100nM) (Gaur et al., 1998b). Concentrations of up to 60mM [K+]o have been 
used to induce elevations in [Ca2+]i. Pershadsingh et al (1989) demonstrated 
a reversible and significant elevation in [Ca2+]i in primary white adipocytes 
upon exposure to medium containing 60mM K+. The effect of K+ on [Ca2+]i 
was blocked upon addition of VGCC antagonist diltiazem (10µM) 
(Pershadsingh et al., 1989). Radioligand binding studies carried out on 
purified adipocyte plasma membranes using [3H]PN-200-110, (a 
dihydropryidine which binds the Cav1.2. Ca
2+ FKDQQHO Į-subunit with high 
affinity Kd=~0.14nM (Dacquet et al., 1989)) and monoclonal antibodies 
raised DJDLQVW WKH Į1-subunit of L-type VGCCs purified from rabbit skeletal 
muscle demonstrated the presence of L-type Ca2+ channels in rat adipocytes 
(Gaur et al., 1998a) (Note study was conducted before the revised 
nomenclature for Cav1.1-Cav1.4 channels was established). Immunoassay 
procedures within the same investigation alloZHGGHWHFWLRQRIWKHǃDQGĮ2-į
VGCC auxhillary subunits (Gaur et al., 1998a). Contrary to the reports above, 
depolarising conditions of 70mM [K+]o, when applied to murine 3T3-L1 
adipocytes, an established adipocyte model, did not induce a significant 
increase in [Ca2+]i; This observation was used in support of the argument 
against Cav1. VGCCs within this cell type (Yorek et al., 1999). 
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3.7.2 Functional evidence for Cav1.3 voltage-gated Ca
2+ channels in 
white fat adipocytes 
Ca2+ influx by Cav1.2/ Cav1.3 Ca
2+ channels are implicated in insulin-
stimulated glucose uptake in adipocytes. In radioactive glucose uptake 
studies, treatment of adipocytes with 30mM KCl decreased the half-maximal 
response to insulin stimulated 2-deoxyglucose (2-DOG), glucose transport by 
~50%. On the contrary, treatment of adipocytes with ionomycin (3µg/ml), an 
ionophore which would cause Ca2+ influx independently of VGCC channels, 
did cause a significant increase in [Ca2+]i, however there was no reduction in 
insulin stimulated glucose transport (Kelly et al., 1989). Similar findings were 
observed by Draznin et al (1987b).  
Insulin and growth hormone (GH) are reported to increase [Ca2+]i in white 
adipocytes, with suggested Ca2+ influx through VGCCs. The elevation in 
[Ca2+]i observed following preincubation of adipocytes with growth hormone 
(500ng/ml) for 3 hours was blocked following addition of 30µM verapamil or 
100nM nimodipine, indicative of the Ca2+ entry occurring through Cav1.2/ 
Cav1.3 VGCCs (Gaur et al., 1996a). The insulin-induced increase in [Ca
2+]i is 
controversial. Draznin et al (1987) report an insulin-induced increase in 
[Ca2+]i (Draznin et al., 1987a), which is inhibited following application of 
25µM nifedipine. Other groups have not observed a [Ca2+]i increasing effect 
of insulin (up to 20nM) (Kelly et al., 1989, Blackmore and Augert, 1989). In 
addition the dihydropryidine Ca2+ channel blocker amlodipine has been shown 
to improve whole body glucose tolerance in rats which had the insulin 
resistant state induced by cyclosporine (Yavuz et al., 2004). 
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3.7.3 Clinical evidence for voltage-gated Ca2+ channels in white fat 
adipocytes 
An association has been demonstrated in a variety of paradigms between 
elevated Ca2+ influx through VGCCs and reduced insulin-stimulated glucose 
transport. This has been demonstrated in subcutaneous adipose tissue from 
the agouti mouse model (Kim et al., 1996), in 3T3-L1 adipocytes (Whitehead 
et al., 2001), and in primary rat adipocytes (Draznin et al., 1989). Evidence 
of amerlioration of exacerbated cellular [Ca2+]i and improved insulin 
responsiveness has been demonstrated in insulin resistant men as those 
receiving treatment with nitrendipine, exhibited an improved glucose 
tolerance as determined by an oral glucose tolerance test. This has also been 
demonstrated in elderly (aged 65+) obese and hypertensive subjects (Byyny 
et al., 1992). Older hypertensive, and particularly older obese hypertensive, 
patients manifest significant insulin resistance when compared to normal 
body weight controls as determined by the 2-DOG uptake assay. Adipocytes 
from abdominal wall fat biopsy exhibited elevated [Ca2+]i in all elderly 
subjects in comparison to those from young controls. Administration of 10mg 
nitrendipine twice daily for one month, restored adipocyte 2-DOG uptake to 
control values in hypertensive subjects (obese and normal weight). Oral 
glucose tolerance tests following nitrendipine therapy demonstrated 
restoration of plasma insulin to control values in obese hypertensive 
individuals (Beer et al., 1993, Byyny et al., 1992). Treatment of non-obese 
hypertensive subjects with amlodipine reduced plasma glucose levels, 
indicative of an improved insulin effectiveness despite insulin levels remaining 
similar prior to and post treatment (Harano et al., 1995).  
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3.8  Experimental aims 
Calcium influx pathways within the adipocyte are poorly defined. The 
observation that application of Cav1.2 and Cav1.3 calcium channel blockers 
restore adipocyte responsiveness to insulin in vitro, as well as ameliorate 
insulin resistance in a clinical setting indicates a functional role of either, or, 
or both Cav1.2, Cav1.3 VGCCs in adipocytes. Additionally, The NCX has been 
shown to be an important Ca2+ pathway in numerous cell types (Blaustein 
and Lederer, 1999). To date there is only one published suggestion of NCX 
mediated Ca2+ influx in white fat adipocytes (Pershadsingh et al., 1989): 
although evidence supporting the existence of the reverse mode of the NCX 
has been demonstrated previously within this laboratory (Pulbutr, 2009). I 
aim to confer findings by others by exploring changes in [Ca2+]i and routes of 
calcium entry with known pharmacological blockers of Cav1.2 and Cav1.3 
channels and the reverse mode of the NCX, in the rat epididymal adipocyte. 
Elevated concentrations of [K+]o have been used by other research groups, in 
conjunction with known pharmacological blockers of Cav1.2, Cav1.3 to 
determine the presence of this channel type on the adipocyte plasma 
membrane. I aim to confirm findings by others and determine whether 
conditions of 50mM [K+]o is a suitable method to identify VGCCs in adipocytes. 
Investigations were conducted both at basal and following acute insulin 
exposure with the intention of identifying changes in [Ca2+]i between the two 
conditions, as well as investigate the hypothesis that insulin does alter 
adipocyte [Ca2+]i by attenuating Ca
2+ influx from the extracellular 
environment. 
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3.9 Methods 
All experiments were carried out using variations of a modified Hank¶s buffer 
solution that contained (in millimoles): 5.6 KCl, 138 NaCl, 1.2 NaH2PO4, 10 
HEPES, 2.6 CaCl2, 1 MgCl2, 4.3 NaHCO3, and 5 glucose, 0.1% (wt/vol) BSA 
(pH 7.4 with NaOH). For Ca2+-free solutions, CaCl2 was replaced by equimolar 
substitution with MgCl2, total Mg
2+ was 3.6mM. For the high potassium 
solutions, the concentration of KCl was elevated from 5.6mM to 50mM. This 
was osmotically compensated via a subsequent reduction in NaCl from 
138mM to 94mM. All drug stocks were made in DMSO and diluted to the 
GHVLUHGFRQFHQWUDWLRQLQWKHDSSURSULDWH+DQN¶VEXIIHU 
3.9.1 Adipocyte isolation and loading 
Epididymal fat pads were excised from male Wistar rats, body weight (250-
340g), fed ad libitum (Charles River Laboratory, Kent, UK). Rats were killed 
by stunning followed by cervical dislocation in accordance with UK Home 
Office guidelines. The white adipocytes were isolated from the epididymal fat 
pads using D PRGLILHG YHUVLRQ RI 5RGEHOO¶V SURFHGXUH (Rodbell, 1964). The 
dissected fat pads were transported in +DQN¶V solution containing 2.6mM Ca2+ 
(supplemented with 0.1% BSA (wt/vol) and 5mM glucose). To prepare the fat 
pad for dissection, it wDV SODFHG LQ D 3HWUL GLVK ZLWK +DQN¶V VROXWLRQ 7KH
eppididymis and major blood vessels were removed to reduce the likelihood 
of isolating other cell types along with adipocytes. The dissected fat pads 
were washed with Hank¶s solution to remove any residual blood or fur. 
Manually the fat pads were transferred (while cutting) to a glass vial 
containing 5mls of 0.5mg/ml type II collagenase (Sigma) in Hank¶s 
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supplemented with 0.01% wt/vol BSA and 5mM glucose. The fat pads were 
then minced with scissors until the fragments were approximately 1/2cm 
square.  
The minced tissue was then transferred to a 25ml Nalgene conical flask. The 
scintillation vial was washed with a further 5ml of Hank¶s, this was also 
transferred to the conical flask, giving a final volume of collagenase of 10ml. 
Adipose tissue was subject to enzymatic digestion for 6-8 minutes at 37oC in 
a Grant water bath (Griffin and George 896331), with agitation at 240 shakes 
per min Following digestion (ascertained by eye based on lack of tissue lumps 
and uniform milky consistency) the digest, followed by 50ml of +DQN¶V 
solution, were filtered through a 250µM nylon mesh (Normesh limited, 
Oldham, UK). This diluted out the collagenase so that it was no longer active 
on the adipose tissue. Filtering the sample also removed any large lumps of 
tissue that were not digested in the previous step. The filtrate was collected 
in a 50ml syringe and adipocytes allowed to separate from the modified 
Hank¶VEXIIHU for five minutes. The adipocytes, due to their high lipid content, 
float and form a visible white layer situated on top of the +DQN¶V solution. 
This characteristic of the adipocytes aids in the isolation process as cell debris 
and other contaminating cell types present within the adipose tissue explants 
(fibroblasts, macrophages, stromal cells, monocytes and preadipocytes 
(Vazquez-Vela et al., 2008)) sink to the bottom. The infranatrant and debris 
were removed by drainage of the +DQN¶V buffer. The adipocytes and the 
+DQN¶V solution surrounding the adipocytes were retained and subject to 
washing with 50mls of the +DQN¶V buffer. The process of draining, floatation 
and washing was repeated twice. After the final wash the adipocytes were 
resuspended in 10mls of +DQN¶V BSA 0.01% (wt/vol) and placed in a Petri 
Chapter 3 
133 
 
dish, and kept at room temperature (21-22oC). The adipocytes were taken 
immediately for imaging. 
3.9.2 Plating 
To image the adipocytes, they were plated onto glass cover-slips. Circular 
glass cover-slips, 13mm in diameter, thickness 0 (BDH biosciences 
406/0189/10), were coated with 50µl poly-D-lysine (P7886; Sigma) at 
100µg/ml in Dulbecco¶s PBS 1x (Na+ Mg2+ free). The poly-D-lysine was 
applied to the centre of the cover slip. The cover-slips were left to air-dry 
overnight. To attach the adipocytes to the cover-slips, the coated cover-slips 
were inverted and placed on a suspension of freshly isolated adipocytes, and 
left for ten minutes. The cover-slip with the attached adipocytes were 
incubated with Fluo 4-AM (at a final concentration of 1µM in 0.1% BSA 
(wt/vol), 5mM glucose, +DQN¶V solution) for 30 minutes in the dark at room 
temperature (21oC-22oC). Loading was performed at room temperature to 
reduce the likelihood of dye compartmentalisation in accordance with the 
PDQXIDFWXUHU¶V UHFRPPHQGDWLRQV ,QYLWURJHQ Prior to imaging, the cover-
slip containing Fluo-4-loaded adipocytes was mounted in a bespoke perspex 
chamber with a glass floor. The adipocytes were washed by perifusion for 10 
minutes in Ca2+-containing +DQN¶V VROXWLRQ. To perifuse the microscope 
chamber, solutions were gravity-fed through polythene tubing. A peristaltic 
pump was used to aspirate away the bath solution. All drug additions were 
made via bath perifusion. Exchange between solutions was performed using 
an electrically controlled two-way valve.  
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3.9.3 Imaging 
To enable imaging of adipocyte [Ca2+]i, adipocytes were loaded with the 
fluorescent Ca2+ indicator dye Fluo-4 AM (acetoxymethyl). Fluo-4 is an analog 
of Fluo-3 with the two chlorine substituents replaced by fluorines. 
Manufacturers report increased fluorescence excitation at 488 nm resulting in 
higher fluorescence signal levels (Invitrogen). Fluo-4 AM can be used at lower 
dye concentrations to generate the same fluorescence signal intensity (Gee et 
al., 2000). Lower loading concentrations and dye loading times of Fluo-4 AM 
make its use in cells a less invasive practice (Gee et al., 2000). 
Cells loaded with Fluo-4 were imaged using an inverted Axiovert 135TV 
microscope (Carl Zeiss Ltd, Welwyn Garden City, UK) using continuous 
episcopic illumination. The light source was provided by a xenon arc lamp. To 
monitor changes in [Ca2+]i, cells were illuminated continuously throughout 
the experiment. The dye was excited at 485nm with the lowest light intensity 
that allowed binocular visualisation of the fluorescent signal when the 
observer was dark adapted. To reduce the risk of photo-bleaching, care was 
taken not to use a higher light intensity than necessary, i.e. within the lower 
limits of camera detection. Excitation light was prevented from interfering 
with the emission light through the utilisation of a 510nm long pass filter. 
Emission light was detected using a Photonics Science ISIS camera. 
Adipocytes were visualised using a x20 air objective lens. Live cell recordings 
were captured at 1 Hz using an 8 bit DT3155 frame grabber card and 
Imaging workbench software (INDEC Biosystems, Santa Clara, CA, USA). 
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3.9.4 Selection criteria for cell analysis 
Fields of adipocytes for investigation were chosen based on the following 
criteria: an obvious adipocyte like structure (cygnet ring shape with a 
protruding nucleus); even dye loading, avoiding cells that looked punctuate 
(Punctuation is indicative of dye compartmentalisation within organelles); 
also with as many cells present in the field of view as possible. No preference 
was given to cells based on the following: cell size; group or single. 
Contamination by other cell types within the fat tissue (vascular smooth 
muscle, fibroblasts, and macrophages) was not observed within any of the 
adipocyte preparations, presumably having been efficiently removed during 
the adipocyte isolation procedure. Contaminating cell types can easily be 
identified as they have morphologies quite distinct from that of an adipocyte. 
Contaminating cell types are likely to be smaller in size, elongated, spindle 
like in shape. 
3.9.5 Two point calibration 
In order to ascertain the extent of fluorescence intensity change as a result of 
a change in intracellular calcium within an experiment, both the maximum 
and the minimum values of fluorescence had to be established for each cell 
within a particular experimental run. This was achieved by carrying out a 
two-point calibration which determined the maximum and minimum 
fluorescence values for the Fluo-4 indicator within each individual adipocyte. 
The maximum fluorescence value ([Fmax]), i.e., the value of the calcium-
saturated Fluo-4 indicator, was determined by perifusing Triton X-100 in 
increasing concentrations: 0.0125% (v/v), 0.025% (v/v), 0.05% (v/v), and 
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0.1% (v/v) in Ca2+ modified +DQN¶VZWYRO) BSA. This was done to 
GHWHUPLQHWKH³LGHDO´7ULWRQ;-100 response, whereby the fluorescence value 
would reach maximum value followed by a decline to the basal value. The 
concentration of Triton X-100 was not increased any further following 
observation of the maximum fluorescence value. The minimum value of 
fluorescence [Fmin] was taken as the fluorescence of the Fluo-4 in the absence 
of extracellular Ca2+, obtained by perfusion of the adipocytes with the calcium 
chelating agent EGTA (10mM). 
The cellular Kd of Fluo-4 was taken as being 345nM (Takahashi et al., 1999, 
Gee et al., 2000, Paredes et al., 2008). Ca2+ indicators can be used to 
measure Ca2+ concentrations between the 0.1Kd-10xKd range (Paredes et al., 
2008). However the Kd is variable and subject to environmental conditions 
including pH, and temperature. To keep these factors as uniform as possible, 
the pH and temperature of the buffers used were controlled as rigorously as 
possible. A thermocouple was used to set and monitor the temperature of the 
perifusion solution. It was assumed that the Fluo-4 bound to Ca2+ with a 1:1 
stoichiometry, and also that the dye was predominantly located in the cytosol. 
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3.9.6 Analysis protocol and statistics 
Using Imaging workbench 5.2, analysis regions of interest (Draznin et al.) 
were selected such that the first ROI (0) was always designated as the 
background. Subsequent ROIs were drawn around each adipocyte. The time-
course and mean fluorescence intensity was then calculated for each cell.  
The experimental data was further analysed using Microcal ORIGIN 5.0 
(Microcal Software Inc., Northampton, MA). Macros were created (see 
Appendices for the macro scripts) to subtract the background fluorescence 
(ROI-0) for each cell, calibrate, and correct for linear trend. The macros were 
named Data and Calibrate respectively. 
3.9.7 The data macro 
The imaging workbench file comprises multiple data columns containing 
information pertaining to the fluorescence, the total pixel area and the total 
fluorescence for each cell. Only the initial value for the total pixel area per 
cell is used for the analysis as it was assumed that the size of the cell would 
remain constant throughout the protocol. 
The background fluorescence was monitored through the course of the 
experiment and an average of the fluorescence background is subtracted 
from the average fluorescence for each cell. The average intensity per cell 
was ascertained by counting the magnitude of every pixel and then dividing 
by the number of pixels. 
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3.9.8 The calibrate macro 
The raw fluorescence trace minus the background was displayed and cells 
were selected on the basis of having a Triton X-100 response. From all of the 
selected cells, a new trace was then displayed showing the average values for 
all cells. Two sets of timing were utilised, one to mark out the calibration 
timings. Using this information, the macro finds a minimum fluorescence 
value and subtracts it from each cell. This is the fluorescence that is left 
following Triton X-100 application in EGTA. We assume that this value is 
constant throughout the protocol and that the fluorescence left is inaccessible 
and not subject to change. The second set of timings allowed for correction of 
any linear trend. The calibration trace was then re-analysed, and the 
maximum fluorescence intensity value found, i.e., the dye saturation point 
with Triton X-100. Equation 3.1 was then utilised to determine [Ca2+]i.  
)max(
min)(][ 2
FF
FFKdCa i 
u   
Equation 0-1.1 Determination of [Ca2+]i. Calibration of a single wavelength indicator can be 
carried out following determination of the maximum and minimum fluorescence values of the 
indicator (Fmax +Fmin) in Ca2+ saturated and Ca2+ free following subtraction of the background 
fluorescence, Kd represents the equilibrium dissociation constant of the fluorescent indicator. The 
cellular Kd of Fluo-4 was taken as being 345nM (Takahashi et al., 1999, Gee et al., 2000, 
Paredes et al., 2008) 
Measurements for [Ca2+]i were taken after every change in the perifusion 
solution, following stabilisation of the [Ca2+]i signal. 
Graphpad PRISM version 5 software (Graphpad software, San Diago, 
California, USA) was used for statistical analysis. Data were subject to 
exclusion on the basis of the following criteria: If the basal [Ca2+]i was 
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<50nM, or >300nM, if the adipocyte was unresponsive to the Triton X-100 
calibration procedure; or if the [Ca2+]i continuously decreased throughout the 
experiment, adipocytes that did not respond to extracellular Ca2+ removal 
were also excluded.  
Data were output as [Ca2+]i, and expressed as mean ± S.E.M. For each 
protocol presented at least 3 different adipocyte preparations were used and 
³Q´WKHQXPEHURIDGLSRF\WHVJLYHQDVWKHVXPWRWDOIURPWKHVHSUHSDUDWions. 
Normality testing was carried out for each experiment. Due to the non-
SDUDPHWULFGLVWULEXWLRQRIGDWDWKH)ULHGPDQ¶VWHVWZDVFDUULHGRXWZLWKWKH
Dunns post-test. Statistical significance was considered when p<0.05.  
3.9.9 Optimisation 
Attempts to carry out the experiments at 32oC (to model physiological 
conditions as closely as possible) were not successful due to loss of 
fluorescent signal. This could be attributed to either dye loss or loss of Ca2+ 
from the cell, possibly by an active transport mechanism. To test the 
possibility that the dye was being extruded by the multiple drug resistant 
transporter (MDR), adipocytes were loaded with a substrate for multiple drug 
resistant proteins, calcein AM (1µM) (Glavinas et al., 2004). Probenecid, a 
blocker of calcein transport (Webster and Carlstedt-Duke, 2002) did not show 
any improvement to signal retention within the adipocyte. Photo-bleaching 
was also considered a possibility, although the signal loss was not constant 
and stabilized at a [Ca2+]i value of approximately 50nM. To account for the 
decline in fluorescence signal intensity, any linear trend was corrected for 
during the analysis. Experimental temperature was also investigated, and it 
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was determined that the fluorescent signal within the cell could best be 
maintained when the experiments were performed at 22oC  
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3.9.10 Protein extraction and Western blots 
3.9.10.1 Brain and heart sample preparation 
Brain was dissected out of a male Wistar rat (weighing approximately 200-
220g) and washed thoroughly in +DQN¶VVXSSOHPHQWHGZLWK0.1% wt/vol BSA, 
to reduce blood contamination. Tissues were transferred to a fresh tube 
containing lysis buffer. The lysis buffer comprised, in mM Tris 20, EGTA 1, 1 
NaF, 10 Beta glycerophosphate and 0.1% (v/v) Triton X-100 pH 7.6. One 
protease inhibitor tablet (Rigo et al.) was added per 10mls of buffer. Brains 
were weighed and typically 1g of tissue was added to 10ml of complete lysis 
buffer. Brain tissue was homogenised using a hand held homogeniser (Ultra-
Turrax T18, IKA Laboretechnik, Germany) until a uniform consistency was 
obtained. Samples were assembled on a rotating wheel and spun for 1 hour 
at 4oC. To separate the non-solubilised matter from the protein, the samples 
were centrifuged at 15,000g for 10 minutes at 4oC. The supernatant was 
transferred to a clean microfuge tube, 50µl of this was kept for the 
determination of sample protein concentration. The remainder of the 
supernatant was re-suspended in lysis buffer. 
3.9.10.2 Adipocyte sample preparation 
Primary white adipocytes were isolated from the epididymal fat pads of 
Wistar, diabetic fatty Zucker and the lean control Zucker rats as described in 
Section 3.9.1. The excess +DQN¶V buffer was removed from the adipocyte 
suspension. 500µl of packed cell volume was transferred to a 1.5ml 
microfuge tube and an equal volume of lysis buffer (as above) added. For 
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solubilisation, the samples were assembled on a rotating wheel and left to 
spin for 45 minutes at 4oC. To separate out the fat and non-solubilised matter, 
the samples were centrifuged at 15,000g for 10 minutes at 4oC. The upper 
layer of fat was removed and the supernatant containing the cell lysate was 
transferred to a clean microfuge tube, 50µl of this was aliquotted and kept for 
determination of sample protein concentration. The remainder of the 
supernatant was re-suspended in one fifth sample volume of a 6X 
concentrated stock of solubilisation buffer. 
3.9.10.3 Lowry assay  
To determine the protein content of all samples, the Lowry assay was carried 
out. Stock solutions of 1mg/ml bovine serum albumin in dH2O were used to 
set up the standard curve. The dilutions are shown in Table 3.5. 
Tube Number Concentration of 
BSA (mg/ml) 
0 0 
1 0.05 
2 0.10 
3 0.15 
4 0.20 
5 0.25 
6 0.30 
7 0.35 
8 0.40 
9 0.45 
Table 3.5. The dilutions of the 1mg/ml BSA stock used to create the standard curve for 
the protein assay. Each concentration was made up in a separate 1.5ml microfuge tube. A new 
standard curve was constructed for every sample set to be assayed for protein concentration. All 
standards and samples were assayed in triplicate. 
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The adipose protein samples were diluted 1:10 (20µl in 180µl dH2O) to a 
total volume of 200µl. The control protein samples of brain and heart were 
diluted to 1:20 and 1:40. To prepare the Lowry AB solution 20mls of Lowry A 
(composition see Appendicies) was mixed with, 100µl NaK tartrate and 100µl 
1% CuSO4 were added. 1ml of Lowry AB solution was added to each standard 
and sample. The Lowry AB and sample/ standard mixture was incubated for 
ten minutes at room temperature. Following incubation, 100µL of 1:1 Folin 
reagent (Sigma): dH2O was added to each sample and standard and the 
mixture immediately vortex mixed. 200µl of each sample and standard were 
transferred in triplicate into a clean 96-well plate. The plate was incubated at 
room temperature for 45 minutes. The plate was then read at 750nm with a 
Spectra MAX 340pc plate reader. Protein standard curves and sample 
concentrations were determined by the Softmax Pro software (Molecular 
Devices). All protein samples were diluted to equivalent protein 
concentrations (1mg/ml) using 1:1 solution of 1X solubilisation buffer and 
lysis buffer. 
3.9.10.4 SDS-PAGE gels 
Protein samples were denatured by being assembled on a heat block set to 
95oC for 5 minutes. Samples were vortexed and then centrifuged for one 
minute at 13,000rpm. Whilst sample preparation took place, 1X 
electrophoresis buffer was prepared by dilution of the 10X stock. 7.5% pre-
cast SDS-PAGE gels (Lonza, 58501) were initially used in this study. Due to 
difficulties detecting protein at a loading concentration of 20µg/µl and a 
limited volume of 20µl with the pre-cast gels, home-made gels were utilised 
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instead. These had a maximum loading volume of 40µl, enabling loading of 
40µg/µl of normalised protein sample. 
3.9.10.5 Composition of SDS-PAGE gels 
Gels were made according to the composition described in Table 2.6 
Component Stacking Gel (ml) 
4% 
Resolving Gel (ml) 7% 
   
H2O 4.880 8.160 
30% acrylamide 1.040 3.680 
Resolving gel buffer, 1.5M Tris-
HCl 
 4.000 
Stacking gel buffer, 0.5M Tris-
HCl 
2.000  
10% SDS 0.080 0.160 
10% APS 0.040 0.080 
TEMED 0.008 0.016 
Total Volume 8.0 16.10 
Table 3.6. The composition of 7% SDS polyacrylamide gels. Volumes stated above are for 
the preparation of two gels. Ammonium persulfate (APS), and tetramethylethylenediamine 
(TEMED) are shown in bold as these components were added to the gel mix immediately before 
casting.  
Ammonium persulfate (APS) and tetramethylethylenediamine (TEMED) cause 
polymerisation of the gel and as such were added to the gel composition last 
of all. Gels were cast in a Bio-Rad Mini PROTEAN gel apparatus and overlaid 
with water-saturated butanol. Resolving gels were left to polymerise for 20 
minutes. Following gel polymerisation, the saturated butanol was washed 
away with dH2O. Residual water was removed by blotting (with filter paper) 
between the glass plates. APS and TEMED were added to the stacking gel mix, 
and this poured on top of the resolving gel. A 10-well 1.5mm Bio-Rad comb 
was inserted into the resolving gel in between the gel plates. The stacking gel 
was left to polymerise for 20 minutes. 
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The gels were locked into the gel holder and placed into the electrophoresis 
tank (Bio-Rad Mini PROTEAN). The tank was then filled with 1X 
electrophoresis buffer. To aid determination of the molecular weight of the 
proteins at a later stage, dual colour Bio-Rad precision plus protein standards 
ranging from 10kD to 250kD were utilised (cat no 161-0374). To load the 
samples and molecular weight markers into the gel, loading tips were used. 
The loading tips were always washed between sample loading by dipping the 
end of the tip into the electrophoresis buffer. This removes excess sample 
accumulation at the end of the pipette tip. Typically 1µl of molecular weight 
marker was loaded into the appropriate well. The control samples of heart 
and brain protein were loaded at 10-15µg/ul. Adipocyte protein 
concentrations were initially loaded at 20µg/µl. This was later increased to 
40µg/µl for all adipocyte samples and 25µg/µl protein for the heart and brain 
samples. The gel was run at 200V for 40 minutes (Bio-rad PowerPacTM 200) 
until the dye front had run to the bottom of the gel. The gel was removed 
from the cassette and carefully separated away from the glass plates. 
3.9.10.6 Electrotransfer 
In preparation of the transfer two pieces of pre-cut filter paper, two sponge 
pads, and nitrocellulose membrane were placed in cold transfer buffer; these 
were allowed to soak for 10 minutes. The stacking gel was removed from the 
resolving gel. To carry out the transfer all components were assembled as 
shown in Figure 3.4. After addition of each component, all bubbles were 
removed by using a roller. 
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Figure 3.4. The order of assembly of the Western blot transfer. The black side of the 
cassette was placed down and the cassette opened out. All components were assembled as 
depicted above and the cassette locked. 
Transfer of proteins from the gel to the nitrocellulose was carried out using 
the Bio Rad Mini PROTEAN apparatus with ice pack inserts. The tank was then 
filled with transfer buffer and transfer was performed for 1 hour at 100V. To 
assess the quality/ success of the transfer ponceau solution (0.1% (w/v) 
ponceau solution in 5% (v/v) acetic acid, Sigma) was added to the 
nitrocellulose membrane. The appearance of red bands was indicative of 
protein, and as such a successful transfer. The membrane can be cut at this 
stage to separate the blot up for incubation with different antibodies, or 
simply to remove any excess membrane. To de-stain, the membrane was 
washed with Tris-Buffered Saline Tween 20 buffer (TBST). Non-specific 
protein binding was reduced by incubating the membrane in 5% (v/v) Marvel 
dried milk in TBST at room temperature, on a shaking platform for one hour. 
3.9.10.7  Antibody incubation 
Due to the difficulties in extracting an appropriate amount of protein from the 
adipocyte samples, in particular those from Zucker rats (due to a noticeably 
increased amount of fat), samples were conserved as much as possible. This 
was achieved by cutting the membrane horizontally in 4 locations. Each 
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VHFWLRQ ZDV SUREHG VHSDUDWHO\ IRU WKH SURWHLQ RI LQWHUHVW DQG WKH ǃ-actin 
loading control. Membranes were enclosed within custom sized heat-sealed 
bags. Primary antibodies were diluted in 5% (v/v) milk in TBST, and 
subsequently added to the bag containing corresponding membrane 
segments, and then sealed. Membrane segments were incubated overnight 
with shaking. Primary antibodies used within this investigation are shown in 
Table 3.7 
Antibody  Supplier 
Cat no  
Host Species  Band 
Size 
kDa  
Working 
dilution  
Species 
Reactivity 
Blocking condition  
Cav1.3 
(a1D)  
Alomone 
ACC-005A  
Rabbit  
(polyclonal) 
265  1:200  Mouse, 
rat 
5% v/v milk TBST 
ɴ-actin  Sigma 
 
Rabbit 42 1:20,000 Human, 
rat, rabbit 
5% v/v milk TBST 
(Na+/Ca2+ 
exchanger) 
NCX1 
Abcam 
Ab6495 
Mouse 
(monoclonal) 
120 1:200 -1:500 Mouse, 
rat, cow, 
guinea 
pig, 
rabbit 
5% w/v milk TBST 
(Na+/Ca2+ 
exchanger) 
NCX3 
Santa Cruz 
SC-48896 
Goat 
(polyclonal) 
64 1:200 
Range 
(1:100-
1:1000) 
Mouse, 
rat, 
human 
5% w/v milk TBST 
Table 3.7. The primary antibodies used within this investigation. 
The plastic bag containing primary antibody and the nitrocellulose membrane 
was cut. The primary antibody in 5% v/v milk TBST was poured into a 
universal tube and placed into the freezer for storage for re-use. (primary 
antibodies were used no more than 3 times). The membrane was placed into 
the glass dish where it was rinsed in TBST (Glass dishes were washed in 70% 
(v/v) IMS dH2O). The membrane was then washed in TBST for 3 periods of 5 
minutes, followed by 3 periods of 15 minutes in TBST. After washing, the 
infra-red dye labelled secondary antibody (Li-COR) was diluted to 1 in 
10,000 in 5% (w/v) milk in TBST. The Donkey anti-mouse 926-68072, goat 
anti-rabbit 926-68021 and donkey anti-goat 926-68074 (Li-&25VHFRQGDU\
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antibodies were used as appropriate. The secondary antibody was added to 
the glass container containing the washed blot, and left to incubate at 37oC, 
on a shaking platform for one hour. Following incubation with the secondary 
antibody the membrane the TBST washing steps were repeated. The 
membrane was then rinsed in dH2O and taken for scanning with the Odyssey 
infrared imaging scanner, with the Odyssey software version 2.1 (LI-COR 
Bioscience, USA). Densitometry analysis was also performed using the 
Odyssey software. All data from independent protein preparations for each 
adipocyte sample type were expressed as the ratio to optical density values 
for the cRUUHVSRQGLQJǃ-actin control. 
Chapter 3 
149 
 
3.10 Results 
3.10.1 Adipocyte morphology and loading 
 
Figure 3.5. A representative image of primary white fat adipocytes isolated from rat 
epididymal fat pads. This is light microscope image of 4 adipocytes, taken at x20 magnification 
using an air objective lens. The distinct cygnet ring shape of the cell is characterised by the 
nucleus being pushed out to one side by intracellular lipid droplet which constitutes 
approximately 95% of the cells volume (Arner, 2005a). The scale bar represents 100µM. 
       
Figure 3.6. A representative field of Fluo-4 loaded primary white fat adipocytes. Viewed 
at x20 under an air objective lens. The image given is a pseudo colour image using a hot to cold 
look up table (LUT). The red colour is representative of high Ca2+ and / or dye content. The blue 
colour is indicative of the absence of Ca2+/dye. The scale bar represents 100µM. 
Figure 3.5 is a representative image of adipocytes, as observed following 
cellular isolation and plating onto glass cover slips. Figure 3.5 shows four 
adipocytes, all are roughly spherical in shape with a protruding nucleus. 
Nucleus 
Nucleus 
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Figure 3.6 shows a field of adipocytes comprising seven cells, following 
incubation for 30 minutes in Fluo 4-AM. The size, loading and location of the 
adipocytes varied within this population. These cells also have the typical 
spherical appearance characteristic of adipocytes. The nucleus nub as shown 
in Figure 3.5 is visible in 3 cells within Figure 3.6. The dark red region located 
to the side of the adipocyte is indicative of either a high [Ca2+]i and/or dye 
content within this region. The cells are varied in the extent to which they are 
loaded. Some cells are brighter and more uniformly loaded than others. 
Analysis was carried out to ascertain whether the vicinity of the cell with 
respect to other members of the adipocyte population was a factor that would 
influence experimental outcome. No correlation was seen between adipocyte 
locale and likelihood of success of dye loading or responsiveness to Ca2+. 
Adipocytes had an average calculated diameter of 78.8 ± 1.79µm with a 
mean cell volume of 268nL ± 16.85nL (n=43), Figure 3.7 shows that 
adipocytes used in this study had a median basal [Ca2+]i of 118nM. 
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Figure 3.7. Distribution of basal [Ca2+]i in adipocytes from all experimental protocols. 
Median [Ca2+]i is 118nM (n=368). The distribution is not Gaussian, warranting the use of non-
parametric statistical analysis. Also note the cut off at 50nM [Ca2+]i in accordance with the 
exclusion criteria outlined in the materials and methods. Note, in subsequent figures the mean 
[Ca2+]i is between 100 and 150, as determined by the mean for all basal [Ca
2+]i¶VUHFRUGHGIRU
each experimental protocol. Means are represented in subsequent figures to enable comparison 
with the published literature. 
3.10.2 Adipocytes have functional Ca2+ influx pathways 
To confirm the presence of Ca2+ influx pathways within white fat adipocytes, 
adipocyte responsiveness to changes in extracellular calcium concentration 
was investigated. It was hypothesised that upon removal of extracellular Ca2+ 
there may be a reversible decrease in [Ca2+]i, with [Ca
2+]i returning to basal 
levels following re-perifusion of extracellular Ca2+. 
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Figure 3.8. A typical background subtracted and calibrated [Ca2+]i trace for an 
adipocyte displaying responsiveness to extracellular Ca2+ removal. Only one trace is 
shown for clarity, note a reduction in [Ca2+]i upon perifusion of extracellular Ca
2+ free at 
approximately 200 seconds, and a recovery of [Ca2+]i upon re perifusion of extracellular Ca
2+ at 
400 seconds. 
There was a mixed cellular response to extracellular Ca2+ removal/ 
reperfusion and the Triton X-100 calibration step at the end of the protocol. 
Correction for linear reduction in fluorescence intensity was carried out in 
adipocytes where applicable. Initially, only adipocytes that were responsive to 
extracellular Ca2+ removal and the Triton X-100 calibration step were taken 
for further analysis, giving rise to a trace as shown in Figure 3.8. Only 
adipocytes responsive to changes in extracellular Ca2+ are presented within 
this thesis as it was hypothesised that these adipocytes were viable and 
responsive to changes in [Ca2+]o.
  The level of [Ca2+]i for the responsive cells 
was calculated on the basis of the maximum and minimum fluorescence 
intensity values for each individual cell. Values for [Ca2+]i were taken from 
the time-course for each cell after each intervention following stabilisation of 
the Ca2+ signal. Responsive cells from at least 3 different adipocyte 
preparations were pooled and used for statistical analysis. 
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Figure 3.9 Shows adipocytes which are responsive to changes in extracellular Ca2+. 
Background subtracted and calibrated data using adipocytes from at least 3 preparations, n=38 
cells. The results show that Ca2+ influx and efflux pathways are present. When Ca2+ is removed 
from the extracellular media the [Ca2+]i significantly decreases by 26%. Upon re addition of 
2.6mM extracellular calcium in the perifusion media the [Ca2+]i returns to the original baseline 
value. Data are presented as mean ± SEM (**P<3)ULHGPDQ¶V 
Figure 3.9 shows that the adipocytes used in this study are responsive to 
changes in extracellular Ca2+, suggestive of the presence of calcium influx 
pathways. 
3.10.2.1 Investigation into the presence of Cav1.2 and Cav1.3 
VGCCs in white fat adipocytes 
To test the hypothesis that the increase in [Ca2+]i observed upon reperifusion 
of extracellular Ca2+ was by way of either Cav1.2 or Cav1.3 channels, 
adipocytes were exposed to 20µM nifedipine, (a dihydropryidine (DHP)), to 
screen for Cav1.2 VGCCs, and 20 µM verapamil, to screen for Cav1.3 VGCCs 
(Koschak et al., 2001, Xu and Lipscombe, 2001, Lipscombe et al., 2004). 
In Figure 3.10a and 3.10b there was a significant reduction in [Ca2+]i upon 
extracellular calcium removal P<0.05. This effect is reversible upon re-
perifusion of extracellular Ca2+. There is no significant effect of either 
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nifedipine or verapamil upon [Ca2+]i. To eliminate any confounding effect of 
the DMSO vehicle, the same perifusion protocol was repeated in the absence 
of blocker, with the DMSO (0.1 %v/v) vehicle only. Adipocytes responded to 
DMSO perifusion by a significant 28% increase in [Ca2+]i when compared to 
recovering [Ca2+]i values (Figure 3.11).  
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Figure 3.10. The effect on [Ca2+]i of perifusion of Cav1.2 and Cav1.3 VGCC blockers. (A) 
nifedipine 20µM, (n=21) and (B) Verapamil 20µM, (n=22) is shown. Data are expressed as mean 
± SEM (*P<0.05, **P<0.01, ***P<0.001) )ULHGPDQ¶V 
Extracellular Ca2+ removal resulted in a significant reversible decrease in 
[Ca2+]i. In this instance, [Ca
2+]i incompletely recovers. Perifusion of DMSO 
significantly increases [Ca2+]i by 22% when compared to recovering Ca
2+. 
The reason for the DMSO effect on increasing [Ca2+]i was unknown. The 
extent of the change in Ca2+ due to the DMSO vehicle with nifedipine and 
verapamil were corrected for accordingly. 
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Figure 3.11. The effect on [Ca2+]i of perifusion of 0.1%v/v DMSO (n=33). Data are 
expressed as mean ± SEM (**P<0.01, ***P<0.001) )ULHGPDQ¶V 
 
Figure 3.12. The effect of perifusion of the Cav1.2 blocker nifedipine, (n=23) and the 
Cav1.3 blocker verapamil (n=11) on adipocyte [Ca
2+]i levels, post correction for effect 
of the DMSO vehicle. Experimental data for this figure were sourced from Figure 3.10 and 3.11. 
Values are shown as % change in [Ca2+]i when compared to recovering Ca
2+in the presence of 
the DMSO vehicle. The [Ca2+]i levels in the presence of verapamil (mean=-26.1 ± 8.3) after 
correction for the DMSO vehicle effect is significantly different when compared to recovering 
[Ca2+]i levels. Nifedipine (mean -13.18 ± 8.9) did not cause a significant reduction in [Ca
2+]i. 
Data are presented as Mean ± SD. 
Data were taken for correction for the effect of the DMSO vehicle from Figure 
3.10 and 3.11. The inhibitor was included in the perifusion medium, providing 
constant exposure of the cells to nifedipine or verapamil during the course of 
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the experimental protocol. Ca2+ channels flicker on and off, as such it is likely 
that any open channels if they are Cav1.2 or Cav1.3 channels will be blocked. 
Following this correction verapamil (20µM) is shown to inhibit basal Ca2+ 
influx when compared to nifedipine (20µM) indicative of a role of Cav1.3 
VGCCs in basal Ca2+ influx (Figure 3.12). 
To investigate a possible role of Cav1.2/ Cav1.3 VGCCs, on Ca
2+ re-entry in 
the white fat adipocyte, Ca2+ channel blockers were added in the absence of 
extracellular Ca2+, prior to re-addition of extracellular Ca2+. 
 
Figure 3.13. The effect of perifusion of 20µM VGCC blockers on Ca2+ re-entry in white 
fat adipocytes. (A) Nifedipine, (n=40) and (B) Verapamil (n=80) on Ca2+ re entry. Data are 
presented as mean ± 6(0333)ULHGPDQ¶V 
Figure 3.13A shows the addition of 20µM nifedipine had no effect on [Ca2+]i in 
the absence of extracellular Ca2+, however nifedipine irreversibly prevented 
[Ca2+]i recovery upon re-perifusion of extracellular Ca
2+. Similar observations 
were made for 20µM verapamil (Figure 3.13B).  
To investigate if Cav1.2/ Cav1.3 channels were open, the channel agonist Bay 
K 8644 was employed (Figure 3.14). When Ca2+ was removed from the 
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extracellular media, [Ca2+]i decreased by 20%, whilst addition of Bay K 8644 
had no effect on [Ca2+]i in the absence of extracellular Ca
2+. Upon re-addition 
of 2.6mM extracellular Ca2+ in the perifusion media, [Ca2+]i fully recovered, 
Bay K 8644 (1µM) had no significant effect on [Ca2+]i in adipocytes in either 
the presence or absence of [Ca2+]o. 
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Figure 3.14. The effect of perifusion of 1µM Bay K 8644 on [Ca2+]i in white fat 
adipocytes. The results are expressed as mean ± SEM (n=14), (*P<0.05) )ULHGPDQ¶V.  
To investigate any confounding effect of the DMSO vehicle the same 
perifusion protocol was carried out in the absence of any Cav1.2/Cav1.3 VGCC 
agonist/ antagonist with the DMSO (0.1%v/v) vehicle only. Figure 3.15 
shows that there was no significant effect of DMSO in the absence of [Ca2+]i, 
or on its recovery on re-perifusion of extracellular Ca2+. 
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Figure 3.15. The effect on [Ca2+]i of perifusion of 0.1%v/v DMSO. Data are expressed as 
mean ± SEM (n=25). (**P<0.01, ***P<0.001) )ULHGPDQ¶V.  
Subsequent experiments were carried out to investigate whether elevation of 
extracellular K+, would elicit the presence of VGCCs. Conditions of high 
extracellular K+ (50mM) are often used to probe for the presence of VGCCs, 
and have been used to do so in a variety of cell types (Yaguchi and Nishizaki, 
2010), including adipocytes. Perifusion of 50mM K+ did not significantly affect 
[Ca2+]i of the total population (n=17). However, 58% (n=10) responded by 
exhibiting increased [Ca2+]i of 18±4.3% upon K
+ perifusion. To determine 
whether a subset of the adipocyte population were exhibiting Ca2+ entry by 
VGCCs, the data for the K+ responsive adipocytes were subject to further 
analysis. Of the adipocytes that did show an increase in [Ca2+]i in response to 
50mM K+, there was no significant effect of verapamil (Figure 3.16B). 
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Figure 3.16. The effect of perifusion of 50mM K+ on [Ca2+]i in white fat adipocytes. All 
adipocytes are shown in A (n=17). In B, only adipocytes that responded to 50mM K+ with a 
significant increase in [Ca2+]i are shown (n=10). Data are expressed as mean ± SEM (**P<0.01, 
***P<0.001) )UHLGPDQ¶V  
Hyperinsulinaemic individuals exhibit insulin resistance (Shanik et al., 2008). 
Both insulin resistance and hyperinsulinaemia are associated with type 2 
diabetes (Shanik et al., 2008). In vitro insulin resistance can be induced in 
isolated white rat adipocytes upon exposure to elevated concentrations of 
insulin (Marshall and Olefsky, 1980, Shanik et al., 2008). The effect of 30 
minute acute insulin (100nM) application on [Ca2+]i was then investigated. 
In Figure 3.17A extracellular Ca2+ removal resulted in a mean decrease in 
[Ca2+]i  of -30% (P<0.005). [Ca
2+]i was restored to basal levels following re-
perifusion of 2.6mM Ca2+. Perifusion of 100nM insulin for 30 minutes did not 
result in a significant change in [Ca2+]i. 65% of the adipocyte population 
responded by increasing [Ca2+]i, 35% of the adipocyte population responded 
by decreasing [Ca2+]i.  
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Figure 3.17. The effect of acute insulin exposure on [Ca2+]i in white fat adipocytes. In A, 
the effect of perifusion of 100nM insulin for 30 minutes on [Ca2+]i,  in adipocytes that are 
responsive to changes in extracellular Ca2+. Data in A are expressed as mean ± SEM (n=17) 
(*P<0.05) )ULHGPDQ¶V  
Insulin had no effect on basal [Ca2+]i. Insulin did not affect the nature of 
response to extracellular Ca2+ removal (Figure 3.17). There was no significant 
difference in [Ca2+]i pre and post insulin exposure. Furthermore perifusion of 
20µM verapamil in insulin did not affect [Ca2+]i in the absence of [Ca
2+]o. 
[Ca2+]i values returned to basal levels upon re-perifusion of [Ca
2+]o in the 
presence of insulin and verapamil. Removal of extracellular verapamil had no 
further effect on [Ca2+]i (Figure 3.18).  
ns 
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Figure 3.18. The effect of perifusion of 20µM verapamil in 100nM insulin on Ca2+ re-
entry pathways in the white fat adipocyte (n=7). Shaded bars indicate the presence of 
insulin in the perifusion media. Data are expressed as mean ± SEM (*P<0.05, **P<0.01, 
***P<0.001) )ULHGPDQ¶V 
Figure 3.19A shows that insulin had no effect on either the ability of 50mM 
[K+]o to elevate [Ca
2+]i, or the subsequent effect of verapamil at inhibiting 
Ca2+ influx. To ascertain, in the adipocytes that did respond by elevated 
[Ca2+]i in 50mM extracellular K
+ whether Ca2+ entry was occurring by VGCCs, 
subanalysis were performed. Of the adipocytes that responded by an increase 
in [Ca2+]i there was no significant effect of verapamil in insulin (Figure 3.19B). 
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Figure 3.19. The effect of perifusion of 100nM insulin on [Ca2+]i in the presence and 
absence of 2.6mM Ca2+ is shown. As is the effect of 50mM K+ in the presence and absence of 
20µM verapamil. Shaded bars represent the presence of insulin in the perifusion media. A shows 
all experimental data (n=11). B shows only adipocytes that responded to 50mM K+ by an 
increase in [Ca2+]i (n=8). Data are expressed as mean ± SEM (*P<0.05, **P<0.01) )ULHGPDQ¶V  
In Chapter 2, it was demonstrated that elevated [K+]o did not affect the Vm 
of white adipocytes. Reductions in [Cl-]o were shown to depolarise the plasma 
membrane. As such, it was further investigated whether the presence of 
Cav1.3 could be elicited by depolarising the adipocyte plasma membrane with 
reduced [Cl-]o and subsequent perifusion of verapamil. 
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Figure 3.20. The effect of extracellular Cl- reduction from 138mM to 5mM on [Ca2+]i in 
the primary white fat adipocyte. A) shows all adipocytes tested, n=15. B) shows only the 
adipocytes that responded to extracellular Cl- removal by increasing [Ca2+]i n=12 out of 15. 
There was no significant effect of verapamil at reducing [Ca2+]i. Data are expressed as mean  
Adipocytes were first subject to extracellular Ca2+ removal to confirm the 
presence and activity of Ca2+ regulatory mechanisms within this adipocyte 
population. Having ascertained adipocyte responsiveness to alterations in 
[Ca2+]o (P<0.05, Wilcoxon), the concentration of extracellular Cl
- was reduced 
from 138mM to 5mM. No significant increase in [Ca2+]i occurred. To ascertain 
the role of L-type VGCCs in the response to 5mM Cl-, only adipocytes that 
responded by showing an increase in [Ca2+]i in response to a reduction in 
extracellular Cl- are shown in B, n=12 out of 15 (P<0.05 Wilcoxon). There 
was no significant effect of verapamil (V) (20µM) at reducing [Ca2+]i levels in 
these adipocytes. 
To test the hypothesis that the reverse mode of the NCX was acting as a Ca2+ 
entry pathway, adipocytes were exposed to reverse mode NCX inhibitors SN-
6 and KBR-7943. 
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3.10.2.2 Investigation into the presence of the reverse mode of 
the sodium calcium exchanger in white fat adipocytes 
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Figure 3.21. The effect of 10µM KBR-7943 upon Ca2+ re-entry within the white fat 
adipocyte. In (A) the effect of KBR-7943 in the absence of insulin is shown (n=18). In (B), 
shaded bars indicate the presence of 100nM insulin in the perifusion media (n=40). Background 
subtracted and calibrated data using adipocytes from at least 3 separate adipocyte preparations 
are shown. Data are expressed as Mean 6(0333)ULHGPDQ¶V 
In Figure 3.21 extracellular Ca2+ removal resulted in a significant decrease in 
[Ca2+]i, indicative of functional Ca
2+ efflux pathways in the primary white 
adipocytes used within this investigation. In Figure 3.21, perifusion of 10µM 
KBR-7943 in the absence of extracellular Ca2+ did not affect [Ca2+]i. Re-
addition of extracellular Ca2+ in the presence of KBR-7943 did not cause any 
significant increase in [Ca2+]i, with washout of KBR-7943 resulting in recovery 
of [Ca2+]i to a value similar to that observed at the start of the perifusion 
protocol. Indicative of an inhibitory effect of KBR upon Ca2+ re entry in non 
insulin conditions. 
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In Figure 3.21B 100nM insulin was added to the perifusion media ~5 minutes 
into the perifusion protocol. [Ca2+]i values did not differ in the presence or 
absence of insulin. Upon re-addition of extracellular Ca2+ there was no 
inhibitory effect of KBR-7943 on Ca2+ re-entry, as [Ca2+]i recovered to a 
value similar to basal [Ca2+]i with no further change in [Ca
2+]i on KBR-7943 
washout.  
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Figure 3.22. The effect of 10µM SN-6 upon Ca2+ re-entry within the white fat adipocyte. 
In (A) the effect of SN-6 in the absence of insulin is shown (n=39). In (B), shaded bars indicate 
the presence of 100nM insulin in the perifusion media (n=28). Background subtracted and 
calibrated data using adipocytes from at least 3 separate adipocyte preparations are shown. Data 
are expressed as Mean ± SEM (* P<0.05, **P3)ULHGPDQ¶V 
In Figure 3.22 perifusion of SN-6 in the absence of extracellular Ca2+ resulted 
in a significant reduction in [Ca2+]i. SN-6 addition in Ca
2+ free resulted in a 
further significant decrease in [Ca2+]i. Re-addition of Ca
2+ to the perifusion 
media in the presence of 10µM SN-6 resulted in a significant increase in 
[Ca2+]i. Upon SN-6 washout, [Ca
2+]i significantly increased further, indicating 
a partial inhibitory effect of SN-6 upon Ca2+ re entry. 
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In summary adipocytes have functional Ca2+ influx pathways. Verapamil was 
shown to block basal Ca2+ influx, suggestive of the presence of Cav1.3 
channels on the plasma membrane of white adipocytes. Conditions of 
elevated extracellular K+ do not significantly increase [Ca2+]i. Acute insulin 
exposure does not increase [Ca2+]i. Additionally SN-6 and KBR-7943 were 
shown to inhibit Ca2+ re-entry in non insulin conditions, suggestive of the 
presence of the reverse mode of the NCX in white fat adipocytes. 
3.11  The behaviour of the NCX at -30mV with extracellular Ca2+ 
concentrations of 2.6mM and 50µM. 
To predict the direction of exchange of the NCX and [ion]i at -30mV for 
2.6mM [Ca2+]o and 50µM [Ca
2+]o, Equation 3.2 was used.  
2
2

 
n
EnEE CaNaNaCa
 
Equation 3.2. Equation describing the mode of exchange of the NCX (Stys et al., 1992). 
This equation was transformed to provide a model of the mode of exchange of the NCX at 
extracellular [Ca2+]i concentrations of 2.6mM and 50µM. ENaCa, ENa and ECa are the reversal 
potentials of the exchanger, Na+ and Ca2+ respectively, n represents the exchanger stoichiometry. 
In this instance the exchanger stoichiometry is assumed to be 3Na+ :1Ca2+, so n=3. 
Figure 2.23 shows the expected equilibrium isotherms for Na+ and Ca2+ under 
the different extracellular [Ca2+]o conditions, [Ca
2+]o=2.6 and nominally 
[Ca2+]o free. 
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Figure 3.23. Steady state [ion]i in the presence and absence of extracellular Ca
2+ at -
30mV in white adipocytes. (A) In the presence of 2.6mM extracellular Ca2+ with a resting 
[Ca2+]i of 120nM this model predicts [Na
+]i to be 7.3mM, at NCX equilibrium. When the 
extracellular buffer is switched to extracellular Ca2+ free the exchanger now operates in Ca2+ 
efflux mode and [Na+]i increases. (B) Upon re addition of [Ca
2+]o as per the protocols in Figures 
3.21 and 3.22 the exchanger will tend to increase [Ca2+]i by operating in reverse mode, i.e. Ca
2+ 
influx mode. 
Figure 3.23 shows that at -30mV in 2.6mM [Ca2+]o the NCX will operate in 
Ca2+ efflux mode, only when [Ca2+]o is removed. When [Ca
2+]o is re-added 
the exchanger will then operate in Ca2+ influx mode. The higher the [Na+]i 
value the more likely the exchanger will operate in reverse mode in 2.6mM 
[Ca2+]o to result in Ca
2+ influx. 
The experiments in section 3.11.3 were carried out to confirm the presence 
of Cav1.3 and the NCX Ca
2+ influx pathways in primary white adipocytes 
A 
B 
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3.11.1 3URWHLQH[SUHVVLRQRIWKHĮ1 subunit of Cav1.3 voltage-gated 
Ca2+ channels in rat white adipocytes 
Western blotting experiments were performed to explore the protein 
exprHVVLRQ RI WKH Į1 subunit of Cav1.3 adipocytes. An expected band of 
~265kDa was detected by the Cav1.3 antibody (Alomone) in rat heart 
(positive control tissue) and in rat white adipose samples from Wistar, Zucker 
lean and Zucker obese rats. Due to antibody batch-to-batch variations and 
time constraints, only a limited number of immunoblots was obtained (n=6, 
Wistar; n=2, Zucker lean/obese), see Figure 3.23. 
The intensity of the CavSURWHLQEDQGVZDVPHDVXUHGǃ-actin was used as 
a loading control, as such CavSURWHLQ OHYHOVZHUHQRUPDOLVHG WRǃ-actin. 
Data are expressed in terms of fold of heart tissue intensity. Due to the low n 
statistics cannot be performed to compare the protein expression of Cav1.3 in 
Zucker rats compared to Leans or controls, however the figure has been 
included as an indicator of Cav1.3 expression between the Zucker rats, the 
OHDQFRQWUROVDQGWKH:LVWDUV7KHH[SUHVVLRQRIWKHĮ1 subunit of Cav1.3 in 
Zucker obese rats appears to be less than half of the expression levels 
observed for the Wistars or the Zucker leans, suggestive of a reduction in 
CavĮ1 subunit expression in adipocytes from obese rats (Figure 3.24).  
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Figure 3.24. Representative Western blot of Cav DQG ǃ-actin expression in heart, 
and in white adipocytes from Wistar, Zucker Lean and Zucker obese rats. Protein sample 
of 25µg was loaded for heart, and 40µg for each adipocyte sample. Only the upper portion of the 
blot is shown, to conserve the samples, the mid and lower portions of the blot were probed for 
the presence of NCX1 and NCX3. 
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Figure 3.25([SUHVVLRQRIWKHĮ1 subunit of Cav1.3 in, Wistar, Zucker obese and Zucker 
lean control rats. The protein levels of Cav1.3 (at aN'DZHUHQRUPDOLVHG WRǃ-actin and 
shown as a % expression relative to heart. Data are expressed as mean ± SEM for the Wistar 
sample (n=6). For the Zucker Lean and Obese samples data are expressed as the mean and 
range (n=2). 
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The specificity of the primary antibodies were examined, by probing the 
protein samples in the absence of primary antisera, (Figure 3.26), no non-
specific binding was detected. 
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Figure 3.26. Representative non primary control of Cav DQG ǃ-actin expression in 
heart, and in white adipocytes from Wistar rats. (Samples were loaded with 25µg protein 
for heart and 40µg protein for each adipocyte sample). Samples were incubated without primary 
antibodies, followed by green anti rabbit secondary antibody at 1:10,000 dilution for 1 hour at 
37oC. 
,QVXPPDU\WKHSUHVHQFHRIWKHĮ1 subunit of Cav1.3 had been confirmed in 
primary white adipocytes from Wistar rats, although further experiments are 
required to confirm the reduction in Cav1.3 expression observed in adipose 
protein samples from obese Zucker rats, when compared to Wistars and 
Zucker leans.  
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3.11.2  Protein expression of NCX1 and NCX 3 in rat white adipocytes 
Western blotting was performed to confirm the protein expression of both 
NCX1 and NCX3 in primary white fat adipocytes. Rat heart was used as the 
positive control for the detection of NCX1 (Ankorina-Stark et al., 2002) and 
rat brain for the detection of NCX3 (Ankorina-Stark et al., 2002). The 
expected band size for NCX1 according to Manufacturers was 120kDa, a band 
of ~130kDa was detected in the brain sample but not in the heart or adipose 
tissue samples. No bands of the expected size in accordance with the 
manufactures guidelines (Santa Cruz) ~64kDa were detected for NCX3 in any 
of the tissues investigated (Figure 3.27). 
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Figure 3.27. Western blotVRI1&;1&;DQGǃ-actin expression in heart, brain, and 
white epididymal adipose tissue from Wistar rats. Tissue lysates of heart, brain and 
adipose tissue were separated by SDS-PAGE prior to Western blot analysis. Positions of 
molecular weight markers in kDa are indicated. A representative blot of one of three independent 
experiments is shown, each with different distinct samples. 25µg of protein was loaded for heart 
and brain tissue samples. 40µg of protein was loaded for each adipose tissue sample. 
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3.12 Discussion 
3.12.1 Resting Ca2+ levels in adipocytes 
Our median resting Ca2+ value of 118nM is similar to those reported in the 
literature for experiments conducted in primary white adipocytes (Table 3.8). 
Differences in resting [Ca2+]i between our investigations and others could be 
attributed to differences between different strains of rat. 
The significant decrease in [Ca2+]i during the perifusion of extracellular Ca
2+ 
free (Figure 3.9) and subsequent recovery of [Ca2+]i upon re-perifusion of 
Ca2+ is indicative of functional Ca2+ influx pathways in un-stimulated 
adipocytes. 
Extracellular divalent cations (Ca2+, Mg2+) have been reported to close 
voltage gated channels and elevate the resting membrane resistance, 
providing a membrane stabilising effect (Hille, 2001). Another suggestion is 
that the interaction between the ionic lipid bilayer and the divalent cations 
provides a barrier to pore growth. To the contrary, lowered extracellular 
divalents have the opposite (destabilising) effects.  
The [Ca2+]i response observed upon extracellular Ca
2+ removal was unlikely 
to occur as a result of membrane destabilisation. In all experiments 
presented within this thesis, the extracellular Ca2+, in extracellular Ca2+ free 
buffer, was replaced by equimolar substitution with Mg2+, a divalent 
equivalent to Ca2+. 
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Strain of 
Rat 
Weight 
(g) 
Ca2+ 
indicator 
Experimental 
Temp 
Technique Ca2+ in 
buffer 
Resting 
Ca2+ value 
obtained 
(nM) 
References 
Sprague 
Dawley 
90-150 Fura-2 30oC Cuvette 2.5mM ~165 Kelly, Deeny et al. 1989 
CD strain 160-180 Fura-2 37oC Perifusion KRB ~100 (Gaur et al., 1998b) 
CD strain  150-200 Fura-2 37oC Perifusion KRB ~200 (Gaur et al., 1998a) 
Sprague 
Dawley 
250 Aequorin 22oC Cuvette 1.4mM 100 (Pershadsingh et al., 1989) 
Sprague 
Dawley 
225-250 Fura-2 37oC Cuvette 3mM 140-370 (Draznin et al., 1987a) 
Table 3.8. A summary of resting white adipocyte [Ca2+]i values obtained in other studies from epididymal fat pads except in * where [Ca
2+]i 
was measured in adipocytes from both epididymal and perirenal fat pads.
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Other studies investigating the presence of Cav1.x channels within the adipocyte 
utilised cuvette-based imaging techniques (Draznin et al., 1987b, Kelly et al., 
1989, Klip and Ramlal, 1987, Draznin et al., 1989, Akiyama et al., 1990). 
Imaging of single cells ensures that the responses seen were those of the 
adipocyte, as adipose tissue comprises various cell types, including; vascular 
cells; endothelial cells; and immune cells (Kershaw and Flier, 2004, Fantuzzi, 
2005). Thus, it is a possibility that contamination of the adipocyte preparation 
with other cell types may contribute to the fluorescence responses seen within 
cuvette experiments. Attempts to replicate the results of others, using the 
cuvette method within this laboratory were unsuccessful. The adipocytes were 
not uniformly distributed across the volume of the cuvette, due to their elevated 
lipid content, they floated to the top of the cuvette away from the light path of 
the spectrophotometer. Another limitation of cuvette-based imaging is that only 
the effects of cumulative drug addition can be measured. The effects of drug 
washout or isotonic solution substitution, for example switching from 5.6mM K+ 
to 50mM K+ for the induction of a VGCC channel response, cannot be measured 
within the same sample. Finally, the use of cuvettes to investigate [Ca2+]i 
assumes a homogenous distribution of fluorescent indicator with stable light 
emission properties throughout the adipocyte cytosol. Investigators have 
observed that fluorescent indicators can be trapped within subcellular 
compartments (Yorek et al., 1999). The subcellular compartments may differ in 
their Ca2+ concentration from that of the cytosol. Live cell imaging in a 
perifusion system enables the selection of cells for investigation, allowing 
exclusion of cells that appear punctuate (an indicator of dye accumulation within 
other compartments). The strengths of imaging are that the effects of drug 
washout, along with changes in the composition of the perifusion solution can be 
monitored on a cell-to-cell basis in real time. It allows the identification of, if 
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any, different groups of responsive cells to any particular intervention and, as 
the imaging technique is in real time, the identification of brief changes in 
response.  
3.12.2 A role of voltage-gated Ca2+ channels in Ca2+ influx in the white 
fat adipocyte? 
The presence and function of VGCC is well established in excitable cell types 
(Fleischmann et al., 1994). Activation of Cav1.1-Cav1.3 Ca
2+ channels in 
excitable cell types induces rapid elevations in [Ca2+]i resulting in muscle 
contraction and nervous transmission/secretion. 7KH Į1 subunit of VGCCs are 
LQFUHDVLQJO\ EHLQJ UHSRUWHG LQ ³QRQ-H[FLWDEOH´ FHOO W\SHV VXFK DV ILEUREODVW
endocrine, and immune cells, where the role of VGCCs is less well understood 
(Fleischmann et al., 1994), however has been speculated to have a role in 
signalling processes. In the instance of T-lymphocytes, both the Į1 DQG ǃ
subunits are expressed, however depolarisation induced Ca2+ entry does not 
play a critical role in the function of this cell type (Badou et al., 2006). As the 
DGLSRF\WHLVDOVRNQRZQWRSRVVHVVDVLJQDOOLQJIXQFWLRQLWLVSRVVLEOHWKDWWKHĮ1 
subunit of Cav1.3 has a role within this. Conversely the role of Ca
2+ entry by 
VGCCs in sperm is well characterised and is reported to regulate flagellar 
movement, aiding propulsion of the sperm along the reproductive tract (Lishko 
et al., 2012).  
Cav1.2 channels activate at -35mV (Lipscombe et al., 2004); are blocked by the 
dihydropryidines (DHP) nifedipine and nitrendipine (Lipscombe et al., 2004, 
Koschak et al., 2001, Xu and Lipscombe, 2001). Cav1.3 channels activate at -
40mV to -55mV and are blocked by the phenylalkylamine (PAA), verapamil (Xu 
and Lipscombe, 2001). The inhibitory potency of DHPs and PAAs is increased at 
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depolarised membrane potentials. (In this current investigation nifedipine and 
verapamil were used to investigate L-type VGCC in basal Ca2+ influx in rat white 
adipocytes). 
Nifedipine failed to significantly inhibit basal Ca2+ influx ameliorating a major 
role of Cav1.2 VGCCs in basal Ca
2+ influx, whereas verapamil (20µM) 
significantly inhibited basal Ca2+ entry suggesting that Cav1.3 may be involved.  
The reported IC50s of nifedipine and verapamil are varied, depending on the cell 
type and means by which this was studied. The IC50 of verapamil is reported to 
be 4µM in rat ventricular calls and motor neurons (Diochot et al., 1995). The 
IC50 of nifedipine is reported to be 36nM in rat aortic smooth muscle (Hirakawa 
et al., 1994), in rat neurons 5µM of nifedipine inhibits 32 ± 1% of calcium 
current (Lorenzon and Foehring, 1995). Verapamil is reported to block Cav1.2 
channels with an IC50 of 30µM (Dilmac et al., 2004) so it is possible that some 
blockade of Cav1.2 may occur alongside Cav1.3 if both channel types are present 
(Dilmac et al., 2004) as 20µM verapamil was used in this study. Also, the DHP 
and PAA receptor site are in close proximity and have shared amino acid 
residues within the binding site (Catterall et al., 2003b, Mohan and Gandhi, 
2008). Conversely, incomplete inhibition of Cav1.3 VGCCs has been reported 
upon application of DHPs (Xu and Lipscombe, 2001). 
VGCC sensitivity to PAAs like verapamil also depends upon the gating properties 
of the channel molecule (Hering et al., 1997). For blockade by PAAs to occur, 
the channels have to pass through an open conformational state. It has been 
proposed that PAAs block the channel from the intracellular side (Hering et al., 
1997). In cell types that possess hyperpolarised membrane potentials channel 
blockade by PAAs LVSUHYHQWHGDW³UHVW´ The observation that verapamil blocked 
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basal Ca2+ influx is suggestive that there may be open VGCCs present on the 
plasma membrane at rest, as such adipocytes may possess a more depolarised 
resting membrane potential. Fleischmann et al (1994) suggested a theoretical 
³ZLQGRZ FXUUHQW´ IRU VWHDG\ VWDWH FHOOXODU &D2+ influx in Cav1.x VGCCs at 
membrane potentials between -40 and -20mV. Fleischmann et al (1994) reports 
the existence of a non inactive current in non spiking muscle cells, at ~-30mV, 
where channel inactivation is incomplete. Gaur et al (1996b) suggested that 
VGCCs may have a role in maintaining the level of resting [Ca2+]i. Additionally 
treatment of adipocytes with nimpodipine, a Cav1.2 VGCC blocker, was shown to 
significantly reduce [Ca2+]i, as attributed to a reduced basal Ca
2+ influx by 
VGCCs (Gaur et al., 1996b). Resting membrane potentials of white fat 
adipocytes have been measured by others (Perry and Hales, 1969, Ramirez-
Ponce et al., 1990, Kamei et al., 1992, Beigelman and Shu, 1972) and were 
investigated within this study (see Chapter 2). The most commonly reported 
adipocyte RMP values occur between -20 and -46mV (See Chapter 2, Section 
2.7.2). It seems reasonable to propose on the basis of the afore mentioned 
literature reports that Cav1.3 may have a role in basal Ca
2+ influx in white 
adipocytes. However, this seems unlikely, as the VGCCs undergo voltage 
dependent inactivation. As the plasma membrane of the adipocyte is stably 
depolarised at rest, the channels are likely to reside in the inactivated state. 
Once VGCCs have been subject to voltage dependent inactivation they need to 
be hyperpolarised for a period of milliseconds to remove the inactivation. 
Inactivated channels cannot return to their conducting state until the 
inactivation has been removed. Inactivation overrides the likelihood of the 
activation process to open the channels (Hille, 2001). As such it is questionable 
as to the likelihood of VGCCs maintaining basal Ca2+ in adipocytes.  
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A limitation of using pharmacological methods to determine the presence of 
specific channel types is that there are increasing reports of non specific drug 
effects upon other channels and transporters. In the instance of the work 
presented, here as basal Ca2+ influx was not inhibited by nifedipine (Figure 
3.12), it is possible that the inhibitory effect of nifedipine upon Ca2+ re-entry 
was due to a non-specific effect of nifedipine upon another channel type, 
possibly the NCX. The dihydropryidine antagonist nicardipine (0.1-10µM) has 
been reported to inhibit Na+/Ca2+ exchanger (NCX) activity in rat cardiac 
sarcolemmal membranes (Takeo et al., 1985). 
In addition to blocking basal Ca2+ influx, verapamil was also shown to inhibit 
Ca2+ re-entry in primary white fat adipocytes (Figure 3.13B). Diltiazem, 
verapamil and nifedipine at concentrations up to 10µM are reported to not have 
an effect on the NCX, (at least in cardiac sarcolemmal vesicles (Hata et al., 
1988)). So, a non specific inhibitory effect of nifedipine or verapamil at 20µM 
(as used in this study) upon the NCX is possible. 
3.12.3  Bay K 8644 had no effect of increasing adipocyte [Ca2+]i 
The major actions of Bay K 8644 to promote Ca2+ influx have been suggested to 
occur by the drug increasing Cav1.x channel openings in Mode 2. At the whole-
cell level, if Bay K 8644 was promoting longer channel open times, an increase 
in cellular [Ca2+]i would be expected.If our adipocytes did possess depolarised 
membrane potentials of approximately -20mV to -30mV as reported, an effect 
of Bay K 8644 at increasing [Ca2+]i would be expected. Such responses have 
been observed in human mesangial cells where a significant increase in [Ca2+]i 
of 18% above baseline [Ca2+]i occurred in the presence of Bay K 8644, with this 
effect being eliminated following removal of extracellular Ca2+ (Hall et al., 2000). 
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The concentration of Bay K 8644 used in the current study (1µM) was consistent 
with that used by other studies that did observe increased membrane currents 
upon addition of Bay K 8644 (Sanguinetti and Kass, 1984, Hall et al., 2000). 
The lack of effect of Bay K 8644 in affecting adipocyte [Ca2+]i (Figure 3.14) is 
unlikely to be attributed to the effects of other channel types, as the actions of 
Bay K 8644 to increase [Ca2+]i are reported to be specific to Cav1.x VGCCs. It is 
possible that adipocytes possess a very low functional VGCC channel density on 
the membrane surface of the adipocyte. Additionally, stimulated Ca2+ influx by 
Bay K 8644 through a small number of channels may not be sufficient to 
increase mean cellular [Ca2+]i. It is also possible that by stimulating cellular Ca
2+ 
influx by Bay K 8644 triggers Ca2+-dependent inactivation of the VGCCs, or 
other cellular Ca2+ extrusion mechanisms are initiated to prevent cytotoxic Ca2+ 
overload. The final possibility is that the VGCCs are not actually present and the 
observed effects of the pharmacological agents on reducing [Ca2+]i (see Figures 
3.12 and 3.13) are due to non-specific effects of nifedipine and verapamil on 
other Ca2+ influx pathways such as the sodium-calcium exchanger. 
3.12.4 High [K+]o  induced increase of [Ca
2+]i was not inhibited by 
Cav1.3 voltage-gated Ca
2+ channel blocker verapamil 
Perifusion of adipocytes in high K+ solution was another experimental approach 
utilised to investigate the presence of VGCC on the plasma membrane of rat 
white adipocytes. In excitable cells such as neurons/ muscle, exposure to 
elevated extracellular K+ decreases the outward K+ gradient resulting in 
depolarisation of the plasma membrane. The resultant plasma membrane 
depolarisation causes the opening of VGCCs and subsequent influx of 
extracellular Ca2+. Elevated conditions of extracellular K+ are reported to cause 
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elevations in [Ca2+]i in white fat adipocytes, suggesting that elevated [Ca
2+]i can 
occur through membrane-induced depolarisation and Ca2+ entry through VGCCs 
(Draznin et al., 1989, Shi et al., 2000, Huang et al., 2004, Gaur et al., 1996a), 
however in Chapter 2, no membrane potential effect of K+ was observed in 
either primary or differentiated 3T3-L1 adipocytes. In Chapter 3, 58% of the 
adipocyte population tested underwent a K+-induced increase in Ca2+, however 
this was not statistically significant (Figure 3.16A, 3.16B). These findings 
contradict previously published observations by other investigators (Draznin et 
al., 1989, Huang et al., 2004, Shi et al., 2000), with the exception of 
observations made by Yorek et al (1999) whereby exposure of 3T3-L1 
adipocytes to 70mM K+ did not cause an increase in [Ca2+]i. Yorek et al (1999) 
utilised cell mounting and perifusion-based methods, similar to those utilised 
within this study. Thus differences in experimental approach may be 
accountable for the observed differences in adipocyte [Ca2+]i response to 
elevated extracellular K+. Another difference is that cuvette methods observe 
changes in [Ca2+]i responses within a cellular population, where as perifusion 
based methods allows the study of single cells, reducing the likelihood of 
obtaining [Ca2+]i measurements from contaminating cell types. The advantage 
of cellular perifusion with ion substituted solutions is that this approach does not 
cause an osmotic effect upon cells under study. The fact that the cells in the 
present study displayed stable dye loading characteristics and reversible [Ca2+]i 
responses to extracellular Ca2+  removal suggest that they were viable. 
To further investigate whether extracellular Ca2+ was indeed entering the 
adipocyte by VGCCs, a subanalysis was performed. Of the adipocytes that 
responded to 50mM extracellular K+ by increasing [Ca2+]i, there was no 
significant effect of 20µM verapamil at inhibiting Ca2+ entry (Figure 2.16B) 
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contrary to the studies of Draznin et al (1988) and Gaur et al (1996) who 
reported an inhibitory effect of 30µM verapamil on high K+ induced increase in 
[Ca2+]i in white adipocytes.  
3.13 Low [Cl-]o induced increase of [Ca
2+]i was not inhibited by Cav1.3 
voltage-gated Ca2+ channel blocker verapamil 
The observation that elevations in [K+]o from 5mM to 50mM do not cause 
depolarisation of the adipocyte plasma membrane is of particular interest. 
Results in Chapter 2 show that removal of extracellular Cl- depolarised the 
plasma membrane of both adipocyte models. The following hypothesis were 
tested; 1) does removal of extracellular Cl- result in increased Ca2+ influx from 
the external environment; 2) whether this influx was via L-type calcium 
channels. There was no significant increase in [Ca2+]i following extracellular Cl
- 
removal, and furthermore perifusion of 20µM verapamil did not inhibit Ca2+ 
influx in the adipocytes that did show elevations in [Ca2+]i (Figure 3.20). The 
obvious conclusion is that depolarisation of the adipocyte plasma membrane 
does not cause Ca2+ entry via L-type calcium channels. Thus, either the channels 
are not present; not functioning as a Ca2+ influx pathway, or they are inactive.  
To further investigate the possibility that extracellular Ca2+ was entering the 
adipocyte by Cav1.2/ Cav1.3 VGCCs, the calibrated single-channel traces of the 
Ca2+ response in K+ during the time-course of the protocol were re-investigated 
for the presence of Ca2+ spikes, indicative of transient Ca2+ influx by way of 
VGCCs with subsequent channel closure. None of the records obtained in this 
project displayed any transient increase in [Ca2+]i. The increase in [Ca
2+]i 
observed upon solution exchange to 50mM K+ occurred over a time-course that 
was of the order of minutes, indicative of Ca2+ entry from a source other than 
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VGCCs. It is possible that the increase in [Ca2+]i observed in 50mM K
+ 
responsive adipocytes was due to activation of the sodium calcium exchanger 
(NCX). The NCX is a bidirectional transporter exchanging 3Na+ for 1Ca2+. The 
NCX is electrogenic, depolarization of the membrane from resting Vm can 
reverse the exchanger's direction (Torok, 2007). On the basis of the adipocyte 
plasma membrane being depolarised at rest it is possible that the NCX will be 
functioning in the reverse mode (Na+ efflux and Ca2+ influx). In addition, the 
concentration of Na+ is low in the high K+ solution (138mM Na+ in 5.6mM K+ and 
93.6mM Na+ in 50mM K+). This was to maintain the osmolarity of the solution, 
however the low concentration of extracellular Na+ will activate the reverse 
mode of the NCX (Rathi et al., 2004), which may lead to an increase in [Ca2+]i. 
It is likely under conditions of low extracellular Na+ that the NCX is operating as 
a Ca2+ influx pathway accountable for the increase in [Ca2+]i observed upon 
perifusion of 50mM K+ +DQN¶VVROXWLRQ7KLVREVHUYDWLRQVXSSRUWVWKHK\SRWKHVLV
that functional NCX is present on the plasma membrane surface of adipocytes. 
This was further investigated in Section 3.10.2.2. 
3.13.1 Investigation into the effect of insulin on [Ca2+]i  and Ca
2+ influx 
pathways in rat white adipocytes 
Insulin has been reported to increase [Ca2+]i in white adipocytes. Studies 
suggest that insulin-induced increases in [Ca2+]i contribute to the development 
of insulin resistance. The increase in [Ca2+]i in insulin was reported to be via 
enhanced Ca2+ entry via VGCCs (Draznin et al., 1987a, Draznin et al., 1989) as 
treatment of adipocytes with 30µM verapamil reduced [Ca2+]i from 239nM to 
128nM and restored adipocyte responsiveness to insulin as determined by the 2-
deoxyglucose (2-DOG) uptake assay in human gluteal adipocytes (Draznin et al., 
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1988). This data corroborated earlier findings by Draznin et al (1987) in rat 
adipocytes, whereby insulin was demonstrated to enhance [Ca2+]i in rat 
epididymal adipocytes by ~30% (Draznin et al., 1987a, Draznin et al., 1988), 
an effect inhibited by 25µM nifedipine. In contrast to observations within this 
study, significant effects of insulin on increasing [Ca2+]i were observed within 10 
minutes in adipocytes from both human and rat (Draznin et al., 1987a, Draznin 
et al., 1988). Later studies by other laboratories demonstrated that insulin was 
not found to increase [Ca2+]i (Blackmore and Augert, 1989, Kelly et al., 1989, 
Schwartz et al., 1991, Gaur et al., 1998b). The reasons for the observed 
differences in insulin effect between investigations are unknown.  
Ca2+ re entry by VGCCs was also compared in the presence and absence of 
insulin. The verapamil response at inhibiting Ca2+ re-entry was significant in 
non-insulin exposed adipocytes (Figure 3.13), however when insulin is present 
the inhibitory response of verapamil was lost (Figure 3.18A). These data 
suggest that in the presence of 100nM insulin, [Ca2+]i is not re-entering the 
adipocyte by VGCCs. In this study insulin did not have an effect on membrane 
potential (Chapter 2 Figure 2.22), so it is unlikely that the loss of inhibition on 
Ca2+ re-entry is due to a membrane potential effect. Insulin also did not 
significantly increase [Ca2+]i. 
The majority of studies that did not observe an effect of insulin on [Ca2+]i were 
those that subjected adipocytes to acute exposure conditions. To observe an 
inhibitory effect on glucose transport, some studies do incubate adipocytes in 
insulin for periods of up to 4 hours (Marshall and Olefsky, 1980). To confirm 
adipocyte responsiveness to insulin, the 2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-
yl)amino]-2-deoxy-D-glucose (2-NBDG glucose) uptake assay was attempted in 
adipocytes in real time, using the protocol described by Nakata et al (2006). As 
Chapter 3 
184 
 
a positive control, protocols were also repeated LQSDQFUHDWLFǃFHOOV(Yamada et 
al., 2000, Nakata et al., 2006) 7KH DGLSRF\WHV DQG SDQFUHDWLF ǃ-cells under 
study failed to maintain 2-NBDG as determined by a distinct lack of fluorescent 
signal.  
3.13.2 3URWHLQH[SUHVVLRQRIWKHĮ1 subunit of Cav1.3 in white 
adipocytes 
Even though pharmacological inhibitors of VGCCs are used to indicate the 
presence of this channel type upon the plasma membrane of the cell under 
study, it is possible that non-specific effects of inhibitors occur on other Ca2+ 
influx mechanisms. On the basis of the results in sections 3.10.2.1, Western 
blots were carried out to examine the expression of the Cav1.3 VGCC proteins in 
the white fat adipocyte. Investigation iQWRWKHH[SUHVVLRQRIWKHĮ1 subunit was 
attempted. This is the largest and most important subunit as it incorporates the 
conduction pore, voltage sensor and the sites of regulation by 
drugs/phosphorylation, as well as the gating apparatus.  
As protein bands of the expected size ~265kDa were observed in preparations 
adipocyte protein lysates, see Figure 3.24. Results indicate that Cav1.3 is likely 
to be present on the adipocyte plasma membrane. Data in Figure 3.25 are 
suggestive of a reduction in Cav1.3 expression in adipose tissue in adipocytes 
sourced from obese rats. As obesity is associated with insulin resistance (IR) it 
is likely that Cav1.3 expression is reduced in IR. Solid conclusions cannot be 
drawn at this stage due to the low experimental n. 
To confirm the bands detected by the anti Cav1.3 antibody were not due to non-
specific binding of the primary antibody to another protein product requires the 
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use of the anti Cav1.3 blocking peptide. Again, due to limited manufacturer 
supply these studies could not be performed. However, to confirm the bands 
visualised were not a result of non-specific secondary antibody binding, a repeat 
set of samples was run and exposed to the anti rabbit secondary antibody only 
(Figure 3.26). No non-specific binding of the secondary antibody was shown. 
3.14 Investigation into the presence of the reverse mode of the NCX in 
rat white adipocytes 
Verapamil was shown to inhibit Ca2+ re-entry in primary adipocytes (Figure 
3.12). Upon acute insulin exposure this inhibitory action of verapamil was 
apparently lost (Figure 3.18), data that suggests Ca2+ re-entry by some other 
means under acute insulin exposure, which was no longer occurring by Cav1.3 
VGCCs. Additionally elevated [K+]o prepared by isotonic substitution of [Na
+]o a 
measure which is expected to reverse the NCX (Ca2+ influx) (Rathi et al., 2004). 
In the absence of insulin exposure of adipocytes to 50mM [K+]o resulted in a 
small increase in [Ca2+]i (Figure 3.16). These data together suggest another 
Ca2+ influx pathway.  
It has also been reported that the NCX operates in the reverse mode of 
exchange at membrane potentials of approximately ~-40mV (Watano et al., 
1996). In Chapter 2, the mean resting membrane potential of adipocytes 
subject to perforated patch investigation was found to be approximately -34mV, 
as such it would be reasonable to suggest that the NCX is operating in reverse 
mode. As acute insulin (100nM) exposure did not have an effect on the resting 
membrane potential of adipocytes tested within this study (Chapter 2, Figure 
2.22), it is therefore possible that the reverse mode of the NCX is acting as a 
Ca2+ re-entry pathway under both non insulin and insulin conditions.  
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Fluo-4 [Ca2+]i imaging data show KBR-7943 inhibits Ca
2+ re-entry in non insulin 
conditions (Figure 3.21A). There was no inhibitory effect of KBR-7943 upon Ca2+ 
re-entry in 100nM insulin (Figure 3.21B). Initially, data are suggestive of the 
reverse mode of the NCX acting as a Ca2+ re-entry pathway in non insulin 
conditions. Further to these observations, modelling of the behaviour of the NCX 
under conditions used within this investigation (-30mV, and [Ca2+]o =2.6mM 
and nominally [Ca2+]o free) was carried out and described in Figure 3.23. It was 
determined that the NCX would only operate in the Ca2+ influx mode following 
extracellular [Ca2+]o removal and subsequent re-addition of 2.6mM [Ca
2+]o. 
KBR-7943 does have inhibitory effects on other channel types. At concentrations 
of approximately 30µM, KBR-7943 has been reported to inhibit Ca2+ influx by 
the NCKX and VGCCs (Iwamoto et al., 1996b). KBR-7943 was used at 10µM 
within this investigation, however non-specific effects of KBR-7943 have been 
reported when used at 5µM. KBR-7943 at 5µM was reported to decrease Ca2+ 
transients in heart tubes from NCX1 knockout mouse embryos (Reuter et al., 
2002), suggesting that the inhibitory effects of KBR-7943 occur by other 
mechanisms. As such, it is possible that KBR-7943 is inhibiting Ca2+ entry via 
VGCCs. In support of this, the data for the inhibitory effects of KBR-7943, in 
insulin conditions is similar to the data obtained when verapamil was used to 
inhibit Ca2+ re-entry (+/- insulin) within the white fat adipocyte, Figure 3.18. 
Verapamil as discussed in Chapter 3 Section 3.5.1 is an L-type Ca2+ channel 
blocker, however it is also reported to have non-specific inhibitory effects on the 
reverse mode of the NCX. Hata et al (1988) reported an inhibitory effect of 
verapamil at inhibiting Na+-dependent Ca2+ uptake in rat sarcolemmal vesicle 
preparations at concentrations >10µM (Hata et al., 1988). Additionally Erdreich 
et al (1983) reported verapamil inhibition of Na+ dependent Ca2+ uptake in rat 
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brain synaptic plasma membrane vesicles with an IC50 of 175µM. The 
differences in verapamil concentration required to observe an inhibitory effect 
upon the NCX may vary between sample preparations, possibly dependent upon 
the isoforms of NCX expressed and the level of NCX expression. Verapamil was 
used at 20µM in experiments conducted within this thesis so it is possible, that 
the drug may inhibit the reverse mode of the NCX.  
It is also a possibility that the effects of KBR-7943 observed in experiments 
conducted within this chapter are attributable to inhibition of store-operated 
Ca2+ entry (SOCE) (Parekh and Putney, 2005). The current literature report low 
mRNA expression levels of SOC channels belonging to the TRPC family in human 
white adipocytes  
SN-6 inhibited Ca2+ re-entry in absence of insulin, suggestive of the presence of 
the reverse mode of the NCX, the inhibitory action of SN-6 upon Ca2+ re-entry 
was lost in insulin. SN-6 has been shown not to inhibit VGCCs at concentrations 
of up to 30µM, rendering SN-6 a more selective reverse mode NCX inhibitor 
than KBR (Iwamoto et al., 2004a). SN-6 was used at 10µM within this 
investigation, as such it is likely that SN-6 when used at this concentration does 
not differentiate between different NCX isoforms. SN-6 is reported to inhibit Na+ 
dependent radioactive Ca2+ uptake in CCL39 cells with IC50 values of 2.9µM, 
16µM and 8.6µM for NCX1, NCX2, and NCX3. This rules out the likelihood of SN-
6 and KBR-7943 acting upon different NCX isoforms. No IC50 for SN-6 inhibition 
of NCX are reported in adipocytes. To confirm this suggestion, a positive control 
for SN-6 is required to ensure the drug is functional at inhibiting Ca2+ influx via 
the NCX. This could have been done either by conducting a repeat perifusion 
protocol with Fluo-4 [Ca2+]i imaging and SN-6 in heart or brain tissue, both of 
which are known to express the NCX. 
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Investigations by Pershadsingh et al (1989) used similar methodologies to those 
used in this thesis to identify both VGCC and NCX in WAT. Pershadsingh et al 
(1989) showed that perifusion of primary white adipocytes from epididymal fat 
pads with Na+-free buffer, as prepared by iso-osmotic substitution of NaCl with 
choline-chloride or KCl showed a two fold increase in [Ca2+]i above basal levels. 
The increase in [Ca2+]i following exchange of the medium to one that contained 
60mM [K+]o was however attributed to Ca
2+ entry by VGCCs as diltiazem (10µM) 
blocked the increase in [Ca2+]i observed in 50mM K
+. These authors assumed an 
adipocyte resting membrane potential of -58mV and were therefore expecting 
depolarisation of the adipocyte membrane upon exchange of the extracellular 
solution to 50mM K+ (Pershadsingh et al., 1989). However, this does not 
account for the increase in [Ca2+]i observed upon exchange of buffer to choline-
chloride, as these conditions are not reported to cause Ca2+ influx by VGCCs. As 
such Ca2+ re-entry within the white fat adipocytes used within this investigation 
was suggested to be occurring by way of both VGCCs and the reverse mode of 
the NCX.  
To further investigate the presence of NCX on the membrane surface of the 
white fat adipocyte, Western blotting was carried out. A band of ~120kDa, most 
likely representative of protein expression of NCX1 was only detected within the 
brain sample. This is not entirely unlikely as NCX1 expression has also been 
reported in the brain (Iwamoto and Kita, 2006). A prominent NCX1 expression 
in the protein sample from heart tissue was expected as shown by Sugano et al  
(2011) using the Abcam NCX1 antibody, this was not seen in our hands; this 
result could arise due to incomplete inhibition of in vitro proteolysis by the 
protease inhibitors used within the sample preparation, or that degradation of 
the protein sample occurred prior to addition of the protease inhibitor cocktail to 
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the sample, suggesting that further optimisation of the protein sample 
preparation is required. Additionally the Abcam antibody is a monoclonal 
antibody. It is possible that if any post translational modifications have occurred, 
or indeed the sample is degraded, then detection of protein by a monoclonal 
antibody is much less likely than by a polyclonal antibody.  
Western blotting failed to determine the presence of NCX3 in any of the tissues 
tested. In accordance with the manufactures guidelines, bands of 64kDa are 
indicative of the presence of the NCX3 protein. The literature report an expected 
band size of 103kDa for NCX3 (Lytton, 2007). According to UniProt, the NCX has 
various isoforms of varying molecular weights from 31kDa-103kDa. Several 
putative modification sites have been identified on NCX3 which could also 
influence the proteins migration behaviour. As the NCX3 antibody is polycolonal, 
it should detect both phosphorylated and post-translationally modified forms of 
NCX3. Additionally, the Manufacturers (Santa Cruz) state that the NCX3 
antibody detects all isoforms of NCX3, eliminating the possibility of non-
detection due to varying isoform expression. 
NCX3 was not detected in the positive control, brain protein lysate, suggestive 
of a problem with the sample preparation. Again it is possible that the protease 
inhibitor used for sample preparation did not inhibit in vitro proteolysis, or that 
the proteolysis occurred within the sample prior to the addition of protease 
LQKLELWRUV %DQGV IRU WKH UHIHUHQFH SURWHLQ ǃ-actin were detected, abrogating 
technical issues in the running of the gel. With regard to the adipose tissue 
samples, it is possible that there was not enough protein sample loaded to allow 
detection of NCX1 or NCX3; or that the collagenase type II used for adipose 
protein preparations may contain esterases which could degrade the NCX 
protein; or simply, that there was indeed no NCX1 or NCX3 expressed within 
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these tissue samples; or finally an inability of the antibody to detect NCX1 
protein under the experimental conditions used within this investigation. 
Additionally as NCX1 protein was not detected in various heart preparations, 
whereby NCX1 expression is well established, it was considered that the 
detection of NCX1 by the antibody used under experimental conditions 
presented here was unreliable 
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3.15 Summary 
Primary white adipocytes are responsive to changes in [Ca2+]o. Fluo 4 imaging in 
conjunction with verapamil suggests a role of Cav1.3 in Ca
2+ influx in adipocytes. 
Conditions of elevated [K+]o cannot be used to determine the presence of VGCCs 
in adipocytes, neither can depolarising conditions of [Cl-]o since neither affected 
[Ca2+]i. TKHSUHVHQFHRIWKHĮ1 subunit in adipocytes however, was confirmed by 
Western blot. 
The results of the [Ca2+]i determinations conducted here are in support of the 
reverse mode of the NCX in white fat adipocytes as both SN-6 and KBR-7943 
inhibited Ca2+ re-entry in non insulin conditions. Additionally, modelling of the 
behaviour of the NCX under conditions used within this investigation were in 
support of the reverse mode of the NCX following [Ca2+]o removal and re-
addition. Unfortunately Western blot investigations were not able to confirm the 
presence of the NCX in adipocytes.  
The inhibitory effect on Ca2+  re-entry of verapamil, SN-6 and KBR was lost in 
insulin, suggestive of another Ca2+ influx pathway in acute insulin exposure 
conditions. 
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  Chapter 4 
Evidence of spontaneously active ion 
channels in differentiated 3T3-L1 
adipocytes 
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4.1 Introduction 
The original aim of this study was to determine the presence of voltage-gated 
calcium channels in the plasma membrane of primary white fat adipocytes. 
Voltage-gated calcium channels are often identified indirectly by depolarising the 
cells plasma membrane with elevated extracellular [K+], which removes the 
outward K+ gradient, the resultant effect of this is elevated [Ca2+]i. Ca
2+ influx 
pathways can then be explored by use of calcium channel antagonists. We failed 
to observe an increase in [Ca2+]i in primary adipocytes upon perifusion of 
extracellular K+, which then prompted investigation into why no effect of 50mM 
[K+]o was observed. Investigation into the ions involved in adipocyte membrane 
potential demonstrated that K+ is not involved in adipocyte RMP. Moreover, 
further investigations showed that Cl- ions are involved in the RMP of both 
primary adipocytes and 3T3-L1 adipocytes. Thus, there is a requirement for Cl- 
channels in the plasma membrane of adipocytes. Consequently, we investigated 
the presence of Cl- channels in differentiated 3T3-L1 adipocytes using the cell 
attached patch clamp technique. Chloride channels are reviewed in the following 
section to aid in the understanding of the type of chloride channel that we may 
expect to find on the 3T3-L1 adipocyte plasma membrane. 
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4.2 Chloride channels 
Cl- channels are ubiquitously expressed anion selective pores, which allow the 
passive diffusion of negatively-charged ions down their electrochemical gradient 
(Suzuki et al., 2006). Cl- channels are present both in the plasma membrane and 
in the membranes of intracellular organelles including the endocyotic and synaptic 
vesicles (Jentsch, 1996, Jentsch et al., 2002). Cl- channels are permeable to 
numerous anions, including iodide, nitrates, bicarbonates, thiocyanates and 
bromide (Suzuki et al., 2006). Cl- unlike Ca2+ does not appear to have a role as 
second messenger (Jentsch, 1996), however Cl- channels do have important roles 
in cellular physiology. Chloride flux through Cl- channels are involved in regulation 
of excitability of nerve and muscle, cell volume regulation, pH regulation of 
intracellular organelles and control of transepithelial transport (Nilius and 
Droogmans, 2003, Jentsch et al., 2002).  
 
Cl- channels have been classified functionally in accordance with their gating 
mechanisms and are grouped into 5 categories as follows:- voltage-dependent 
chloride channels (CIC); cystic fibrosis transmembrane regulator (CFTR) which is 
regulated by protein kinases; volume-regulated chloride channels (VRAC) (Nilius 
et al., 1996) ZKLFK DUH UHJXODWHG E\ FHOO VZHOOLQJ JO\FLQH RU ǻ-amino butyric 
chloride channels (GABA) which are opened upon ligand binding (Nilius and 
Droogmans, 2003); finally, Ca2+-activated chloride channels which are regulated 
by elevations in [Ca2+]i. A summary of Cl
- channel conductances is shown in Table 
4.1. The molecular structures of CIC channels, CFTR channels and GABA-chloride 
channels has been determined (Nilius and Droogmans, 2003), however the 
structures of VRAC and Ca2+ gated Cl- channels have yet to be elucidated. 
Chapter 4 
195 
 
4.2.1 Voltage-dependent/gated Cl- channels 
The ClC channels belong to a large gene family of Cl- channels, comprising 9 
genes (in mammals). They are grouped into one of three branches on the basis of 
their sequence homology, see Figure 4.1. The first branch comprises plasma 
membrane channels, whereas the channels encoded by branches two and three 
are Cl- channels of the intracellular membranes (Jentsch et al., 2002). The first 
branch comprises ClC-1 which is expressed in skeletal muscle (Suzuki et al., 
2006). ClC-2, a ubiquitously expressed channel activated either by 
hyperpolarisation or cell swelling, and finally ClC-Ka and ClC-Kb, otherwise known 
as ClC-K1 and ClC-K2 in the rat, respectively, which are exclusively expressed 
within the kidneys (Jentsch, 1996, Estevez et al., 2001). Unlike other ClC channel 
which yield Cl- currents by themselves, ClC-Ka and ClC-Kb require association 
ZLWKDN'Dǃ-VXEXQLW³EDUWWLQ´ in order to conduct Cl- currents (Estevez et al., 
2001, Planells-Cases and Jentsch, 2009). The second branch comprises ClC-3, 
ClC-4 and ClC-5, which are expressed in the brain and kidneys. Inactivation of 
ClC-5 gives rise to kidney stones (Jentsch, 1996). The third branch comprises 
ClC-6 and ClC-7 which are found ubiquitously and believed to be present on 
intracellular membranes; we would not expect to observe CIC-6 and CIC-7 on the 
plasma membrane surface of our 3T3-L1 adipocytes, as such they are not 
reviewed in this section. 
Branch 3
Intracellular membrane
CIC
Plasma membrane
CIC-1 CIC-2 CIC-Ka CIC-3 CIC-4 CIC-5
CIC-6 CIC-7
CIC-Kb
Branch 1 Branch 2
 
Figure 4.1. The groupings of CIC chloride channels 
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The structural determination of ClC channels arose following the identification of 
channel homologues in Escherichia coli (EcClC) and in Salmonella typhimurium 
(StClC) (Dutzler, 2004). X-ray structures of bacterial ClC channels show that the 
EcClC channel is a dimeric complex comprising 2 identical subunits which 
comprise 10-12 transmembrane segments (Mindell et al., 2001). The ion 
conduction pathway does not occur at the interface between the 2 associating 
subunits, instead, each subunit comprises a central ion-conducting pore and 
selectivity filter (Dutzler, 2004, Dutzler et al., 2002, Fahlke et al., 1998). Each 
pore can be gated independently (Mindell et al., 2001). Concatermeric studies of 
ClC-0 (the torpedo Cl- channel) together with either ClC-1 or ClC-2 also support 
the dual pore hypothesis (Weinreich and Jentsch, 2001). If the CIC channel does 
have 2 pores, and hence 2 conducting pathways, we would expect to see 2 sets 
of conductance on our single channel records. However, the dual pore model is 
reported not to be applicable to every ClC isoform since site-directed mutagenesis 
and single-channel patch clamp studies have challenged this model with respect 
to the ClC-1 isoform (Fahlke et al., 1998). Each subunit comprises two halves 
which span the membrane in opposite directions (Dutzler et al., 2002). The 
molecular weights of the channel complex vary from ~60kDa to 110kDa. The ClC 
family are anion-selective with selectivities of Cl->I- (Estevez et al., 2001, Dutzler 
et al., 2002). 
 
Some ClC channels are depicted as being Cl- activated, owing to observations that 
in order for Cl- channels to be gated by voltage there is a requirement for the 
presence of Cl- within the channel pore. One suggested model is that the pore 
comprises of two anion binding sites, one mediating conduction selectivity 
(towards the intracellular side) and the other gating selectivity (towards the 
extracellular side). The passage of Cl- is blocked by a glutamate-side chain closer 
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to the extracellular side. The property of Cl- activation is hypothesised to act by 
Cl- both entering the pore, and inducing conformational changes mediating the 
movement of the glutamate side-chain, allowing diffusion of Cl- through the 
channel (Dutzler et al., 2002). Another model states that the channel harbours 2 
Cl- ions, with the entry of a 3rd Cl- ion into the channel pore inducing conduction 
(Corry et al., 2004). In contrast to voltage-gated Ca2+ and K+ channels, primary 
sequence analysis of voltage-gated Cl- channels does not reveal a voltage-sensing 
domain, like the S4 segment (Jentsch et al., 2002). However, mutations in 
domain 1 of CIC-1 indicate that the charged amino acid residues within this 
transmembrane domain may act as a voltage sensor (Fahlke et al., 1995). When 
aspartic acid at the extracellular end of domain 1 was switched for glycine, there 
was altered voltage dependence within this channel (Jentsch et al., 2002, Fahlke 
et al., 1995). Alongside voltage regulation, currents through ClC Cl- channels are 
also regulated by pH and extracellular [Ca2+] (Estevez et al., 2001, Weinreich and 
Jentsch, 2001). 
4.2.2 CIC-1 
ClC-1 is expressed in skeletal muscle and acts as a membrane potential stabiliser. 
The membrane potential stabiliser effects evident from ClC-1 mutations gives rise 
to myotonia congenital, characterised by defective muscle relaxation. Various 
mutations are involved in the pathogenesis of mytonia (Schmidt-Rose and 
Jentsch, 1997). ClC-1 is voltage-gated by 2 mechanisms, a fast voltage-gate 
(acting on individual pores) and a slow voltage-gate (acting on both pores as a 
common gate), with channel closure occurring upon membrane depolarisation 
(Weinreich and Jentsch, 2001). Whole-cell current measurements indicate that 
the channel exhibits inward rectification. Low intracellular pH causing slowing of 
gating kinetics in combination with an increased channel open probability at 
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negative charges were utilised in order to resolve the channel events of ClC-1. 
Single-channel recording shows that the ClC-1 channel has 2 open conductance 
levels of 1.2pS and 2.4pS. Channel properties were reported to be in concordance 
with the presence of 2 independently gated conductance states (Saviane et al., 
1999). In agreement with the dual pore model, concatemers of ClC-0 and ClC-1 
also showed 2 independent conductance levels of ~8pS (ClC-0) and ~1.8pS (ClC-
1) (Weinreich and Jentsch, 2001). ClC-1 is inhibited by the compound 9-AC (IC50 
10.6µM). The ClC-1 ClC-0 concatamer is inhibited by 9-AC with an IC50 of 8.2µM 
(Weinreich and Jentsch, 2001). 
4.2.3 ClC-2 
ClC-2 is, according to northern blot analysis, ubiquitously expressed; however 
immunohistochemical analysis indicates elevated expression levels in the brain 
(Jentsch et al., 2002). ClC-2 is involved in cell volume control, and in setting 
intracellular Cl- concentration (Schmidt-Rose and Jentsch, 1997). Investigations 
on the single channel level with equal Cl- concentration in the intracellular and 
extracellular solution have shown that ClC-2 is activated by hyperpolarisation, 
with slow gating properties, exhibiting a single channel conductance of 2-3pS 
(Weinreich and Jentsch, 2001). ClC-2 is also activated by cell swelling and acidic 
pH, where elevated pH in excess of pH 7.4 result in channel closure. Disruption to 
ClC-2 gives rise to testicular and retinal degeneration (Jentsch et al., 2002). 
Multiple agents are used as ClC-2 antagonists, however none of the following 
inhibitors is specific to this channel type: 0.5mM 5-nitro-2-(3-
phenylpropylaminobenzoic acid (NPPB), 1mM 9-AC and diphenylcarbonate (DPC)  
reversibly inhibit ClC-2 currents (Furukawa et al., 1998). The inorganic cations 
Cd2+and Zn2+ (IC50 23µM) block hyperpolarisation activated Cl
- current (Clark et 
al., 1998). 
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4.2.4 ClC-Ka /ClC-Kb 
CIC-Ka and CIC-Kb are exclusively expressed in the kidney and inner ear, 
therefore we would not expect to observe this Cl- channel type in the 3T3-L1 
adipocytes. As such, this channel type will not be reviewed in this thesis. For 
excellent literature on CIC-Ka and CIC-Kb channels see the following references. 
(Planells-Cases and Jentsch, 2009) (Corry et al., 2004, Jentsch et al., 2002).  
4.2.5 ClC-3, CLC-4 and CLC-5 
CLC-3, 4 and 5 are endosomal Cl- channels (Jentsch et al., 2005), and therefore 
are unlikely to be involved in regulation of Vm within 3T3-L1 adipocytes. CLC-3 
and CLC-4 are close homologues of CLC-5 (Kornak et al., 2001) with ~80% 
sequence homology (Jentsch et al., 2005). CLC-5 is a renal chloride channel 
expressed on the endosomes of the renal and intestinal epithelia, where it 
functions as a Cl-/H+ exchanger, exchanging 2Cl- with 1H+. This activity is highly 
voltage dependant, outwardly rectifying and active at voltages positive to +20mV, 
however as plasma and intracellular membranes do not display voltages of 
+20mV, it is unclear as to the mechanism of activity of CLC-5 in the physiological 
setting (Gunther et al., 2003). Again, see the following literature for further 
information pertaining to this group of channels. 
 (Piwon et al., 2000), (Hara-Chikuma et al., 2005, Mohammad-Panah et al., 
2003). (Nilius and Droogmans, 2003). (Wrong et al., 1994). (Piwon et al., 2000, 
Gunther et al., 2003, Luyckx et al., 1999),. 
 
4.2.6 CFTR (Cystic fibrosis transmembrane conductance regulator) 
The sequence encoding the CFTR protein has been localised to chromosome 7. 
The gene product, the CFTR protein, comprises 1,480 amino acids. 
Chapter 4 
200 
 
Hydrophobicity analysis of the cDNA sequence show the CFTR protein is organised 
into a doubly repeating motif of 6 transmembrane domains with a nucleotide 
binding fold (NBF). The two halves of the protein are linked by the regulatory (R) 
domain. The R domain is highly charged and suggested to serve a regulatory 
function as it possesses several phosphorylation sites for Ca2+ calmodulin kinase, 
cyclic AMP dependent protein kinase A (PKA) and protein kinase C (PKC) (Fuller 
and Benos, 1992, Harris, 1992, Seibert et al., 1999). The predicted structure of 
CFTR is resemblant of the ATP-binding cassette superfamily of proteins. CFTR 
activates upon phosphorylation of the regulatory domain and the subsequent 
hydrolysis of ATP (Fuller and Benos, 1992) as channel activity is absent in when 
non-hydrolyzeable ATP analogues are present (Schultz et al., 1995). 
 
Expression of CFTR is primarily within the epithelial lining of numerous tissue 
types, including pancreatic ducts, sweat glands, kidney tubules, lung and jejunum 
(Harris, 1992, Antigny et al.). Mutations within the gene encoding CFTR, the most 
commonly reported mutation associated being F508 with the deletion of 
phenyalanine at position 508, give rise to cystic fibrosis. Cystic fibrosis is 
potentially fatal, manifesting symptoms of reduced permeability to chloride within 
exocrine glands affecting both absorptive and secretory processes (Quinton, 
1990). The defective CFTR protein has a reduced if not absent expression within 
the apical membrane (Schultz et al., 1999), with the CFTR protein that is 
incorporated having a shorter half life (Antigny et al.). The CFTR channel does 
still retain chloride channel functionality, although there is reduced Cl- ion 
conductance (Fuller and Benos, 1992). Typically CFTR Cl- FRQGXFWDQFH¶V DUH
~10pS (Jentsch et al., 2002, Tabcharani et al., 1990), an outwardly rectifying 
channel with a linear current voltage (I-V) relationship in symmetrical Cl- 
solutions (Anderson et al., 1991). Asymmetrical Cl- solutions cause rectification of 
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the I-V relationship. The permeability sequence of CFTR is reported as BR->Cl->I-
>F- (Anderson et al., 1991). To date there are no specific blockers of CFTR 
channel (Sheppard, 2004), although sulphonylureas, disulfonic stilbenes and the 
arylaminobenzoates have been reported to interact directly with the CFTR channel 
resulting in blockade (Schultz et al., 1999). 
4.2.7 Volume-regulated anion channels 
Regulation of cell volume is essential for the maintenance of cell integrity in the 
face of internal and external challenges. Alterations in cell volume arise as a 
result of various physiological processes, such as glycolysis, cell division, 
secretion events and muscle contraction (d'Anglemont de Tassigny et al., 2003). 
Cell swelling also occurs in pathophysiological conditions, e.g, ischaemic stroke, 
and hypoxic and ischaemic insults. Ultimately swelling occurs either due to an 
increase in extracellular hypotonicity or under isosmoitc conditions when 
intracellular osmolytes are increased (Jentsch et al., 2002, Chamberlin and 
Strange, 1989). Conversely, extracellular hypertonic conditions drive water out of 
the cell. In response to altered cell volume, transport processes are activated 
which alter the concentration of intracellular solutes. The responses to cell 
shrinkage and swelling are termed regulatory volume increase (RVI) and 
regulatory volume increase (RVI), respectively. In the defence against cell 
swelling, K+ channels and Cl- channels (volume-regulated anion channels, VRAC) 
are activated. Cl- channels participate in regulatory volume decrease (RVD). Upon 
increased cell volume, an outwardly-rectifying Cl- current is activated giving rise 
to Cl- efflux in conjunction with (in the presence of a significant water 
permeability of the plasma membrane) water loss. As well as maintaining cell 
volume, the VRAC channels also participate in pH regulation and regulation of 
membrane potential (Nilius and Droogmans, 2003). The swelling-activated anion 
Chapter 4 
202 
 
selective conductance is designated ICL,swell. ICL,swell shows increased permeability 
to various anions with a permeability sequence as follows, SCN->I->Br->Cl->F-> 
Gluconate-. The mechanism underlying ICL,swell activation is yet to be elucidated, 
however it is known that activation is dependent on the presence of intracellular 
ATP, although hydrolysis is not required as non hydrolysable ATP analogues also 
induced activation of ICL,swell (Jentsch et al., 2002). Various single channel 
conductances have been reported for volume-activated Cl- channels. Small 
conductance VRAC recorded from Ehrlich ascites cells and chord plexus have a 
single channel conductance derived from nonstationary noise analysis of 
macroscopic current of 0.1pS to 8pS. Given the small conductance, it would be 
very difficult to observe conductances due to the activity of this channel type. The 
channel density for a small conductance channel is estimated to be 50,000-
70,000 channels per cell. Intermediate-conductance VRAC channels have been 
observed in glia cells, osteoblasts, ostoclasts, epididymal cells and muscle cells 
showing conductances of 20-90pS. Large conductance channels, 200pS to 400pS, 
have been described in cardiac myocytes, astrocytes and neuroblastoma cells. 
Discrepancies between single-channel conductance levels could be attributed to 
the derivation of conductance values from noise data, or it could be indicative of a 
broad population of VRAC channels. The pharmacology of this channel type is 
indicative of the latter (Jentsch et al., 2002). The channel blockers as 
characterised for voltage-activated Cl- current (DIDs, SITS, 9-AC) have a low 
affinity for volume-activated Cl- currents. The inhibitors for VRAC current vary in 
potency between cell types. This could be attributed to either a variety of 
different channel types or differing mechanisms of volume sensitive activation. 
NPPB, flufenamic acid, niflumic acid, 1-9-d-deoxyforskolin and verapamil induce 
half-maximal block of VRAC at concentrations ranging from the µM range to the 
mM range (Nilius et al., 1996). Despite the electrophysiological characterisation 
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of VRAC, their molecular identification has yet to be determined. Various proteins 
have been proposed as molecular candidates for VRAC; P-glycoprotein (P-gp); 
pICLn (a ubiquitously expressed cytoplasmic protein involved in regulating the 
assembly of the cells RNA splicing machinery (Pesiridis et al., 2009); 
phospholemman, a cardiac sarcolemmal protein (Moorman et al., 1992); CLC-2, 
but have since been dismissed (Suzuki et al., 2006, d'Anglemont de Tassigny et 
al., 2003, Nilius et al., 1996). 
 
P-glycoprotein is a member of the ABC transporter family, as is CFTR. The 
structural and sequence similarities between P-glycoprotein and CFTR prompted 
investigation into P-glcoprotein as a VRAC (Valverde et al., 1992). Despite the 
original finding that P-glycoprotein increased swell-activated Cl- currents, the 
notion of P-glycoportein as a VRAC was discarded as other labs were unable to 
replicate the original findings (Suzuki et al., 2006, Jentsch et al., 2002, De Greef 
et al., 1995). pICLN has been implicated either as a VRAC or one of its regulators 
(Nilius et al., 1996). Hydropathy investigations failed to detect any 
transmembrane domain, however oocytes injected with PICLN mRNA exhibited a 
VRAC current with similar properties of anion selectivity, outward rectification and 
inactivation at positive potentials, to those observed in mammalian cells 
(Paulmichl et al., 1992). The similarities in electrophysiological characteristics led 
suggestion that PICLN was the mammalian channel. This notion was disbanded 
following findings that PICLN was a cytosolic protein, instead it is suggested to be a 
potential regulator of the unidentified channel as monoclonal antibodies raised 
against PICLN blocked hypotonicity activated ICSWELL (Krapivinsky et al., 1994).  
 
Phospholemman (PLM) is a molecular candidate for VRAC (Moorman et al., 1992). 
PLM molecules can form Cl- channels. PLM when expressed in Xenopus oocytes 
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exhibits similar electrophysiological properties to CLC-2, activation by 
hyperpolarisation and low pH with slow gating kinetics. PLM and CLC-2 are 
however structurally different. PLM comprises only one transmembrane segment 
and has only 72 amino acids (Moorman et al., 1992). It is still unresolved as to 
whether this is a molecular candidate for ICL,swell (Nilius et al., 1996). 
4.2.8 Calcium-activated chloride channels 
CaCC are activated by elevations in [Ca2+]i (Jentsch et al., 2002), and are 
expressed in both excitable and non-excitable cell types, such as neurons, cardiac 
and smooth muscle cells, epithelial, endothelial and blood cells (Nilius and 
Droogmans, 2003). They participate in physiological processes, such as neuronal 
excitability, transepithelial transport, oocyte fertilisation (Eggermont, 2004). 
Study of channel properties by investigation of macroscopic current is indicative 
of both small and intermediate conductance Cl- channels. Small conductance 
channels (1-3pS) were identified in cardiac myocytes and smooth muscle cells. 
Common features of CaCCs is that they are activated in a voltage-dependent 
manner by way of elevated [Ca2+]i, although there are two proposed mechanisms 
of Ca2+-induced channel activation between different tissues. Ca2+ may bind 
directly to the channel (observed in vascular endothelial cells and guinea pig 
hepatocytes (Koumi et al., 1994)) or it may activate the channel indirectly by 
phosphorylation of Ca2+/calmodulin-dependent protein kinase as observed in T84 
intestinal epithelial cells owing to the observation that CaCCs have been stably 
activated in excised patch experiments, indicative of direct Ca2+ activation (Koumi 
et al., 1994, Van Renterghem and Lazdunski, 1993). Others have observed 
channel rundown under these circumstances (Hartzell et al., 2005, Wagner et al., 
1991), suggesting either that there is more than one channel isoform, or that 
different regulatory pathways exist (Eggermont, 2004). CaCCs are outwardly 
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rectifying displaying slow activation, >100ms at positive potentials, deactivating 
at negative potentials (Eggermont, 2004). As the kinetics of CaCCs are both Ca2+ 
and voltage-dependent, fast activation occurs in conditions of elevated [Ca2+]i in 
conjunction with strong depolarisation. The permeability sequence of CaCCs is I-
>NO3
->Cl->F->CH3SO4
- (Evans and Marty, 1986). The molecular biology of CaCCs 
is still unresolved, further data is required as CLCA have not been biophysically 
characterised (Eggermont, 2004). Pharmacological inhibitors of CACC are poorly 
selective, limiting the structural and functional characterisation of these channels 
(Eggermont, 2004), although block by DIDs and niflumic acid has been reported 
(Jentsch et al., 2002, Koumi et al., 1994) 
4.2.9 *O\FLQH DQG ǻ-amino butyric acid (GABAA) activated chloride 
channels 
The expression of these channel subtypes was originally believed to be limited to 
the CNS, however glycine and GABA receptors have in recent years been reported 
in both brown and white adipose tissues (Nicolaysen et al., 2007). GABA is a 
neutral amino acid which is released from the GABAergic neurons. GABA and 
glycine are major inhibitory neurotransmitters in mammalian CNS, as they are 
ligands for the GABAA chloride channel and glycine receptor. Within the CNS, 
GABAA and glycine receptor activation results in cellular Cl
- influx with 
hyperpolarisation, which subsequently inhibits neuronal activity as this response 
contributes to the early part of the inhibitory post synaptic potential. GABA also 
binds the GABAB receptors, however this will not be discussed herin as the GABAB 
channel is coupled via G proteins to calcium and potassium channels (Clement, 
1996). Glycine and GABAA receptors belong to the ligand-gated ion channel 
superfamily along with nicotinic acetylcholine receptors, and 5HT3 receptors; 
which exhibit primary sequence homology and conserved structural attributes 
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between members (Jentsch et al., 2002). GABAA receptors are reported to be 
heterooligomeric pentamers cRPSULVLQJĮǃDQGHLWKHUǻ įRUİVXEXQLWV(Farrar 
et al., 1999), arranged around a central pore, with each subunit comprising 4 
transmembrane domains. The N and C terminus are extracellular. Multiple GABAA 
subunits have been cloneG ,Q KXPDQV VL[ Į VXEXQLW aN'D LVRIRUPV KDYH
EHHQ LGHQWLILHG ZLWK WKUHH ǃ VXEXQLWV aN'D DQG WKUHH ǻ VXEXQLWV ZLWK
DGGLWLRQDO į İ SǇ VXEXQLWV :LWKLQ HDFK VXEXQLW FODVV LVRIRUPV VKDUH 
sequence homology, however this falls to 30% between classes. GABAA receptors 
are reported to have varying single channel conductances varying from 12pS, 17-
20pS, 27-30pS (Jentsch et al., 2002, Bormann, 1988) dependent on the 
combination of subunits within the channel. Glycine receptors are also reported to 
have multiple conductance states. Seven single channel conductances have been 
observed; 12pS-14pS; 18pS-23pS; 24pS-36pS; 42pS-49pS; 59-72pS; 80-94pS; 
105pS-112pS, with native glycine receptors and heteromeric receptors having a 
smaller single channel conductance than homomeric receptors (Jentsch et al., 
2002). Glycine and the GABAA show permeability sequence of SCN
->I->Br->Cl->F- 
(Bormann, 1988, Jentsch et al., 2002). The GABA binding site is situated between 
WKH Į DQG ǃ VXEXQLWV 7KH DFWLRQV RI*$%$DUHPRGXODWHGE\ YDULRXV FKHPLFDO
substrates of which there are multiple sites within the GABAA receptor complex 
(Teuber et al., 1999). Drug binding to one site induces a conformational change 
in the GABAA receptor which alters the affinity of the other binding sites to drugs 
of other classes. GABAA is activated by muscimol and inhibited competitively by 
bicuculline and allosterically by benzodiazepines and barbiturates (Bormann, 1988, 
Eldefrawi and Eldefrawi, 1987). GABAA & glycine receptors are targets for a range 
of pharmaceutical drugs such as; antiepileptics (Rigo et al., 2002); anxiolytics 
(Ran et al., 2004); sedatives; hypnotics (Moraga-Cid et al.); muscle relaxants 
(Young et al., 1974).  
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Channel  
Type 
Conductance 
(pS) 
Activated by Pharmacology Gating Permeability Distribution Presence 
in  
Adipocyte? 
References 
CIC-1 1.2 and 2.4 Voltage Inhibited by 9-AC 
(IC50 10.6µM) 
Voltage, 
exhibits 
both fast 
and slow 
gating 
properties 
 Skeletal muscle Maybe (Weinreich and 
Jentsch, 2001) 
CIC-2 2-3 Hyperpolarisation, 
Cell swelling, acidic 
pH 
Inhibited by 1mM 
9-AC, 0.5mM NPPB. 
Cd2+ and Zn2+ 
(IC50) 
Slow gating 
properties 
 Ubiquitous with 
elevated levels 
in the brain 
No (Jentsch et al., 
2002, Furukawa 
et al., 1998, 
Clark et al., 
1998) 
CIC-Ka/ 
CIC-Kb 
     Exclusive to 
kidneys and 
inner ear 
No (Planells-Cases 
and Jentsch, 
2009) 
CIC-3, 
CIC-4 and 
CIC-5 
Unknown Voltages positive to 
+20mv 
   Endosomal 
chloride 
channels 
No (Jentsch et al., 
2005, Gunther et 
al., 2003) 
CIC-6, 
CIC-7 
     Predominant on 
the endosomes/ 
No (Jentsch et al., 
2005) 
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lysosomes 
CFTR 10 Phosphorylation of 
regulatory domain 
and subsequent ATP 
hydrolysis 
   Epithelial lining Maybe (Tabcharani et 
al., 1990) 
VRAC Small =0.1-8 
Intermediate = 
20-90 
Large=200-400 
Increase in cellular 
volume. 
[ATP]i required 
DIDS, SITS, 9-AC. 
Half maximal block 
induced by NPPB, 
verapamil, 
flufenamic and 
niflumic acid 
 SCN->I->Br->Cl-
>F- 
Ehrlich ascites, 
glia, 
osteoblasts, 
osteoclasts, 
epididymal and 
muscle cells. 
No (Jentsch et al., 
2002) 
Ca2+ 
activated 
Cl- 
1-3 Activated in a 
voltage dependent 
manner by [Ca2+]i 
DIDs and niflumic 
acid 
Slow I->NO3
->Cl->F-
>CH3SO4
- 
Excitable and 
non excitable 
cells 
 (Nilius and 
Droogmans, 
2003, Nilius et 
al., 1996, 
Jentsch et al., 
2002) 
GABAA 12 
17-20 
27-30 
GABA and glycine TBPS, bicuculine, 
picrotoxin 
 SCN->I->Br->Cl-
>F- 
Central nervous 
system 
No (Bormann, 1988, 
Jentsch et al., 
2002) 
Table 4.1 A summary of the characteristics of Cl- channels. NPPB, 5-nitro-2-(3-phenylpropylaminobenzoic acid). DPC, diphenylcarbonate. DIDs 4, 4'-
diisothiocyanatostilbene-2, 2'-disulfonic acid. SITS, stilbene isothiocyanate sulfonic acid. TBPS tert-butylbicyclophosphorothionate. 9-AC, 9-Anthracene Carboxylic acid. 
NB the single channel conductance (pS) of chloride channels, is dependent upon the recording conditions ie, Vm, [Cl-]i [Cl
-]o and temperature. 
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4.3 Experimental aims 
In Chapter 2 it was demonstrated that the Cl- ion contributes to the membrane 
potential of both primary adipocyte and differentiated 3T3-L1 adipocytes. As 
such, there is a requirement for the presence of Cl- channels within the plasma 
membrane of both adipocyte models. In this chapter the cell attached 
configuration of the patch clamp technique was used to investigate the presence 
of Cl- channels on the plasma membrane of differentiated 3T3-L1 adipocytes.  
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4.4 Methods  
4.3.1 Characterisation of chloride channels in differentiated 3T3-L1 
adipocytes 
The cell-attached configuration of the patch clamp technique was used to 
measure and investigate single-channel currents in 3T3-L1 adipocytes. 
Differentiated 3T3-L1 cells with a round morphology and a coalesced fat droplet, 
were selected for patching (see Chapter 3, Figure 3.7). Membrane currents were 
measured with the Axopatch 1D patch clamp amplifier (Axon instruments), 
filtered with an 8 pole Bessel filter at 2KHz and digitised at 10kHz prior to 
storage in the pClamp software programme. Currents flowing through the 
membrane patch were recorded at various pipette holding potentials. All 
experiments were performed at 22oC. The membrane potential across the patch 
(Vm) was calculated by subtraction of the pipette holding potential (Vp) from 
resting membrane potential (Putney et al.), Vm=Vr-Vp. The resting membrane 
potential was assumed to be approximately -30mV as measured using the 
perforated patch configuration (See Chapter 3, Section 3.6.2).  
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All procedures for pipette pulling and sylgard coating were as outlined in 
Chapter 3, Section 3.5.4.1. To reduce noise in the recording introduced by the 
patch pipette, thick walled borosilicate capillaries were utilised (GC150F, 
Harvard apparatus). Pipette UHVLVWDQFHV ZHUH W\SLFDOO\ 0 )RU WKH SLSHWWH
solution, a variety of ion-substituted solutions were used, comprising either Cl- 
or gluconate (Yavuz et al.) as the major anion and either Na+ or K+ as the major 
cation. The composition of the pipette solutions are described in Table 4.2. The 
pH of the KCl, NaCl and NaGlu pipette solutions were adjusted to pH 7.4 with 1M 
NaOH.  
Pipette 
solutions 
Composition of the pipette solutions (mM) 
KCl NaCl MgCl2 CaCl2 TES NaGlu Total Cl
- 
KCl 140  1.1 2.6 10  147 
NaCl  140 1.1 2.6 10  147 
NaGlu   1.1 2.6 10 140 7 
Table 4.2. A summary of the composition of all pipette solutions utilised in the single 
channel recording. TES= [N-Tris(hydroxymethyl) methyl-2-aminoethane sulfonic acid. NaGlu= 
Sodium Gluconate. 
4.3.2 Optimisation of single channel recording methods 
HEPES was initially used as a pH buffer, but was later substituted by TES in the 
composition of the pipette solution. HEPES has been reported to block Cl- 
channel conductance in cultured Drosophilia neurons, giving rise to flickering 
and multiple sub-conductance levels (Yamamoto and Suzuki, 1987). HEPES, 
when present on either the intracellular or extracellular side of the membrane at 
10mM concentrations or higher, is also reported to block ion conductance of an 
outwardly-rectifying anion channel in human pancreatic carcinoma epithelial-like 
cells (Hanrahan and Tabcharani, 1990). An example of a single-channel 
recording obtained when HEPES was used as the pipette solution with KCl is 
shown in Figure 4.2. In the recordings descried here, ion channel conductance 
was not observed at every membrane voltage tested. At the membrane 
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potentials where single channel currents were observed, the currents were not 
the typical square shape as expected for unitary single channel current events 
(Armstrong and Hille, 1998). Instead they appeared to have multiple 
conductance levels, and the inconsistency in open/ closed conductance is 
indicative of flickering and therefore suspect open channel block of the Cl- 
channels. 
 
                
Figure 4.2. A single-channel recording of single-channel currents from 3T3-L1 adipocytes 
when HEPES KCl is used as the pipette solution. C shows the absence of channel activity. Each 
solid line represents a 1pA increment in ion channel current. The membrane potential of the cell at 
which currents were recorded are shown on the left-hand side. Vm values were corrected for 
experimental liquid junction potentials during the analysis. Outward currents are shown as 
downward deflections and inward currents are shown as upward deflections.  
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4.3.3 Measurement of liquid junction potentials  
Liquid junction potentials arise wherever two solutions comprising different ion 
activities and concentrations are in contact. The magnitude of the resultant 
junction potential is dependent on the ions that are present in the pipette and 
the bath solutions, in particular the concentration, valency and mobility of the 
ions. In the cell attached configuration, when the recording pipette is first 
inserted into the bath solution, voltage offsets arise as a result of the ions in the 
pipette and bath solutions moving down there concentration gradients. The 
resultant voltage offsets are corrected by the amplifier when the current is 
zeroed in the voltage-clamp configuration. Following gigaseal formation between 
the patch pipette and the cell membrane, the pipette solution is no longer in 
contact with the bath solution. The junction potential disappears, however the 
offset that arises as a result of amplifier compensation is still present. The 
amplifier offset is of equal magnitude to the junction potential, but of opposite 
sign.  
To measure the liquid junction potential for the cell attached configuration, the 
original reference electrode containing 150mM K+ was substituted for one 
containing 3M KCl. K+ and Cl- have similar motilities and as such, the high 
concentration of K+ and Cl- prevent the formation of a liquid junction potential at 
the reference to bath junction. The patch pipette was filled with pipette solution, 
(either KCl, NaCl or NaGlu) and was subsequently submerged in the bath 
containing +DQN¶V solution. The voltage offset that occurred as a result of the 
formation of a liquid junction potential between the pipette and the +DQN¶V 
solution was compensated to zero. Immediately following compensation, the 
bath solution was exchanged and pipette solution perifused in place of the 
+DQN¶V. The resulting offset was measured.  
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Each measurement was repeated 6 times for each of the 3 pipette solutions. The 
3M KCl reference electrode was replaced for a fresh electrode following each 
measurement. The following formula was used to calculate the correct Vm, 
Vm=RMP-(VP+LJP). 
4.3.4 Comparison of experimental and calculated liquid junction 
potentials 
With KCl solution as the pipette solution, single-channel currents were recorded 
in the cell-attached configuration. Currents were recorded at room temperature 
~22oC, at various membrane potentials. Membrane potentials were corrected for 
junction potentials in the analysis See Table 4.3. Junction potentials were 
calculated both experimentally (n=7 for each pipette solution) and using the 
liquid junction potential calculator provided within Clampex. The junction 
potentials for the KCl solution between the experimental and calculated values 
in Clampex were similar. For NaCl and NaGlu, the experimental and 
computerised cell potential values were dissimilar. The calculated potential is 
sensitive to the selection of the single ion activity parameter. This could be a 
source of discrepancy between the calculated and the experimental values. 
Experimentally-derived junction potential values were used for correction of our 
Vm values. 
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Pipette solution 
(major cation/anion 
pairs) 
Junction potentials for the cell attached 
configuration 
 Experimental JPCalc v7 in Clampex 
KCl +2.65 +3.2 
NaCl -2.48 -0.6 
NaGlu +4.59 +10 
Table 4.3. A comparison of experimental and calculated junction potentials for the cell 
attached configuration of the patch clamp technique. For pipette solutions containing the 
various anion/ cation pairs (n=7 for each pipette solution).  
4.4 Data recording and analysis 
Data were collected with the Clampex software, and subsequently analysed 
using pCLAMP. The median amplitudes of the membrane currents observed were 
determined as multiple levels of channel openings were presented. The median 
current-voltage relationships were plotted for each cell-attached patch clamp 
experiment. The conductance was determined from the slope of the current-
voltage plot. The mean ± S.E.M of the channel conductances obtained for each 
pipette solution were compared with the Mann-Whitney test. 
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4.5 Results 
4.5.1 Investigation into the identity of the channels present on the 
membrane surface of the 3T3-L1 adipocyte 
With KCl-rich pipette solution, multiple levels of spontaneous single-channel 
currents were recorded (Figure 4.3). Single channel currents were present at all 
membrane potentials tested (-60mV to +60mV). Channel open and closed times 
were varied and inconsistent. The single-channel current amplitude was also 
varied, this being indicative of either single channel sub states, or conductance 
occurring simultaneously through more than one channel type present in the 
patch of the pipette. Multiple levels of single channel conductance were 
observed when KCl, NaCl or NaGlu were used as the pipette solution (data not 
shown). When the median current-voltage relationship was derived from the 
data in Figure 4.3, as shown in Figure 4.4, data show a channel reversal 
potential of 0mV, with an expected outward chloride current at -30mV. To 
investigate the presence of non selective cation channels in the plasma 
membrane of the white fat adipocyte, single-channel experiments were initially 
carried out with NMGCL. Cell attached patch clamping on 3T3-L1 adipocytes was 
time consuming, as such, due to time constraints, the methodology to 
investigate non selective cation channels was changed, and the perforated patch 
clamp configuration used instead. The results are described, in Chapter 2.  
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Figure 4.3. A representative trace, from a single patch, of single-channel currents 
recorded in 3T3-L1 adipocytes when TES KCl is used as the pipette solution. C shows 
channel closure. Each solid line represents a 1pA increment in ion channel conductance. As such, 
various levels of channel opening, possibly substates, were observed. Channel opening time also 
varied. The membrane potential of the cell at which currents were recorded are shown on the left 
hand side. Vm values were corrected for experimental liquid junction potentials during the analysis. 
Inward currents are shown as downward deflections and outward currents are shown as upward 
deflections. 
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Figure 4.4 The median current voltage relationship derived from the data obtained from 
the single channel recording in Figure 4.3 (in differentiated 3T3-L1 adipocytes with TES 
KCL as the pipette solution). Data points were corrected for LJP and for membrane potential, 
such that the reversal potential for the channel is shown. The reversal potential for the channel is at 
0mV. At the equilibrium potential (Em) of -30mV an outward chloride current would be expected. 
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Figure 4.5. Determination of [Cl-]i for each of the pipette solutions used within this 
investigation. Values were determined on the basis of the reversal occurring at the equilibrium 
potential, as given by the Nernst equation (see Chapter 2, Equation 2.1). All values are corrected for 
liquid junction potentials.  
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The values for [Cl-]i as calculated by the Nernst equation (Figure 4.5) for each of 
the pipette solutions used are in excess of the [Cl-]i reported for a generic cell 
(see Chapter 2, Table 2.1). Additionally the channel type patched within this 
investigation does not reverse at the Cl- reversal potential, see Table 2.1. Both 
observations are in support of a non selective cation channel conductance in 
adipocytes. 
4.5.2 Determination of ion channel conductance 
The slope conductance was determined for the KCl, NaCl and NaGlu pipette 
solutions to identify the ion responsible for the currents observed in the single-
channel traces. The median currents from each single channel patch experiment 
were plotted against holding potentials (Vm had previously been corrected for 
junction potential). The slope conductance was acquired from the plot, and used 
to represent single channel conductaQFHǻ)LJXUH)RUWKH.&OVROXWLRQ
only 7 out of 20 I-V plots were linear; for the NaCl pipette solution, 5 out of 18 
traces were linear and for the NaGlu solution, 3 out of 13 traces were linear. 
Only linear traces (see Figure 4.6) were used in the calculation of slope 
conductance (Table 4.4). The occurrence of non-linear current traces could be 
indicative of rectification or the presence of multiple ion conductances. Further 
analysis with the plotting of all channel conductances obtained at each holding 
potential for each pipette solution failed to show any clustering or trend, and 
was not pursued any further. Channel conductances observed for each pipette 
solution were intermediate, with no difference between them. It is unlikely that 
a single ioQ LV UHVSRQVLEOH IRU WKH FRQGXFWDQFH¶V REVHUYHG$GGLWLRQDOO\ WRDLG
identification of channel types present in 3T3-L1 adipocyte membranes, reversal 
potentials were calculated from each IV plot for each solution tested. No 
clustering or trend was observed (Figure 4.5). No conclusion could be made 
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pertaining to the identity of the channel types present in the plasma membrane 
of 3T3-L1 adipocytes. 
Chloride channels are reported to have multiple levels of ion conductance. To 
ascertain whether the channels present in the membrane patch were chloride 
channels, Cl- was removed from the pipette solution by direct equimolar 
substitution with gluconate. It was hypothesised that if the currents were 
passing through chloride channels, the removal of the Cl- ion would significantly 
reduce the number of channel currents observed. To account for large variance 
of the data and a low experimental number of repeats, conductance measured 
using pipette solutions in which Cl- was the major cation were compared with 
the conductances obtained where Glu- was the major cation using a Mann 
Whitney U test. There was no significant difference between the two sets of 
slope conductance. It is possible that there may be some ion current passing 
through non selective cation channels, which may account for the single channel 
conductance seen when NaGlu was used as a pipette solution. 
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Figure 4.6. A representative graph of showing the median current voltage relationship 
obtained from a single channel current recording from a 3T3-L1 adipocyte, data points 
were corrected for LJP. The pipette used in this recording was filled with KCL solution. In this 
representative graph a single channel conductance of 16.36pS was found. 
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Pipette Solutions 
(major cation/anion pairs)  
Conductance (pS), mean ±SEM  
KCl 18.2±4.6 
NaCl 25.31±4.8 
NaGlu 10.3±4. 
Table 4.4. The slope conductance of the median current voltage relationship obtained 
from each experimental pipette solution (n=3-7). There was no significant difference in 
conductance between any combination of pipette solution used, nor when solutions where chloride 
was the major anion were pooled and compared against NaGlu.  
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Figure 4.7. A plot of single channel conductance Vs reversal potential for all linear single 
channel recordings in all solutions tested. (n=3-7). 
4.5.3 GHK modelling 
Since substitution of [Na+]o for [K
+]o did not have any significant effect on 
adipocyte Vm (See Figure 2.10), this data suggests they permeate across the 
cell membrane via a non selective cation channel. To model this [Na+]i and [K
+]i 
and [Na+]o and [K
+]o were represented as monovalent [M
+]i and [M
+]o 
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respectively, as they cannot be distinguished between in terms of any effect on 
Vm.  
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Equation 4.1 GHK determination of [M+]i. Equaiton A represents the GHK formula for this 
scenario, B is a simplified version of A where YDOXHV RI Į DQG [Cl-]i were determined that would 
predict Vm as obtained from the following [Cl-]o substitution experiment. Į   3Ns/PCl , with PNs 
representing the relative permeability for the non selective cation channel. 
Extracellular conditions of :- 
Decreasing [Cl-]o from 138mM to 5mM [Cl
-]o,
  giving rise to, Vm=0 (see Figure 
2.14) 
Using values of PNS/PCl=0.36, [Cl
-]i was predicted to be 10mM and [Na
+]i + [K
+]i  
(ie [M+]i ) 145mM. However, the median Vm in 5mM [Cl
-]o depolarised to -7mV 
(see Figure 2.14), modelling predicts, to obtain a negative Vm in 5mM [Cl-]o 
that there would need to be a positive ion conductance leaving the adipocyte or 
a ±ve ion conductance entering the cell, as such, the presence of another ion 
permeability was suggested. In the adipocytes that did not depolarise to 0mV it 
is possible that there is a very small background permeability to K+ with a Pk/PCl 
of 0.23, however this is so small that very little change in Vm would occur in 
[Na+]o substitution with [K
+]o. 
 
 
A 
B 
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4.6 Discussion 
To date, adipocyte electrophysiology has not been comprehensively studied. 
There are few reports describing ion channels present on the adipocyte plasma 
membrane or their roles in adipocyte physiology. The majority of 
electrophysiological studies have been conducted in primary tissue explants or 
in differentiated adipocytes from pre-adipocytes. This could be due to the 
difficulty in applying electrophysiological methods to the adipocyte. Primary 
adipocytes are composed predominantly of lipid with only a thin cytoplasm. Seal 
formation within the giga ohm range is difficult because of persistent clogging of 
the pipette tip with lipid. Often due to the fragility of the cells, it is difficult to 
maintain seals upon the adipocyte cytoplasm in an experimental perifusion 
system. Previously, adipocytes were considered to be somewhat inert and not a 
focus of intense study. It is only in recent years that the complex role and 
functions of adipocytes in energy homeostasis have become apparent. See 
Chapter 1, Section 1.3. 
Differentiated 3T3-L1 adipocytes were used for the cell-attached investigations 
due to the observation that the likelihood of seal formation was improved with 
differentiated 3T3-L1 adipocytes. In chapter 2, the two adipocyte models 
exhibited similar electrophysiological responses, as such we can assume in this 
case that the experimental outcomes are transferrable between the 
differentiated 3T3-L1 adipocytes and the primary adipocytes.  
K+ is believed to be the predominant ion that controls Vm for many cell types, 
however it is uncertain as to whether it regulates Vm in adipocytes. The Vm of 
primary and 3T3-L1 adipocytes were measured in this study to be -34.4±1.5mV 
(n=68) and -28.5±1.2mV (n=88), respectively. The Vm values obtained were 
similar to the Vm observations of others. See Chapter 2, Table 2.3. 50mM 
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extracellular K+ failed to depolarise the plasma membrane of primary rat 
adipocytes prompting investigation into the ion species involved in adipocyte Vm. 
Extracellular Cl- removal was shown to depolarise both cell types, indicative of 
Cl- channels on the plasma membrane. 
Single-channel currents were observed in all pipette solutions used, however 
they were not the standard box shape of single channel currents or resembling 
of single-channel traces observed for NSCC or Cl- in brown adipocytes (Sabanov 
and Nedergaard, 1995). The sharp transient openings, originally suspected to be 
caused by HEPES blockade of the channel were not altered upon buffer 
substitution to TES. 
The conductance of the currents observed with NaCl as the pipette solution was 
20.6±4.6pS. This was reduced when Cl- was substituted with aspartate 
10.3±4pS however this was not a significant reduction in conductance, possibly 
as a result of the low number of repeats. Channel events were still occurring 
with a conductance of 10pS, likely to be due to Na+ conductance through NSCC 
channels. The conductances observed when either NaCl or KCl were used were 
similar (Table 4.4). It was suspected that both Cl- and NSCC channel types were 
responsible for the events observed. Open probability was not calculated due to 
the difficulties in discerning the single-channel events between these. Due to the 
large number of replicates needed to compile single-channel data and the 
difficulties in discerning between events of Cl- and NSCC, the perforated patch 
clamp technique was re-visited to investigate the presence of NSCC on white fat 
adipocytes and 3T3-L1 adipocytes. These data are presented in Chapter 2. 
With regard to Cl- channels, there is only one published report of Cl- channels in 
white adipocytes (Inoue et al., 2010), although the recording of Cl- channels in 
these cells have been observed previously within this laboratory (Pulbutr, 2009). 
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An outwardly-rectifying chloride current was identified in mouse adipocytes with 
the whole-cell patch clamp technique. Current was induced following adipocyte 
exposure to a hypotonic challenge, with diminution following return to isotonic 
solution. The Cl- channel was identified as a volume-sensitive outwardly 
rectifying Cl- channel, the basis of the response to hypotonic challenge and the 
significant inhibition of current at positive potentials by glibenclamide. It is 
unlikely that this channel is the same as observed in this study as the 3T3-L1 
adipocytes used here were bathed in isotonic solution. Metabolic changes also 
induce changes in intracellular osmolytes which could lead to regulatory volume 
decrease (RVD) in adipocytes, again it is unlikely this is the case in our 
adipocytes as they were patched in their basal state. 
Anion channels have been more frequently observed in brown adipocytes. 
Initially, ion efflux studies utilising radio-labelled Cl- GHPRQVWUDWHG DQ Į-
adrenoceptor induced (stimulated by 1µM noradrenaline) efflux of Cl- ions 
(Dasso et al., 1990). The characteristics of the channel responsible for this 
efflux were not characterised as it is not possible to ascertain this information 
with ion flux studies. Later, perforated patch clamp investigations by Pappone 
and Lee (1995) identifLHG DQ Į-adrenoceptor stimulated Ca2+ activated Cl- 
current in rat brown adipocytes. It is well documented that stimulation of brown 
adipocytes with noradrenaline results in a triphasic membrane potential 
UHVSRQVH WKH ILUVW SKDVH EHLQJ DQ Į-adrenoceptor stimulated rapid 
depolarisation. All authors to date who report anion channels in brown adipose 
tissue agree that Cl- HIIOX[LVDFDQGLGDWHIRUWKHPHGLDWLRQRIWKHĮDGUHQHUJLF
induced depolarisation observed (Sabanov and Nedergaard, 1995, Pappone and 
Lee, 1995, Bae et al., 1999). The observation that an increased outward Cl- 
permeability induces membrane depolarisation suggests that Cl- is not passively 
distributed across the membrane and is in fact maintained at elevated [Cl-]i 
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concentrations. Equilibrium potential calculations by Dasso (1990), and Pappone 
(1995) indicate that brown adipocytes are capable of maintaining elevated [Cl-]i 
concentrations (Dasso et al., 1990, Pappone and Lee, 1995). 
In addition to the Ca2+ activated Cl- current, a separate volume activated 
chloride current was detected in the same brown adipocytes. It is unlikely that 
either of the channels reported in brown adipocytes are representative of the Cl- 
currents observed in this study as adipocytes were bathed in isotonic solution, 
and the currents observed were spontaneously active whilst the Cl- current 
FRPPRQO\UHSRUWHGLQEURZQDGLSRF\WHVUHTXLUHGĮ-adrenoceptor stimulation. 
Non-selective cation channels have been reported in both brown and white 
adipocytes (Koivisto et al., 1993, Siemen and Reuhl, 1987). Later studies by 
Sherwin identified an ATP activated non-selective cation conductance in white 
primary white fat adipocytes by whole-cell and perforated-patch methods. It 
was suggested that the NSCC conductance would result in cellular depolarisation 
(Lee and Pappone, 1997). This is in agreement with the observations of Ringer 
et al (2000). Ringer et al  UHSRUWHG D ǃ-adrenoceptor activated inward 
Na+ current carried by the NSCC in brown fat, this NSCC is reported to be 
responsible for the 3rd phase depolarisation in the tri-phasic response to 
adrenoceptor stimulation. The inward Na+ current was potentiated in the 
SUHVHQFHRIǃ-adrenoceptor agonists BRL 37344 and BRL 35135A (100nM) and 
as expected was inhibited by insulin (100nM) (Ringer et al., 2000). 
NSCC conductances reported to date in white adipose tissue are ~21pS-28pS 
(Sabanov and Nedergaard, 1995). This is double the suggested putative NSCC 
conductance reported here at 10pS. Ringer et al (2000) suggested that NSCC 
were similar between brown and white adipose cell types, with the physiological 
knowledge of one being transferrable to the other. The NSCC current presented 
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in this chapter appears to be different to those previously reported in brown and 
white adipocytes as channel events were spontaneously active, frequently 
detectable in the cell-attached configuration, and did not require adrenergic 
stimulation.  
It is possible that the currents observed were due to the presence of glutamate 
receptors in adipocytes, these are ligand gated cation channels that pass Na+ 
and K+ in equal proportions giving rise to an equilibrium potential of ~0mV. 
Glutamate receptors are predominantly expressed in the synapse, however their 
presence has been demonstrated in BAT and epididymal WAT by 
immunohistochemistry (Nicolaysen et al., 2007). In addition to its role as an 
excitory neurotransmitter glutamate has also been reported to have an 
important role in cellular energy metabolism, as such the presence of glutamate 
does not necessarily represent a neurotransmitter function. As adipocytes have 
an important role in energy metabolism it is possible that these channels do 
indeed exist in adipocytes. The slope conductance of synaptic non NMDA (N-
methyl-D-aspartate) glutamate receptor channels has been reported to be 
~15pS, additionally these channels have been reported to exhibit a linear 
current-voltage relationship (Traynelis et al., 1993). These characteristics match 
those of the channels observed within this study, as such it is possible that non 
NMDA glutamate receptor channels are present in adipocytes. 
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4.7 Summary 
To summarise, ion channels are present and active on the plasma membrane 
surface of 3T3-L1 adipocytes. The presence of Cl- channels has been shown on 
the basis of the membrane potential effects of Cl- observed in Chapter 2 in 
conjunction with the observed multiple substates when Cl- was present in the 
pipette solution (Figure 4.3). The identities of the Cl- channel (s) present on the 
membrane surface of the 3T3-L1 adipocytes remains unidentified. For CIC 
channel activation there is a requirement for Cl-, as such in the absence of Cl- 
we would expect not to observe Cl- channel conductance. Furthermore VRAC is 
DQ XQOLNHO\ FDQGLGDWH IRU WKH UHJXODWLRQ RI PHPEUDQH SRWHQWLDO 95$&¶V DUH
inhibited by Verapamil. In this study verapamil (20µM) did not cause a 
membrane potential response in our perforated patch clamp experiments in Cl- 
rich solution. See Chapter 2, Figure 2.10. Of the Cl- channels reviewed, we 
suggest CFTR as a candidate for the Cl- conductances observed within this study. 
Both adipose and epithelial cells are derived from the mesoderm. Mesenchymal 
stem cells can be differentiated into either adipocytes (Billon et al., 2008) or 
endothelial cells (Oswald et al., 2004). As the two cell types share the same 
embryological origin, it is possible that CFTR may also be expressed in our 
differentiated 3T3-L1 cells. 
In our cell-attached patch clamp, ion substitution of Cl- for gluconate still gave 
channel activity. The channel type active in NaGlu is unlikely to be a member of 
the CIC channels. There was a reduction in conductance when Cl- was 
substituted for Glu-. Statistics identified this as being not significant, however 
this could be attributed to the low n number. As channel events were still 
occurring when NaGlu- was used as the pipette solution we suggest the presence 
of NSCC on the adipocyte plasma membrane. Extracellular substitution of bath 
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Na+ for NMG- had a significant hyperpolarising effect on membrane potential 
(see Figure 2.19). As the channel observed within this thesis had a reversal 
potential of 0 and a slope conductance of 16pS it is possible that this channel is 
a non NMDA glutamate receptor channel. 
Additionally Nernst estimates of [Cl-]i of ~100mM were 10x in excess of that 
which were predicted by the GHK equation (~10mM). 100mM [Cl-]i is also 
excessively high under the given experimental conditions when compared to 
that which has been reported for any other cell type. 
Further pharmacological and molecular characterisation are required to clarify 
the identity of the Cl- and NSCC channels responsible for the events observed in 
this study.    
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5.1 Summary of Findings 
Currently, Ca2+ influx pathways in adipocytes have not yet been fully 
characterised. An increase in cellular Ca2+ influx by dihydropyridine-sensitive 
Cav1.2/ Cav1.3 VGCCs on the plasma membrane of the adipocyte is suggested 
as being one potential mechanism underlying the induction of the insulin 
resistant state in adipocytes (Draznin et al., 1987b). Adipocytes have a 
prominent role in the maintenance of whole-body energy homeostasis, as such 
disruption of the ability of the adipocyte to maintain energy homeostasis is 
implicated in the onset of peripheral insulin resistance and type II diabetes 
(Antuna-Puente et al., 2008). Ca2+ is an essential and ubiquitous second 
messenger, as discussed in Sections 1.3.1 to 1.3.2, Ca2+ is essential for lipolysis, 
lipogenesis and insulin stimulated glucose uptake, as such it is likely that 
dysregulated [Ca2+]i can have detrimental effects on adipocyte function. 
Additionally, very little is known about adipocyte Vm and the ion FRQGXFWDQFH¶V 
that regulate this. Cav1.2 /Cav1.3 channels are reported to activate upon 
membrane depolarisation, and are reported to deactivate under conditions of 
prolonged depolarisation (Hille, 2001). Other physiological regulators of 
adipocyte function such as adrenoceptor agonists/ antagonists are also 
suggested to regulate adipocyte function via alterations in membrane potential 
(van Mil et al., 1995, Xue et al., 2001), as such it is possible that Vm does play 
an important role in adipocyte function, and possibly influence adipocyte Ca2+ 
homeostasis. Perforated-patch investigations revealed the resting membrane 
potential of white fat adipocytes and differentiated 3T3-L1 adipocytes to be     
~-30mV, a similar value to that already reported by others but using different 
techniques (Perry and Hales, 1969, Ramirez-Ponce et al., 1990, Beigelman and 
Shu, 1972). Elevation of [K+]o did not have a significant effect on adipocyte Vm. 
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In Chapter 2, the ion species involved in the control of adipocyte Vm were found 
to be Cl- and Na+. The identity of the underlying Cl- conductances observed 
remains unknown despite the single-channel investigations presented in Chapter 
4.  
In Chapter 3, [Ca2+]i imaging investigations are suggestive of functional Ca
2+ 
influx pathways on the plasma membrane of adipocytes. Utilisation of known 
voltage-gated calcium channel (VGCC) antagonists nifedipine and verapamil 
were indicative of Cav1.3 having a role in basal Ca
2+ influx. Western blot 
investigations confirmed the presence of WKH Į Vubunit of Cav1.3 in primary 
white fat adipocytes. However, it is unlikely that VGCCs have a role in the 
maintenance of basal [Ca2+]i, asDWVWDEOH9P¶VRIa-30mV VGCCs are likely to 
reside in an inactivated state. Contrary to the observations of others, conditions 
of elevated [K+]o cannot be used in conjunction with known VGCC inhibitors to 
determine the presence of VGCCs on the plasma membrane of adipocytes, since 
these conditions do not have a significant effect on adipocyte Vm. Depolarising 
conditions of Cl- also did not cause any significant elevation in [Ca2+]i. VGCCs 
can activate, with resultant Ca2+ influx at depolarisations up to 0mV. If however 
VGCCs reside in an inactivated state, it is required that the inactivation is 
removed prior to reactivation. Since no further increase in [Ca2+]i was observed 
on decreasing [Cl-]o to 5mM, a condition known to depolarise adipocyte Vm to 
~-7mV, suggests that the Cav1.3 channels are either absent or inactive. 
The reverse mode of the NCX has been previously reported in primary 
adipocytes, especially at the depolariVHG9P¶VRIa-30mV that were measured. 
In support of this idea, the [Ca2+]i imaging data in Chapter 3, Figure 3.16 show 
a small increase in [Ca2+]i following substitution of [Na
+]o for [K
+]o. As such, the 
involvement of the NCX as means of Ca2+ entry was further investigated. [Ca2+]i 
imaging data in conjunction with known pharmacological NCX inhibitors SN-6 
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and KBR-7943 was indicative of the presence of the reverse mode of the NCX as 
a Ca2+ entry pathway. Modelling of [ion]i also suggests that at a [Ca
2+]i of 
~100nM, and an RMP of -30mV that the exchanger would operate in the forward 
mode. The reverse mode would occur as a Ca2+ re-entry pathway following 
[Ca2+]o removal and the subsequent re-addition of [Ca
2+]o. Western blotting was 
carried out to further investigate protein expression of the NCX in adipocytes, 
however this was unable to confirm the presence of the NCX. Due to the 
reported non-specific effects of NCX inhibitors upon other channel types, the 
presence and role of the reverse mode of the NCX in adipocytes remains 
uncertain. To confirm that the elevation of [Ca2+]i observed upon buffer 
substitution for low [Na+]o was due to the activity of the reverse mode of the 
NCX (see Figure 3.16), this protocol should have been repeated with NCX 
inhibitors SN-6 and KBR-7943, however due to time constraints and the 
consistent issues surrounding retention of the Fluo-4 AM dye in adipocytes, this 
could not be repeated.  
Utilising animal knockout modes and molecular techniques, such as SiRNA 
(small interfering RNA) knockdown to inactivate the gene for the NCX, are other 
molecular techniques which may aid the determination of the role of the reverse 
mode of the NCX as a pathway of Ca2+ entry in adipocytes (Jackson and Linsley, 
2010). 
Insulin did not cause a significant affect on [Ca2+]i following 30 minutes of acute 
exposure. It is possible that insulin does not give rise to dysregulated Ca2+ 
influx under the conditions used within this investigation. To further investigate 
the effect of the insulin resistant state upon [Ca2+]i, it would be valuable to 
conduct [Ca2+]i imaging experiments in adipose tissue sourced from insulin 
resistant rats/ human subjects. Within this investigation, re-addition of [Ca2+]o, 
the inhibitory effect of verapamil and KBR-7943 on Ca2+ influx were lost in acute 
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insulin conditions, suggestive of insulin promoting Ca2+ influx via another 
pathway.  
Additionally, investigations within this thesis are suggestive of the presence of 
non-selective cation channels (NSCCs) on the plasma membrane of the 
adipocyte. Substitution of [K+]o for [Na
+]o did not affect adipocyte membrane 
potential, however when [Na+]o was subject to equimolar substitution by NMG-
Cl (a compound which does not permeate NSCCs), membrane hyperpolarisation 
resulted. Addition of 2-APB, a known inhibitor of TRPC and TRPM NSCCs (see 
Table 2.6) (Chapter 2, Figure 2.20) did not have an effect on membrane 
potential, which lessens the likelihood of this channel type being a cation influx 
pathway in adipocytes. NSCCs as a Na+ entry pathway have previously been 
reported in primary white adipocytes (Ringer et al., 2000). Additionally, cellular 
Ca2+ entry via NSCCs have been reported in other cell types (Magoski et al., 
2000), so it is also likely that the NSCCs present in the adipocyte plasma 
membrane are also a source of Ca2+ influx in the white fat adipocyte. Cell 
attached investigations in Chapter 4 revealed channel characteristics that were 
in support of the presence of a NSCC in adipocytes. There was no significant 
difference in channel conductance between pipette solutions containing either 
Na+ or K+. Single channel slope conductances reported within this investigation 
of 16pS are similar to that reported for the non NMDA glutamate receptor 
channel (~15pS). Additionally this channel type passes Na+ and K+ equally, has 
a linear current voltage relationship and a reversal potential of 0. Expression of 
non NMDA glutamate receptor channels is predominantly within the central 
nervous system, however, non NMDA glutamate receptor channels have been 
reported in BAT, and various WAT adipose tissue depots (Nicolaysen, 2007). 
Further pharmacological investigations are required to confirm the identity of 
the NSCCs present on the plasma membrane surface of the white fat adipocyte. 
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Due to the plethora of reported NSCCs and the promiscuous effects of NSCC 
antagonists on other channel types (Pena and Ordaz, 2008), pharmacological 
investigations need to be performed in conjunction with molecular and patch-
clamp methods. Overall as [Ca2+]i has an important role in adipocytes; [Ca
2+]i 
measurements in conjunction with functional measurements of glucose uptake 
or lipolysis are required to study this hypothesis. Due to time constraints, 
functional assays were not performed within this investigation. 
5.2 Does another second messenger act to regulate adipocyte function? 
It is possible that another intracellular messenger acts in conjunction with 
[Ca2+]i to regulate adipocyte function. PIP2 is a possible candidate. It is also 
possible that the altered adipocyte calcium homeostasis occurs secondary or 
tertiary to the effects of insulin. As shown in Chapter 3, there was a reduced 
expression of Cav1.3 on the plasma membrane of adipocytes sourced from 
Zucker obese rats. In insulin resistance, IRS-1 levels and activity are decreased 
(Dresner et al., 1999). IRS-1 is associated with PI3K, which generates the 
complex phosphorylation cascade involving PIP2 and PKC. Additionally, PIP2 is 
present in lower concentrations in animal models of type 2 diabetes (Thore et al., 
2007), with insulin-induced insulin resistant adipocytes exhibiting a decrease in 
plasma membrane PIP2 (Horvath et al., 2008). Cellular levels of PIP2 are 
decreased in insulin resistance induced by chronic insulin-stimulation in 3T3-L1 
cells (Ryan and Hinchcliffee, 2011). The mechanism by which insulin resistance 
decreases PIP2 is yet to be elucidated, although consequences of PIP2 depletion 
have been reported. Depleted PIP2 levels cause partial inhibition of Cav1.2 and 
Cav1.3 channel activity (Roberts-Crowley et al., 2009), and reduced vesicle 
trafficking in exocytotic processes (Thore et al., 2007). It is therefore possible 
that insulin resistance induced reductions in PIP2 leading to reduced trafficking 
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and activity of VGCCs, resulting in reduced VGCC expression in the adipocyte 
plasma membrane and subsequently, reduced Ca2+ influx. Currently, the role of 
PIP2 in Ca
2+ channel trafficking has not fully been clarified. It is known, however, 
WKDW DVVRFLDWLRQ RI 9*&& Į-VXEXQLWV ZLWK GLIIHUHQW ǃ-subunits does affect the 
sensitivity of VGCCs to levels of PIP2 (Roberts-Crowley et al., 2009). PIP2 is also 
implicated in adipokine secretion, with a requirement for PIP2 in the trafficking 
of adiponectin containing secretory vesicles (Bedi et al., 2006). Both PIP2 and 
Ca2+ are required for GLUT4 trafficking, reductions in either or both would give 
rise to reduced insulin-stimulated glucose uptake. Diacylglycerol (DAG) is a 
second product of PIP2 hydrolysis, which together with Ca
2+ activate PKC, and 
certain TRP channel isoforms (Hardie and Muallem, 2009). As PKC is also 
involved in insulin-stimulated glucose uptake (Kahn et al., 2006), it is possible 
that insulin-induced reductions in PIP2 and subsequently lowered [Ca
2+]i levels, 
also act at the level of PKC to reduce insulin-stimulated glucose uptake. PIP2 is 
the precursor to IP3, which regulates store-operated calcium release. It seems 
plausible to suggest that low PIP2 levels would not sufficiently activate store-
operated calcium release, potentially ameliorating insulin-induced stimulation of 
store-operated Ca2+ release as a source of elevated [Ca2+]i, although it has been 
suggested that low levels of cellular PIP2 are sufficient for IP3-induced calcium 
release (Loew, 2007). The role and identities of store-operated Ca2+ channels in 
adipocyte Ca2+ homeostasis requires further investigation. Conversely, elevated 
[Ca2+]i is also associated with a loss of PIP2 (Thore et al., 2007). Thus, it is 
possible that there is a complex interplay between cellular [Ca2+]i and PIP2, with 
alterations in either having the capacity to affect the level of other. 
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5.3 Membrane potential, [Ca2+]i and PIP2 
Secretory cell types, such as pancreatic islet beta cells, conduct their secretory 
processes at positive membrane potentials in response to plasma membrane 
depolarisation. Adipocytes, by comparison, have a relatively-depolarised 
membrane potential and as such it is likely that adipokine secretion from 
adipocytes is constitutive, with the alterations in adipokine secretion following 
insulin resistance attributed to altered cellular levels of PIP2 rather than 
membrane potential. PIP2 is required for adiponectin secretion. Insulin 
resistance results in reduced cellular PIP2 levels, and reduced adiponectin 
secretion, which would result in elevated circulating levels of the insulin 
resistance inducing cytokines TNF-ĮDQG,/(OHYDWHGOHYHOVRI71)-ĮDnd IL-6 
can further contribute to the development of insulin resistance by stimulation of 
adipocyte lipolysis. Exogenous lipids have been shown to inhibit Ca2+ currents of 
ERWK QDWLYH DQG UHFRPELQDQW 9*&&V IURP DOO WKUHH IDPLOLHV RI Į1-subunits 
(Cav1.x ± Cav3.x)(Roberts-Crowley et al., 2009), potentially causing further 
inhibition of Ca2+ influx. 
PIP2 is known to protect against Na
+ dependent inactivation of the NCX when it 
is operating in the forward mode (Ca2+ efflux), although the effects of PIP2 upon 
the reverse mode of the exchanger are unknown. It is likely that the NCX has a 
role in maintaining Ca2+ influx in the white fat adipocyte, although further 
investigation, possibly by way of NCX knockouts or patch-clamping are required 
to confirm this hypothesis. 
5.4 Critique of adipocyte models used within this investigation 
Experiments within this thesis were performed using rat primary adipocytes and 
differentiated 3T3-L1 adipocytes. Primary rat white adipocytes are commonly 
used for biochemical and electrophysiological studies as they are widely 
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available, in comparison to primary human adipose sources. However, species 
variations have been reported between adipocytes of rat and human origin, with 
differences in adipokine secretion and lipolysis. The role of adipocyte-derived 
TNF-ĮLQWKHSDWKRJHQHVLVRILQVXOLn resistance in rodents has been established, 
however this has not been clarified in adipocyte-derived TNF-Į (Ruan et al., 
2002). Also the expression of adipocyte ǃ-adrenoceptors varies between rodents 
DQGKXPDQVZLWKH[SUHVVLRQRIWKHǃ1-adrenoceptor being prominent in humans, 
DQG WKH ǃ3-adrenoceptor predominating in rodents. This is an important 
FRQVLGHUDWLRQIRUIXQFWLRQDOVWXGLHVDVWKHDIILQLW\RIWKHǃ-adrenoceptor agonist 
LVRSUHQDOLQH LV  WLPHV KLJKHU IRU WKH ǃ1-DGUHQRFHSWRU RYHU WKH ǃ3-
DGUHQRFHSWRU VXFK GLIIHUHQFHV LQ ǃ-adrenoceptor expression would affect the 
FHOOXODU UHVSRQVHV RI DGLSRF\WHV WR ǃ-adrenoceptor agonists. As differences 
between human and rodent adipocytes have been noted, it may be more 
appropriate to conduct experiments in human adipocytes (in vitro) or in a 
clinical setting (in vivo), to ensure that findings in rodent adipocyte samples are 
truly transferrable to human adipocytes. However, technical and experimental 
manipulations of primary adipocytes are difficult due to the elevated cellular 
lipid content and thin cytoplasm, particularly in the instance of adipocytes 
sourced from animal models of obesity, or obese/ insulin resistant humans. In 
these instances, adipocytes tend to be enlarged further and are more difficult to 
handle.  
Differentiated 3T3-L1s were also used within this study, their advantages have 
been discussed in Chapter 3. However, there are reported differences in cellular 
physiology between isolated primary adipocytes and clonal cell lines. This was 
not an issue for the perforated patch investigations presented in Chapter 3, as 
electrophysiological responses to experimental manipulations were similar 
between the primary and differentiated 3T3-L1 adipocytes (Yorek et al., 1999), 
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suggestive of a similar mechanism underlying membrane potential for both cell 
types. Another consideration is the use of primary adipocyte cultures (pre-
adipocytes differentiated into mature adipocytes in culture). The advantage of 
primary culture of pre-adipocytes is that it reduces the risk of collagenase 
treatment removing surface proteins. Thus, primary cell culture of adipocytes 
may aid detection of channel proteins expressed at the adipocyte cell membrane 
particularly in Western blot and in patch clamp experiments. Additionally, the 
[Ca2+]i measurements made within this thesis represent the total [Ca
2+]i of the 
adipocyte cytoplasm. If intracellular Ca2+ signal transduction is localised, the 
methods used within this thesis would be unable to detect this in adipocytes. If 
adipocytes were flattened in morphology, then [Ca2+]i imaging techniques would 
be more likely to detect localised [Ca2+]i events. However, confocal [Ca
2+]i 
imaging has been employed in adipocytes and no regional [Ca2+]i hotspots were 
identified (personal communication with Dr P.A Smith). 
In summary, results from the [Ca2+]i measurement studies have revealed the 
presence of VGCCs and the reverse mode of the Na+/Ca2+ exchanger in white 
rat adipocytes, a visual overview is presented in Figure 5.1 .The presence of 
VGCCs in white adipocytes was confirmed in this study, however their 
physiological functions have not been fully elucidated. Further experiments are 
needed to advance the knowledge about the molecular and biophysical 
characteristics of these channel types in white fat adipocytes. The physiological 
roles of these Ca2+ influx pathways in other adipocyte functions, such as insulin-
stimulated glucose uptake and adipokine secretion and lipolysis, require further 
investigation. Furthermore, K+ was found not to affect adipocyte resting 
membrane potential. Although Cl- and Na+ were found to be the ion species 
regulating adipocyte resting membrane potential, the identity of the channel 
types underlying these conductances is also yet to be determined.  
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Figure 5.1. Overview of ion channels present on the adipocyte plasma membrane. A, ion 
channels reported by others in adipocytes (Pershadsingh et al., 1989, Ramirez-Ponce et al., 1990, 
Beigelman and Shu, 1972). B, ion channels identified within this thesis.  
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Appendices 
Macros 
The calibrate Macro 
//calibrate 22Apr2009// 
worksheet -d B%[%h,>'A']; 
%n=C%h; 
%A=%h; 
ncs=wks.ncols; 
nrs=wks.nrows; 
type %h %n $(i) $(ncs); 
//check cells// 
  
 for(i=ncs;i>1;i--){ 
  window -t plot calibrate1 %n; 
  layer -w %A i 1 i nrs 200; 
  getyesno KEEP Y; 
  layer -d; 
  if (y==0){ 
   del wcol(i); 
  }; 
 }; 
//now form average// 
ncs=wks.ncols; 
nct=ncs+1; 
worksheet -c average; 
col(average)[nrs]=0; 
wcol(nct)=0; 
for(i=2;i<=ncs;i++){ 
wcol(nct)=wcol(nct)+wcol(i); 
}; 
//calculate average and plot// 
wcol(nct)=wcol(nct)/(ncs-2); 
wks.col$(nct).label$=$(ncs-1); 
 
%n=%h; 
window -t plot calibrate2 G%nAverage; 
layer -w %n nct 1 nct nrs 200; 
 
k=0; 
getnumber 
(Start) xst 
(End) xen 
(Linear regression) k:2s 
(Regress start) xre 
(Calibration times); 
 layer -d 
The data macro 
 
//calibrate 24Apr2009// 
worksheet -d B%[%h,>'A']; 
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%n=C%h; 
%A=%h; 
ncs=wks.ncols; 
nrs=wks.nrows; 
//type %h %n $(i) $(ncs);// 
 
//check cells// 
 for(i=ncs;i>1;i--){ 
  window -t plot calibrate1 %n; 
  layer -w %A i 1 i nrs 200; 
  getyesno (Use record) Y; 
  layer -d; 
  if (y==0){ 
   del wcol(i); 
  }; 
 }; 
 
//now form average// 
ncs=wks.ncols; 
nct=ncs+1; 
tot=ncs-1; 
worksheet -c average; 
col(average)[nrs]=0; 
wcol(nct)=0; 
for(i=2;i<=ncs;i++){ 
wcol(nct)=wcol(nct)+wcol(i); 
}; 
//calculate average and plot// 
wcol(nct)=wcol(nct)/(ncs-2); 
wks.col$(nct).label$=$(ncs-1); 
 
%n=%h; 
window -t plot calibrate2 G%nAverage; 
layer -w %n nct 1 nct nrs 200; 
 
//get calibration timings// 
k=0;kd=350; 
getnumber 
(Kd Fluo4 in nm) kd 
(Calib Start) xmid 
(Calib End) xen 
(Linear regression) k:2s 
(Regress start) xst 
(Calibration times); 
//type $(xre) $(xst) $(xen);// 
layer-d; 
 
//find min fluo and correct//; 
 loop (n,2,ncs){ 
  limit %(%h,n) -b xmid -e xen; 
  wcol(n)=wcol(n)-limit.ymin; 
 }; 
 
//linear regression and normalization// 
 if (k==1){ 
  loop (n,2,ncs){ 
   lr %(%h,n) -b xst -e xmid; 
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   wcol(nct)=lr.b*wcol(1)+lr.a; 
   wcol(n)=wcol(n)*100/wcol(nct); 
  }; 
 }; 
 
//find max and calculate cal//; 
 xen=xen-120; 
 loop (n,2,ncs){ 
  limit %(%h,n) -b xmid -e xen; 
  ymax=limit.ymax; 
  wcol(nct)=wcol(n)/(ymax-wcol(n)); 
  limit %(%h,n) -b xmst -e xmid; 
  wcol(n)=kd*wcol(nct); 
  ymin=limit.ymin; 
  //type $(n) $(ymax) $(ymin) $(350*ymin/(ymax-ymin));// 
 }; 
//worksheet -s 2 1 ncs nrs;// 
//worksheet -p 200 calibrate1;// 
 
 ncs=wks.ncols-1; 
 nrs=wks.nrows; 
 for(i=ncs;i>1;i--){ 
  worksheet -s i 1 i xmid; 
  worksheet -p 200 calcium1; 
  getyesno KEEP Y; 
  layer -d; 
   if (y==0){ 
    del wcol(i); 
   }; 
  }; 
 
//now form average// 
ncs=wks.ncols-1; 
nct=ncs+1; 
col(average)[nrs]=0; 
wcol(nct)=0; 
for(i=2;i<=ncs;i++){ 
wcol(nct)=wcol(nct)+wcol(i); 
}; 
//calculate average and plot// 
wcol(nct)=wcol(nct)/(ncs-2); 
wks.col$(nct).label$=$(ncs-2); 
 
%n=%h; 
worksheet -s 2 1 ncs xmid; 
worksheet -p 200 calcium1; 
window -r %h G%n; 
 
Sources of the chemicals 
Chemicals obtained from Alomone labs, Israel: Anti-Cav1.2 rabbit primary 
antibody (ACC-003A), Anti-Cav1.3 rabbit primary antibody (ACC-005A).  
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Chemicals obtained from BDH Lab supplies, UK: Glycine, NaCO3, NaH2PO4 
Chemicals obtained from Bio-5DG3UHFLVLRQ3OXV3URWHLQ'XDO&RORXU6WDQGDUGV
(161-0374). 
Chemicals obtained from Fisher Scientific, UK: NaCl, NaOH, Sucrose 
Chemicals obtained from Invitrogen Molecular Probes, USA: Fluo-4 
acetoxymethyl ester (AM) (F14201). 
Chemicals obtained from LI-COR Biosciences Odyssey, USA: Goat anti-rabbit 
(680nM red) secondary 962-68021, Donkey anti-mouse (680nM red) 926-68072, 
Donkey anti-goat (680nM red) 926-68074. 
Chemicals obtained from Sigma, UK: Ammonium persulfate (APS), 
Amphortericin B, Anti-ǃ-actin mouse primary antibody, Bay K 8644, BSA, 
Collagenase type II (C6885), EGTA, Folin reagent, HEPES, Isoprenaline, MgCl2, 
Nifedipne, Poly-D-lysine, Ponceau S solution, Sodium dodecyl sulphate, Tris-
base, Tween® 20, Verapamil 
Chemicals obtained from Tocris, UK: KBR-R7943 
DMSO was used as a diluent for: 2-APB, BayK8644, Fluo-4 AM, KB-R7943, 
nifedipine, verapamil.  
Acetic acid was used as the diluent for insulin stock solution. 
Hanks solution 
Hanks physiological solution containing (in mM): 5.6KCl, 138 NaCl, 1.2 NaH2PO4, 
10 HEPES (N-2-Hydroxyethylpiperazine-1¶-2-ethansulfonic acid), 2.6CaCl2, 
1MgCl2, 4.3NaHCO3., pH 7.4 (NaOH). 
)UHVK+DQN¶VVROXWLRQZDVPDGHGDLO\DQGVXSSOHPHQWHGZLWKP0JOXFRVHDQG
0.01% (w/w) bovine serum albumin (BSA, Sigma catalogue number A3803). 
+DQN¶V%6$ VROXWLRQ ZDV XVHG IRU WKH LVRODWLRQ RI SULPDU\ DGLSRF\WHV WKH
maintence of cell suspensions and as the perifusion medium for the Fluo-4 AM 
[Ca2+]i imaging experiments. For the Ca
2+-free solutions CaCl2 was replaced by 
equimolar substitution with MgCl2 to maintain the concentration of divalent 
FDWLRQVDOWVLQWKH+DQN¶VVROXWLRQ 
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 Chemical composition of the Hanks solutions (mM) 
KCL NaCl MgCl2 CaCl2 HEPES NaHCO3 NaHPO4 
+DQN¶V
solution 
5.6 138 1.2 2.6 10 4.3 1.2 
Isotonic high 
K+ solution 
50 92.6 1.2 2.6 10 4.3 1.2 
Isotonic low 
Na+ solution 
5.6 97.6 1.2 2.6 10 4.3 1.2 
 
Solutions used in western blotting experiments 
5 x TBE buffer contains: 
 27g Tris-base 
 13.75g Boric acid 
 10ml 0.5 M EDTA (pH 8.0) 
 Dissolve all in 500 ml double distilled H2O 
 
Lysis buffer contains: 
 20mM Tris 
 1 mM EGTA  
 320 mM Sucrose 
 0.1% Triton X100 
 1mM NaF 
 10mM Beta glycerolphosphate 
 Dissolve in dH2O, pH7.6 
 
 
Appendices 
318 
 
Lowery A solution 500ml contains: 
 2g NaOH 
 1g SDS 
 10g NaCO3 
 
Lowery B solution contains: 
 1% CuSO4 
 2% NaK Tartate 
 
2X Solubilisation buffer contains: 
 2.5ml 0.5M Tris 
 2.0ml Glycerol 
 2.0ml 10% SDS 
 2.5ml dH2O 
 1.0ml Beta mercaptoethanol 
 40µl 2.5% Bromophenol blue 
 
Electrophoresis buffer (1 Litre) contains: 
 30.3g Tris 
 144g Tris 
 10g SDS 
 
Transfer buffer (2.5 Litres) contains: 
 7.58 
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 36g Glycine 
 2.0L dH2O 
 0.5L Methanol 
Keep in cold room 
 
TBST (0.1% Tween)(10 Litres) contains: 
 30.29g Tris 
 73.12g NaCl 
 Dissolve in 1 Litre dH2O 
Adjust to pH 7.6 
Make up to 10 litres, add 10ml Tween 20 to a final concentration of 0.1% 
Investigation into the presence of non selective cation channels in DRG 
neurons 
To source a positive control and confirm the actions of 2-$3%'5*¶VIURPPDOH
wistar rats were isolated. Cellular isolation and patch clamp methods were 
performed as described by (Sagar et al., 2004). We failed to successfully patch 
DRG neurons, with the predominant difficulty being an inability to successfully 
form seals. Instead calcium imaging with Fluo4-AM was utilised. 
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Figure 1. Investigation into the presence of non selective cation channels in DRG neurons 
by measurement of [Ca2+]i with Fluo 4-AM. Perifusion of 20mM OAG did not cause any 
significant increase in [Ca2+]i OAG in the presence of 100µM 2-APB did significantly increase [Ca
2+]i , 
with [Ca2+]i significantly increasing further following washout of both OAG and 2-APB *P<0.05, 
**P<0.01, ***P<0.001) %RQIHUURQL¶VPXOWLSOHFRPSDULVRQWHVWQ  
OAG was used as an activator of non selective cation channels (Grimaldi et al., 
2003), and 2-APB as an inhibitor of non selective cation channels (Togashi et al., 
2008). Figure 1 shows that perifusion of 20mM (1-oleoyl-2-acetyl-sn-glycerol) 
OAG did not significantly increase [Ca2+]i. Perifusion of 20mM OAG with 100µM 
2-APB caused a significant increase in [Ca2+]i 3 %RQIHUURQL¶V PXOWLSOH
comparison test) which was not reversed following removal of OAG and APB. 
6XEDQDO\VLV VKRZHG WKDW  RI '5*¶V KDG DQ LQFUHDVH LQ >&D2+]i following 
perifusion of 20mM OAG (n=3 out of 13), however this was not significant. Of 
these cells, 2-APB did not reverse the increase in [Ca2+]i. 2-APB caused a 
further increase in [Ca2+]i iQRIDOO'5*¶VWHVWHGRXWRIUHJDUGOHVV
of the nature of response to OAG.  
It was hypothesised that the synthetic diacylglycerol analog, 1-oleoyl-2-acetyle-
sn-glyverol (OAG) would activate TRP channels, this effect being manifest by an 
increase in [Ca2+]i. It was expected this effect would be ameliorated upon 
perifusion of 2-APB in the presence of OAG, with [Ca2+]i levels returning to basal 
following washout of all agents. The observation that 20mM OAG does not cause 
an increase in [Ca2+]i indicDWHV WKDW2$* LVQRW DFWLYDWLQJ753&¶V DVH[SHFWHG
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(Grimaldi et al., 2003), Fig 1. This could be because that there is not a strong 
expression of OAG responsivH 753&¶V LQ WKH '5*¶V ZLWKLQ RXU SUHSDUDWLRQ RU
that the channels are inactive.  
Inside out patch clamp and calcium imaging in CHO-K1 cells expressing either 
TRPC3. 4, 5 and 6 revealed that 100µM OAG activated and stimulated Mn2+ 
influx in cells expressing either TRPC3 or TRPC6 only (Hofmann et al., 1999) but 
not in TRPC1/4/5 expressing cells. Inhibition of TRPC5 channels by OAG has also 
been reported (Okada et al., 1999). 
'5*¶V DUH UHSRUWHG WR H[SUHVV 753& DQG 753& LW LV SRVVLEOH WKDW WKH
inhibitory effect of OAG on TRP5 is masking any Ca2+ influx potentiating that 
may be occurring through TRPC6. Without knowledge of the channel expression 
and function on the membrane surface of the DRGs used in this investigation it 
is only possible to speculate on potential rational for the discrepant OAG effect 
seen. 
With regard to 2-APB, the results presented here are contradictory to the 
original hypothesis. 2-APB is activating Ca2+ influx, possibly by activating 
another channel type, or that there is a strong expression of another channel 
type within our preparation with opposite responses to both agents used here, 
masking any effects that would be apparent in an expression system only 
containing TRPC channels. 
Discrepant effects of 2-APB have previously been reported the suspected 
accountability for which is due to the ability of 2-APB to form dimmers 
(Dobrydneva and Blackmore, 2001) affecting drug binding to the receptor site 
on the channel. The discrepant effects were on the basis of varied levels of 
inhibition between different cell/channel types and experimental models and 
location of drug binding site, as opposed to potentiating a calcium influx signal 
or interaction with other agonists/antagonists. It is possible that 2-APB is 
causing Ca2+ release from stores. 2-APB is reported to inhibit InsP3 induced Ca
2+ 
release (Maruyama et al., 1997), however blockade of Ca2+ release through 
InsP3 by 2-APB is also considered to be inconsistent (Bootman et al., 2002). 2-
APB is not equally potent at inhibiting InsP3-inducd Ca
2+ release within different 
cell types. One suggestion is that InsP3 receptors exist as different isoforms 
(InsP3 1-3), with 2-APB exhibiting varying selectivity for each isoform. 
Increasing InsP3 concentration can eradicate the inhibitory effect of 2-APB, the 
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presence of 1µM of Ins(1,4,5)P3 completely reversed the inhibitory effects of 2-
APB on Ca2+ efflux in rat cerebellar microsomes (Maruyama et al., 1997). As 
such different cell types with differing basal, or capacities to generate 
Ins(1,4,5)P3 are likely to require differing concentrations of 2-APB to observe an 
inhibitory effect on Ca2+ release (Bootman et al., 2002). 
 
 
